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Silylated enol diazoacetates, prepared by the selective O-silylation of 
diazoacetoacetates in the presence of a mild base, are extremely valuable in 
synthesizing noval heterocyclic compounds. The incorporation of a silyl enol unit in 
the α-diazoacetate moiety creates a unique molecule that displays multifaceted 
reactivities under the catalysis of conceptually different catalytic systems.  
Upon catalytic dinitrogen extrusion of silylated enol diazoacetate by dirhodium 
catalysis, the corresponding rhodium bound enol carbene intermediate resembles a 
metallo-1,3-dipolar species and undergoes a formal dearomatizing [3+3]-cycloaddition 
with isoquinolinium/pyridinium methylides that furnishes substituted quinolizidines. 
The development of the catalytic asymmetric variant of this cycloaddition reaction by 
catalysis with the previously unreported chiral dirhodium carboxylate catalyst−Rh2(S-
PTIL)4 has allowed convenient access to highly enantioenriched quinolizidines. 
Coordination of the Lewis basic methylides to dirhodium(II) prompts the 
  
rearrangement of the enol carbene that is bound to dirhodium to produce a 
donor−acceptor cyclopropene which undergoes a diastereoselective [3+2]-
cycloaddition with isoquinolinium/pyridinium methylides. With the overall reaction 
outcome controlled by the amount of catalyst used, an increase in the mol % of catalyst 
loading suppresses the [3+2]-cycloaddition pathway.  
In a reaction that proceeds under mild conditions with remarkable functional 
group tolerance, catalytically generated rhodium enol carbene intermediate reacts with 
nucleophilic silylated ketene imines and produced structurally diverse 3-amino-2-
cyclopentenones bearing a quaternary carbon at the 4-position in high efficiency. The 
key step for the overall transformation emanates from the [3+2]-cycloaddition of 
silylated ketene imine and rhodium enol carbene with the nucleophilic silylated ketene 
imine attacking the vinylogous position of rhodium enol carbene. 
Under Lewis acid catalysis, silylated enol diazoacetates participates in 
diastereoselective [3+2]-cycloaddition reactions with azomethine imines to produce 
highly functionalized β-methylene-β-silyloxy-β-amido-α-diazoacetates. Catalyst-
directed selectivity of competitive 1,2-C→C, -O→C and -N→C migrations from the 
β-methylene-β-silyloxy-β-amido-α-diazoacetates demonstrates that the differential 
selectivities rely on the control of the stereoelectronic property of the catalytically 
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Chapter 1: Competitive Enantioselective [3+3]-Cycloaddition 
and Diastereoselective [3+2]-Cycloaddition of Pyridinium/-
Isoquinolium Ylides with Enol Diazoacetate. 
I. Introduction 
1.1 General Information about Dirhodium(II) Carboxylates and Carboxamidates 
Dirhodium(II) carboxylates and carboxamidates are catalysts noted for their 
ability to catalytically generate rhodium carbene intermediates with diazocompounds 
as well as for the diversity of their structural framework.1-5 Dirhodium(II,II) tetraacetate 
- the first dirhodium compound to have been synthesized - possesses a paddlewheel 
structure with bridging ligands surrounding the dirhodium core and leaving two open 
coordination sites at the axial positions (Figure 1.1).6 Dirhodium(II) carboxylates and 
carboxamidates share this fundamental structural motif, and they are capable of 
decomposing ethyl diazoacetate and generating rhodium carbene intermediate which 
undergoes subsequent group transfer reactions.7,8  
 
























Subsequent developments in diazo chemistry, especially with α-diazocarbonyl 
compounds, have elevated dirhodium carboxylates and carboxamidates to a superior 
position compared with other metal catalysts.9-11 The catalytically generated rhodium 
carbene intermediate, which is highly electrophilic, can react with a variety of 
nucleophiles to furnish products ranging from C-H insertion, cyclopropanation, 




A = R3C, R2N, RO, R3Si, RS
X = H, Alkyl, COR, COOR, CONR2




































Scheme 1.1 Transformations Involving Rhodium Carbene Intermediates (L = 
Carboxylate or Carboxamidate) from Catalytic Dinitrogen Extrusion of 
Diazocompounds. 
 
Although sharing a common structural motif with dirhodium carboxylates, 
dirhodium carboxamidates show more structural diversity.12 Because of the 





dependent upon the placement of nitrogens and oxygens on each rhodium, are viable: 
(2,2-cis), (2,2-trans), (3,1), and (4,0) (Scheme 1.2), but only the (2,2-cis)-isomer is 
formed in synthetically meaningful yields. A mechanistic study aiming at the 
understanding of the ligand exchange process suggests that the strong tendency for the 
formation of the (2,2-cis)-isomer is the result of a stepwise ligand replacement.13  
 
 
Scheme 1.2 Structural Representation and Potential Isomers of Dirhodium(II) 
Carboxamidates. 
 
1.2 General Information for Chiral Dirhodium(II) Carboxylates and Carboxamidate 
and Their Applications in Catalytic Asymmetric Transformations. 
A dominant focus of chemical catalysis today is the enantioselective synthesis 
of chiral compounds, where one enantiomer of the two mirror-image forms is produced 
in a significantly larger quantity.14 One especially intriguing solution to this demand is 
the use of a chiral catalyst, which accelerates the reaction process and transfers its 
chirality to the reaction product(s). Among all the catalytic systems devised so far, a 
few stand out as exceptionally prominent for their high control of enantioselectivity on 
different reactions with board substrate tolerance. This generality of the catalytic 







































practices with well-established catalytic systems. Those catalytic systems that provide 
high enantiocontrol over a wide range of different reactions with broad substrate 
tolerance are referred as “privileged catalysts”.14 The development of chiral dirhodium 
carboxylates and carboxamidates has been one of the frontiers in asymmetric 
catalysis.2,4,12,15 Although various chiral carboxylate and carboxamidate ligands have 
been incorporated into the Rh24+ core,16-19 so far only those chiral dirhodium catalysts 
having chiral amino acid-derived ligands have displayed generally high enantiocontrol 
over different types of reactions;1-4,12,15,20,21 and they are privileged chiral dirhodium(II) 





























Rh2(S-TBSP)4, Ar = p-(t-Bu)C6H4
Rh2(S-DOSP)4, Ar = p-(n-C12H25)C6H4
Rh2(S-PTA)4, R = Me
Rh2(S-PTV)4, R = i-Pr
Rh2(S-PTTL)4, R = t-Bu
Rh2(S-PTAD)4, R = Adamantyl
a








Figure 1.2 Representative examples of privileged chiral dirhodium(II) catalyst. 
aAlthough the synthesis of Rh2(S-PTAD)4 catalyst has been accompolished by Davies, 
it follows the same designing principle that Hashimoto first introduced.  
 
The dirhodium(II) tetrakis[N-phenylsulfonylprolinate] catalyst, which is 





intramolecular C-H insertion reaction (Scheme 1.3). Further development of the 
catalyst by Davies leads to the discovery of Rh2(DOSP)4,1,3,21,22 which has been 
demonstrated to display excellent stereoselectivity for asymmetric reactions involving 
styryldiazoacetates and aryldiazoacetates.23,24 Commercially available (S)- or (R)-
prolines are used to synthesis the bridging ligand of Rh2(DOSP)4. The presence of a 
long alkyl chain grants the catalyst excellent solubility in most organic solvents 
including n-pentane. As a result, this unique feature greatly expands the solvent 
compatibility of Rh2(DOSP)4. Extensive studies have been performed targeting 
understanding of the exceptional stereocontrol achieved with uses of chiral dirhodium 
catalyst.23,25 The chiral prolinate ligands on dirhodium(II) can form a chiral 
environment that governs the alignment of the carbene and the trajectory of the 
incoming nucleophile. The concept of conformational flexibility for the carboxylate 
ligands was first introduced by Hashimoto and co-workers.26 Later on, this explanation 
was used by Davies to rationalize the dramatic solvent effect associated with 
Rh2(DOSP)4 catalytic system.1 The orientation of the bridging ligands results in 
different comformers and each has its unique selectivity and reactivity. The solvent 
effect can be explained by the conformation change of the catalyst in different solvents. 
Although the flexible nature of dirhodium carboxylate catalyst invokes uncertainty of 
modeling as well as predictions of enantiocontrol, their applicability to a wider range 
of diazo compounds for highly stereoselective transformations is strengthened by their 







Scheme 1.3 Dirhodium(II) Tetrakis[N-phenylsulfonylprolinate]-catalyzed 
Intramolecular Asymmetric C-H Insertion. 
 
The unmatched catalytic performance of Rh2(DOSP)4 in asymmetric 
transformations involving donor/acceptor diazo compounds can be exemplified in the 
highly enantioselective C-H insertion reaction.1 Selected examples of this type are 
shown in Scheme 1.4. The particularly challenging enantioselective C-H insertion into 
unactivated sp3-hybridized C-H bond can be rendered in high yield and excellent 
selectivity. Insertion reactions targeting activated C-H bonds such as an allylic or 
ethereal C-H bond, during which there is stabilization of the build-up of partial positive 
charge in the transition state, shows high reactivity and enantioselectivity. An 
immediate application of this asymmetric C-H insertion methodology is the preparation 
of a chiral amino acid ligand that is not available from natural sources.27 For instance, 
the reaction of adamantane with styryl diazoacetate under the catalysis of Rh2(S-
DOSP)4 results in the generation of a chiral ester in high optical purity, which, upon 
further elaboration, leads to the synthesis of Rh2(S-PTAD)4 catalyst (Scheme 1.5). This 
same strategy has been implemented in the synthesis of other chiral dirhodium 



































































Scheme 1.4 Rh2(S-DOSP)4-catalyzed Asymmetric C-H Insertion with 
Aryldiazoacetates and Styryldiazoacetates.   
 
 
Scheme 1.5 Preparation of Rh2(S-PTAD)4 by Asymmetric C-H Insertion of Styryl 




















The establishment and understanding of chiral dirhodium carboxamidate 
catalytic systems is mainly through the efforts of Doyle and coworkers,2,4,8,12,15 who 
visualize that introduction of chiral carboxamidate ligands to the dirhodium core can 
be achieved by ligand exchange reactions in a high boiling-point solvent 
(chlorobenzene) with an acid scavenger (sodium carbonate) in a Soxhlet extractor.31,32 
However, initial trials to screen a broad array of chiral carboxamides suggest that 
acyclic amides were not potent candidates because ligand substitution reactions 
demand the cis-(E)-amide conformation rather than the trans-(Z)-conformation 












Disfavored for ligand exchange
Cis-(E)
Favored for ligand exchange  
Scheme 1.6 Conformation of Amide Influences the Ligand Exchange Reaction. 
 
Subsequent studies demonstrate that cyclic amides are generally applicable to 
ligand exchange under the condition stated above, and the structures are usually 
intended to represent only the (2,2-cis)-isomer (Scheme 1.2).31 The separation of the 
major (2,2-cis)-isomer from the minor (3,1)-isomer can be easily achieved by 
crystallization or using CN-bonded silica gel chromatography.31 Two rhodium atoms 
are connected by a Rh-Rh single bond, and the Lewis basic species such as acetonitrile 
occupies the axial coordination sites to form air-stable red crystalline solids.32 
Following the first report of a chiral dirhodium carboxamidate catalyst - dirhodium(II) 
tetrakis[methyl 2-oxopyrrolidine-5(S)-carboxylate] [Rh2(5S-MEPY)4],7 four types of 





dirhodium core with the chirality of the ligand dictated by the carbon adjacent to the 
nitrogen.4 The ester attached to the chiral center on the pyrrolidinone ring is crucial for 
asymmetric induction in catalytic reactions. The more electron-rich carboxamidate 
ligand compared to carboxylate causes the reactivity of dirhodium carboxamidates to 
be generally lower but more selective towards rhodium carbene formation and 
subsequent reactions.2 For instance, the Rh2(5S-MEPY)4 catalyst is an effective 
catalyst for intramolecular cyclopropanation reactions (Scheme 1.7).15  
 
Scheme 1.7 Intramolecular Enantioselective Cyclopropanation Catalyzed by Rh2(5S-
MEPY)4.  
 
Scheme 1.8 Intramolecular Enantioselective C-H Insertion Catalyzed by Rh2(4S-
MPPIM)4.  
 
Scheme 1.9 Intramolecular Enantioselective Cyclopropanation of Phenyldiazoacetate 












up to 94% ee































The conformational bias exerted by the imidazolidinone ligand of 
Rh2(MPPIM)4 imparts additional steric interaction with rhodium-bonded carbene and 
this catalyst offers superior enantiocontrol for intramolecular C-H insertion reaction 
(Scheme 1.8).34 Incorporation of the strained four-membered azetidinone ligands into 
the dirhodium core elongates the Rh-Rh bond distance, and Rh2(MEAZ)4 has 
significantly higher reactivity than Rh2(MEPY)4 (Scheme 1.9).35 Although the more 
reactive chiral dirhodium(II) carboxylates are useful for certain intramolecular 
reactions, they are most effective for intermolecular C-H insertion reactions of 
aryldiazoacetates and styryldiazoacetates.15 A computational study addressing ligand 
effect on the dirhodium system suggests that electron donation of the ligand to the 
rhodium atom is responsible for the differential selectivity and reactivity between 
dirhodium carboxylate and carboxamidate systems.19 The relatively rigid chiral 
environment of chiral dirhodium(II) carboxamidates is another distinctive feature of 
the dirhodium carboxylate system (Figure 1.3).33 The ester functionality attached to 
the chiral center protrudes from the “walls” of the catalyst and creates an asymmetric 
environment and influences the alignment of the carbene. The approach of a 
nucleophile is impaired from the regions occupied by the carboxylate groups of the 
four ligands (Figure 1.3c). Unlike the Rh2(DOSP)4 catalytic system, a strong solvent 

















Figure 1.3 Dirhodium(II) Tetrakis(methyl 2-oxopyrrolidine-4(R)-carboxylate):  (a) 
and (b) are Common Representations; (c)  X-ray Structure of Rh2(R-MEPY)4 
Bisacetonitrile Complex. 
 
In an effort to expand catalytic applications of chiral dirhodium 
carboxamidates, a major breakthrough has been unveiled when chiral dirhodium(II,II) 
carboxamidates were found out to be capable of catalyzing the hetero-Diels-Alder 
reactions of 1-methoxy-3-trimethylsilyloxy-butadiene (“Danishefsky diene”) and 
aromatic aldehydes in excellent yields and good enantiomeric excesses (Scheme 
1.10).36 Further optimization of the reaction condition reveals that turnover numbers as 
high as 10,000 could be achieved with Rh2(4S-MPPIM)4 in greater than 90% yield and 
more than 95% ee.37           
 






























             Although excellent results have been achieved in the hetero-Diels-Alder 
reaction with chiral dirhodium(II,II) carboxamidates as highly effective chiral Lewis 
catalysts, the scope of the reaction is limited to aromatic aldehydes bearing electron-
withdrawing substituents on the aromatic ring.36,37 One feasible solution to the problem 
is to employ a more electron-rich diene as potential substrate, and this approach has 
been successfully implemented by Hashimoto in the Rh2(S-BPTPI)4-catalyzed the 
hetero-Diels-Alder reactions of various aldehydes with (E)-1-dimethylamino-3-tert-
butyldimethylsiloxy-1,3-butadiene (“Rawal diene”) (Scheme 1.11).38  
An alternative solution is enhancement of the Lewis acidity of the catalyst 
through the formation of cationic dirhodium(II,III) carboxamidates from the 
corresponding dirhodium(II,II) carboxamidates in the presence of a stoichiometric 
amount of nitrosonium salts (Scheme 1.12a).39 The chiral cationic dirhodium(II,III) 
carboxamidates exhibit enhanced Lewis acidity along with better stereocontrol 
(Scheme 1.12b). Encouraged by the remarkable performance of chiral 
dirhodium(II,III) carboxamidates in the catalytic enantioselective hetero-Diels-Alder 
reactions, a series of cationic dirhodium(II,III) carboxamidates have been employed in 
catalyzing the asymmetric 1,3-dipolar cycloaddition of α,β-unsaturated aldehydes with 
nitrones.39 Despite the fact that excellent diastereoselectivity and enantiocontrol could 
be easily achieved, the regioselectivity issue remains unsolved. A recent study of 
solvent effects on dirhodium(II,III) carboxamidate catalytic system shows that 
halogenated solvents such as dichloromethane or chlorobenzene coordinate to the 
electrophilic rhodium center and deactivate the catalyst.40 Reactions carried out in 





reactions performed in halogenated solvents (Scheme 1.13). Overall, the chiral 
dirhodium carboxamidate catalytic system has been demonstrated to be highly effective 
in both metal carbene and Lewis acid catalysis. 
Rh2(S-BPTPI)4
1 mol%




















Scheme 1.11 Hetero-Diels-Alder Reactions Catalyzed by Chiral Dirhodium 
Carboxylate with Rawal Diene. 
          
Scheme 1.12 (a) Formation of Chiral Cationic Dirhodium(II,III) Carboxamidates by 
Oxidation of Nitrosonium Salts. (b) Enhanced Lewis Acidity and Stereocontrol with 











Note: NOSbF6 can be used instead of NOBF4
















When Ar = p-nitro,
With Rh2(5S-MEPY)4, 53% conversion, 73% ee;
With Rh2(5S-MEPY)4BF4, 94% conversion, 94%ee.





































ee of 3,4-endo regioisomer = 21-94%
ee of 3,5-endo regioisomer = 46-71%





ee of 3,4-endo regioisomer = 94-99%
ee of 3,5-endo regioisomer = 52-72%  
Scheme 1.13 Solvent Effect on Dirhodium(II,III) Carboxamidate Catalyzed 
Asymmetric 1,3-Dipolar Cycloaddition Reactions. 
 
Hashimoto and coworkers have developed a catalytic system that combines the 
high reactivity of the dirhodium prolinate system as well as the diversity of the chiral 
dirhodium carboxamidate system.26,38,41-53 The approach for the preparation of the 
ligand can be applicable to a variety of amino acids and the ligand exchange reaction 
with Rh2(OAc)4 is facile and often high yielding. The resulting catalyst is compatible 
with normal silica gel chromatography, and the separation is generally easily. The 
combination of N-protecting group and the R group of the amino acid side chain 
(Figure 1.2) enables the generation of a matrix of chiral dirhodium catalysts, which 
maximizes the tuneability of the chiral environment surrounding the catalytically 
generated rhodium carbene center. More importantly, the substitution on N-phthaloyl 
group with halogens furnishes a more Lewis acidic dirhodium catalyst with 
dramatically enhanced catalytic reactivity and stereoselectivity in several 
transformations (Scheme 1.14).49-51 The benefit for the introduction of halogen atoms 
on the N-phthaloyl group has been verified in the catalytic asymmetric intramolecular 







Scheme 1.14 Enhanced Reactivity and Selectivity by the Introduction of a Halogenated 
N-Phthaloyl Group. 
 
The wide applications of Hashimoto’s catalysts in catalytic asymmetric 
transformations illustrate their effective enantiocontrol and high reactivity.  The low 
catalyst loading often required demonstrates their robustness under the reaction 
conditions. Among all the Hashimoto’ Rh(II)-carboxylate catalysts reported, those 
derived from N-phthaloyl-protected amino acids have emerged as exceptionally 
powerful catalyst for asymmetric synthesis. In this series, the tert-leucine-derived 
complex-dirhodium(II) tetrakis[N-phthaloyl-(S)-tert-leucinate] [Rh2(S-PTTL)4], has 
displayed outstanding catalytic performances in asymmetric reactions, including 
intramolecular C-H insertion,54-56 tandem ylide formation/1,3-dipolar 
cycloaddition,50,57 amination,58,59 cascade ylide formation/2,3-sigmatropic 
rearrangement, cyclopropenation.60 Although the crystal structure of dirhodium(II) 
tetrakis[N-phthaloyl-(S)-phenylalaninate],60 Rh2(S-PTPA)4, indicates that two 

















Rh2(S-PTTL)4: 56% yield, 89% ee















Rh2(S-TFPTTL)4: 5h, 94% yield, 95% ee













Rh2(S-TFPTTL)4: X = F








tetracarboxylate, independent proposals from Fox61,62 and Charette63,64 for the origin of 
enantioselectivity in Rh2(S-PTTL)4-catalyzed asymmetric transformations suggest that 
a “chiral crown” conformation, where all four N-phthalimide groups are located on the 
same face of the catalyst in an α,α,α,α-conformation, is ultimately the structure that 
affords high enantioselectivity. Crystallographic evidence for the chiral crown structure 
in bimetallic paddlewheel complexes has been established in subsequent studies,61 
which includes work on Rh2(S-NTTL)4-catalyzed cyclopropanation65, Rh2(S-
TBPTTL)4-catalyzed cyclopropenation,43 and Rh2(S-NTTL)4-catalyzed electrophilic 
aromatic substitution of indoles.66 Inspection of transition state models involving chiral 
crown catalysts implies that non-covalent ligand-substrate interactions contribute to the 
induction of asymmetry.61,62,66 Examination of the X-ray structure of Rh2(S-PTTL)4 
crystals grown from ethyl acetate (Figure 1.4), reveals that two chiral cavities are 
located on the two faces of the dirhodium catalyst. All four tert-butyl groups are 
oriented on the same face of the catalyst with each C-(t-Bu) bond roughly parallel to 
the central Rh-Rh bond and this unique displacement forms a shallow chiral cavity (~11 
Å in dimension). The alignment of the four phthalimido groups on the opposite face of 
the catalyst generates a wider cavity (~15 Å in dimension). This wide chiral cavity 
constitutes the reactive face and contributes the high level of asymmetric induction. 
Moreover, computational analyses further support that the chiral crown conformation 
has the lowest energy for all conformations that are tested. Consistent with this 








Figure 1.4 The Chiral Crown Conformation Adopted by Rh2(S-PTTL)4. 
 
1.3 General Information for Diazocompounds and Reactivity Profiles of 
Vinyldiazoacetate 
Ethyl diazoacetate can be synthesized by diazotization of glycine, and this 
reaction represents the first report on the preparation of an α-diazocarbonyl 
compound.67 Introduced by Regitz and coworkers,68 the diazo transfer technique, 
which invokes transferring a diazo group from a donor to an acceptor, is now a general 
and exceptionally useful method for the syntheses of various types of diazocarbonyl 
compounds. Sulfonyl azides are the most frequent donors, and a ketone or an ester is 
usually the acceptor. Deprotonation of a carbonyl compound by an appropriate base is 
required to achieve transfer of a diazo group to the α-methylene position. For those 
substrates, which bear two flanking carbonyl groups, the α-methylene protons are 








































instance, the conversion of acetoacetate to diazoacetoacetate occurs smoothly in the 
presence of Et3N at room temperature (Scheme 1.15). The synthesis of 
styryldiazoacetate and phenylacetate can also be accomplished by the standard diazo 
transfer method in the presence of DBU with appropriate precursors (Scheme 1.15).  
 
Scheme 1.15 Representative Examples for the Synthesis of Diazoacetate under Direct 
Diazo Transfer. 
  
Although, diazocarbonyl compounds are in general stable and storable, most 
vinyldiazoacetates are unstable, undergoing a spontaneous [1,5]-cycloaddition to yield 
pyrazoles (Scheme 1.16), therefore they can only be stored only for a short time.5 
Cyclic vinyldiazoacetate and enol diazoacetate in general do not participate in 







































Scheme 1.16 Intramolecular Cyclization of Styryldiazoacetates. 
 
Based on the electronic nature of the substituents bonded to the carbene center, 
the metal carbene intermediate can be broadly categorized into donor/donor, 
donor/acceptor, and acceptor/acceptor metal carbenes (Scheme 1.17).1 Catalytic 
dedinitrogenation of vinyldiazoacetate leads to the formation of a donor/acceptor metal 
carbene that possesses unique reactivity due to the delocalization of the double bond π 
electrons (Scheme 1.18). The resulting vinyl metal carbene intermediate can undergo 
the typical reactions of an electrophilic metal carbene, namely cyclopropanation, 
cyclopropenation, C-H insertion and ylide rearrangement. More importantly, it 
resembles a metallo 1,3-dipole equivalent and participates in cycloaddition reactions 
or engages in addition reactions at the vinylogous position rather than at the carbene 
position.69-74 This unique reactivity profile is due to the extended conjugation of the 
double bond attached to the carbene center (Scheme 1.18). 
 



























Scheme 1.18 Diversified Reactivities of Vinyl Metal Carbenes. 
 
1.4 Donor/Acceptor Cyclopropene Generation from Enol Diazoacetate and Synthetic 
Application of the Donor/Acceptor Cyclopropene 
The generation of donor/acceptor cyclopropenes from enol diazoacetates has 
been reported by Davies and coworkers en route to the study of the 
cyclopropanantion/Cope rearrangement reaction sequence between pyrroles and 
silylated enol diazosulfinate.75 Upon reacting the enol diazosulfinate 31 with Boc-
protected pyrrole, the anticipated [4+3]-cycloaddition product 32 is not observed. 
Instead vinylsulfone 34 is afforded in low reaction yield. A key intermediate proposed 
was the donor/acceptor cyclopropene 33 generated by the enol diazosulfinates (Scheme 































with cyclopentadiene to generate 35, which further rearranges to afford the [3.2.l]-





































Scheme 1.19 Cyclopropene Generation by Catalytic Dinitrogen Extrusion and [4+2]-
Cycloaddition Reaction of Cyclopentadiene and Donor/Acceptor Cyclopropenes. 
 
Since this preliminary report, the synthetic utility of the cyclopropene has been 
largely underappreciated until several recent efforts by Doyle and coworkers to unearth 





an elegant example the use of donor/acceptor cyclopropene as the alkene component 
in a diastereoselective Povarov reaction with imines underscores the high reactivity and 






























Scheme 1.20 Diastereoselective Povarov Reaction of Donor/acceptor Cyclopropene 
and Substituted Imines. 
 
1.5 Cyclopropene as Rhodium Vinylcarbene Precursor 
Dirhodium-catalyzed cyclopropenation reactions of alkynes with a catalytically 
generated rhodium carbene intermediate from diazo compounds have been intensively 
studied, and several chiral dirhodium catalytic systems have been employed to control 
the enantioselectivity of such transformations.8 By comparison to the well-known 
cyclopropenation reactions, the use of substituted cyclopropenes as carbene precursors 
has not been fully explored; and their applications in organic synthesis are still 
primitive.  
Paul Müller has systematically examined the differential catalytic reactivity of 
Rh2(pfb)4 with other transition metal complexes in the rearrangement of 
multisubstituted cyclopropenes (Scheme 1.21).9-11 Although some degree of similarity 
has been discovered for Rh2(pfb)4 and Cu complexes, the drastic differences in most 





and their reaction outcomes are consistent with the formation of a rhodium 
vinylcarbene from substituted cyclopropenes. For instance, treatment of the 
triphenylcyclopropene 37 and 39 with a catalytic amount of Rh2(pfb)4 results in the 
formation of 1,2-diphenylindene 38 or α,β-unsaturated ketone 40 depending on the 
substitution pattern on the cyclopropene ring. Heating the 
diphenylcyclopropenecarboxylate 41 under catalysis by Rh2(pfb)4 in toluene 
presumably generates a vinylcarbene, which forms an oxonium ylide via 
intramolecular addition of the ester carbonyl that rearranges to the final furan product 
42. Rhodium vinylcarbene formation and subsequent 1,2-hydride migration have been 
observed when an alkyl-substituted cyclopropene 43 is employed. Interestingly, a small 
amount of cycloheptatriene product 48 is also isolated accompanied by the anticipated 
C-H insertion product 47, which could be rationalized by the Büchner reaction of the 
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Scheme 1.21 Rhodium Vinylcarbene Formation from Cyclopropene by Rh2(pfb)4 
Catalysis. 
 
Janine Cossy has recognized the unique advantage of using cyclopropenes as 
rhodium vinylcarbene precursor to access to pure donor-type carbenes and has recently 
reported a very useful approach for the diastereoselective construction of multi-
substituted carbocycles and oxygen heterocycles (Scheme 1.22).77,78 





49 with two equivalents of n-BuLi to afford the corresponding lithiated 
dimethylcyclopropene, which subsequently adds to an aliphatic aldehyde. The aliphatic 
chain attachment on the dimethylcyclopropene structure offers an opportunity to study 
the intramolecular C-H insertion reaction of the rhodium vinylcarbene generated from 
the dimethylcyclopropene. The dimethylcyclopropene 50 shows very high reactivity 
towards dirhodium-catalyzed vinylcarbene formation, and the reaction proceeds 
rapidly at room temperature in dichloromethane with only 0.5 mol% Rh2(OAc)4. While 
the reaction outcomes could be complicated by the formation of the two regioisomeric 
vinylcarbene intermediates, reaction seems to proceed exclusively towards the 
formation of the rhodium vinylcarbene 53, which can be schematically understood by 
the initiation of dirhodium catalyst coordination to the less substituted cyclopropene 
carbon. The rhodium vinylcarbene 53 undergoes intramolecular 1,5-C-H insertion with 
moderate diastereoselectivity, and inserts into a sp3-hybridized ethereal C-H bond with 
excellent diastereocontrol. A deuterium labeling experiment suggests that the C-H 
insertion process of the rhodium vinylcarbene proceeds through a concerted 
stereospecific mechanism, and the observed high diastereoselectivity can be interpreted 
from a seven-membered cyclic boat conformation as the transition state with minimal 



























































dr > 95:5, yield 46-99%R = alkyl, aryl







Scheme 1.22 Diastereoselective Construction of Carbocycles and Oxygen 
Heterocycles through Dirhodium-catalyzed Isomerization of Substituted 
Cyclopropenes. 
 
The direct use of the donor/acceptor cyclopropenes as rhodium vinylcarbene 
precursors has not been studied. 
1.6 Examples of [3+3]-Cycloaddition Reactions for Enol Diazoacetate. 
The first example of [3+3]-cycloaddition for enol diazoacetates is reported by 
Doyle and coworkers.79 Activation of enol diazoacetate is achieved by the catalytic 
formation of a rhodium bound enol carbene intermediate. Although two potential 
reaction sites are available for nucleophilic addition reactions, only the vinylogous 





subsequent ring closure and concomitant release of dirhodium catalyst complete the 
catalytic cycle (Scheme 1.23). The reaction can be rendered highly enantioselective 




























Scheme 1.23 Catalytic Asymmetric Synthesis of 3,6-Dihydro-1,2-oxazines by [3+3]-
Cycloaddition of Enol Diazoacetate with Aryl Nitrones. 
 
As an extension for the [3+3]-cycloaddition of nitrones and enol diazoacetate, 
a formal [3+3]-cycloaddition reaction of enol diazoacetate 64 and hydrozone 65 has 
also been accomplished.70 The lone pair of nitrogen on hydrozone attacks the 
vinylogous electrophililc carbon followed by a 1,4-hydrogen transfer to furnish the 
imino enol product 67, which under Lewis acid catalysis undergoes intramolecular 
Mukaiyama-Mannich addition to generate tetrahydropyridazine 68 (Scheme 1.24). 
The unusual reactivity that enol diazoacetates display in the [3+3]-
cycloaddition reactions presents a major impetus for the exploration of enol 















































Scheme 1.24 Construction of Tetrahydropyridazine by Cascade N-H Insertion and 
Intramolecular Mannich Addition. 
 
1.7 Chemistry of Heteroaromatic Ylides. 
The pyridinium/isoquinolium dicyanomethylides 69 and 70 have been 
discovered during the investigation of the reactivity of tetracyanoethylene oxide with 
different nucleophiles.80 Condensation of tetracyanoethylene oxide with excess 
pyridine in THF at 0 °C forms a yellow precipitate which has a composition of 1:1 ratio 
pyridine and dicyanomethylide (Scheme 1.25). The related isoquinolinium 
dicyanomethylide 70 is prepared in a similar way. The pyridinium/isoquinolinium 
dicyanomethylides are immediately recognized as 1,3-dipoles, and they react smoothly 





cycloaddition products, which upon loss of hydrogen cyanide affords indolizidine 71 
and 72 in good yields (Scheme 1.26). Since this initial discovery, a few reports studying 
the cycloaddition reaction of pyridinium/isoquinolium methylides with different 
dienophiles have emerged.81-83 In an interesting example, diphenylcyclopropenones 
engage in the [3+2]-cycloaddition with pyridinium dicyanomethylides (Scheme 
1.27).84 The resulting indolizidine undergoes ring expansion reaction to generate the 





































Scheme 1.26 1,3-Dipolar Cycloaddition Reaction of Pyridinium/Isoquinolium 

























Scheme 1.27 [3+2]-Cycloaddition of Pyridinium Dicyanomethylide and 
Diphenylcyclopropenone. 
 
Pyridinium/isoquinolium dicarbomethoxymethylides are isolable and are stable 
solids.85 They can be prepared as stable ylides from phenyliodonium ylides under 
dirhodium catalysis (Scheme 1.28). Although they have also been shown to undergo 
[3+2]-cycloaddition reaction with dienophiles, they are significantly less reactive than 
are the corresponding dicyanomethylides.85 Ylides stabilized with only one electron-
withdrawing group can only be generated in situ by the deprotonation of an 
isoquinolium bromide precursor.86 The methylide is highly reactive toward dipolar 
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1.8 Research goal 
Quinolizidines are isolated from myriad sources in nature, and they display 
diverse biological activities.87-91 Among nitrogen-containing heterocyclic compounds, 
substituted quinolizidine alkaloids are exceptionally prominent,87 and some of them are 
lead compounds for the development of anticancer, anti-inflammatory, and 
cardiovascular drugs.88-91 Despite longstanding biological and synthetic interest in 
quinolizidines, methodologies for the synthesis of these valuable compounds have been 
limited. Asymmetric approaches to these systems have relied on either using reactants 
from the chiral pool,88-91 introducing chirality through the use of chiral auxiliaries,92,93 
or catalytic enantioselective approaches.94-97 However, catalytic methods have been 
limited as well, and rhodium-catalyzed asymmetric [2+2+2]-cycloadditions of 
isocyanates,94 catalytic asymmetric formal aza-hetero-Diels-Alder reactions95,96 and 
one report of an organocatalytic enantioselective dearomatization of N-alkyl 












































Scheme 1.30 Reaction Pathways to Enantioselective Syntheses of Substituted 
Quinolizidines.  
 
Although aromatic frameworks are capable of participating in reactions as 
electrophiles98-104 or nucleophiles,105-108 the development of catalytic asymmetric 
transformations directly engaging the aromatic π system has been achieved only 
recently.109 Catalytically generated metal carbene intermediates79 have been shown to 
react with aromatic and heteroaromatic rings and furnish products ranging from 
electrophilic aromatic substitution (Friedel-Crafts reaction),110 cyclopropanation and 
the subsequent Cope rearrangement (Büchner reaction),110 and stable ylide-forming 
reactions.111 In these transformations, the electrophilic nature of metal carbenes 
dominates. Since the catalytically generated chiral dirhodium carbene intermediates 
from enoldiazoacetates can be visualized as chiral metallo-1,3-dipole equivalents with 
their vinylogous position electrophilic and their metal carbene center nucleophilic, the 
formal [3+3]-cycloaddition strategy could be extended to stable and readily available 
isoquinolinium/pyridinium methylides with asymmetry introduced in the ring-closing 





variant of this cycloaddition reaction would offer direct access to enantioenriched 
highly substituted quinolizidines that are amendable to further functionalization.113,114 
Meanwhile, the donor/acceptor cyclopropene generated from enol diazoacetate could 
potentially undergo [3+2]-cycloaddition reaction with pyridinium/isoquinolium 
methylides, which will be in direct competition with the [3+2]-cycloaddition if both 
reaction pathways have comparable reaction rates. The exploration of these two 
competing reactions will provide fundamental mechanistic insights into rhodium 



































Scheme 1.31 Formal Enantioselective [3+3]-Cycloaddition of Metallo-1,3-dipoles 
with Isoquinolinium/Pyridinium Methylides 
 
II. Results and Discussions 
2.1 Results 
Optimization of reaction conditions aimed at maximizing the efficiency and 
selectivities for [3+3]-cycloaddition was initiated between isoquinolinium 





adding a solution of enol diazoacetate 59a to a mixture of partially soluble 
isoquinolinium dicyanomethylide 70a and the dirhodium catalyst, reactions occurred 
at room temperature (Table 1.1). When conducting the title reaction (eq 1) with excess 
59a in the presence of 1.0 mol% Rh2(Oct)4, complete consumption of the 
dicyanomethylide 70a was achieved after 3 h. Two products were obtained as a 2:1 
mixture in high isolated yield, and their structures were determined by spectroscopic 
analysis to be those from the anticipated (Scheme 1.31) [3+3]-cycloaddition (78a) and 
an unexpected diastereoselective [3+2]-cycloaddition of 70a with the donor-acceptor 
cyclopropene formed from 59a by catalytic dinitrogen extrusion reaction (79a).75,115,116 
Use of Rh2(S-DOSP)41,3,23,24 as the catalyst formed 78a and 79a in a 1:4.2 product ratio 
(entry 2), but enantioselectivity for 78a was very poor and for 79a was not evident. 
Switching to Hashimoto’s Rh2(S-PTA)4 catalyst117-119 resulted in a significant increase 
in enantioselectivity for the [3+3]-cycloaddition product 78a (entry 3). The alkyl group 
of the Hashimoto’s dirhodium catalysts impacted the enantiomeric excess for 78a 
(entries 3-6), and optimal enantioselectivity for 78a was achieved with previously 
unreported Rh2(S-PTIL)4 whose ligand incorporates an additional chiral center. 
Lowering the reaction temperature to 0°C slightly enhanced both the chemo- and 
enantioselectivity for 79a but with low reaction yield (entry 7); and alternatively 
performing the reaction at 60°C provided only inferior selectivities (entry 8). Use of the 
more Lewis acidic Rh2(S-TCPTTL)4,44-46,50,51,54,56-58 however, reversed 
chemoselectivity with [3+2]-cycloaddition product 79a as the sole reaction outcome 
(entry 9), and this reversal in chemoselectivity was mirrored in results from the use of 





Table 1.1 Optimization of Reaction Conditions for Enantioselective Formal [3+3]-























Rh2(S-PTA)4: Alkyl = Me, X = H
Rh2(S-PTV)4: Alkyl = i-Pr, X = H
Rh2(S-PTTL)4: Alkyl = t-Bu, X = H























entrya catalyst (y mol%) 78a:79ab,c yield 
(%)d 
ee (%) of 
78ae 
1 Rh2(Oct)4 (1.0 mol%) 2.0:1 85 — 
2 Rh2(S-DOSP)4 (1.0 mol%) 1:4.2 83 –20 
3 Rh2(S-PTA)4 (1.0 mol%) 3.7:1 81 49 
4 Rh2(S-PTV)4 (1.0 mol%) 1:1.7 79 90 
5 Rh2(S-PTTL)4 (1.0 mol%) 10:1 69 89 
6 Rh2(S-PTIL)4 (1.0 mol%) 1.6:1 83 93 
7f Rh2(S-PTIL)4 (1.0 mol%) 1.9:1 49 94 
8g Rh2(S-PTIL)4 (1.0 mol%) 1:2.1 70 90 
9h Rh2(S-TCPTTL)4(1.0 mol%) 1:>20 49 nd 
10h Rh2(tfa)4 (1.0 mol%) 1:>20 71 — 
11 Rh2(S-PTIL)4(0.5 mol%) 1:1.5 69 93 
12 Rh2(S-PTIL)4(1.5 mol%) 4.3:1 82 93 
13 Rh2(S-PTIL)4 (2.0 mol%) 15:1 85 93 
14 Rh2(S-PTIL)4 (2.5 mol%) >20:1 89 93 





16 Rh2(S-PTV)4 (3.0 mol%) >20:1 88 90 
aReactions were performed at room temperature with 0.1 mmol of 70a (1.0 equiv). An 
excess of 59a (1.8 equiv) in 1.0 mL toluene was added to the reaction mixture via 
syringe pump over 1 h with continued stirring for another 2 h. bRatios were determined 
by 1H NMR analysis of reaction mixtures. Duplicate reactions show remarkable 
consistency in the 78a:79a ratio. cThe stereochemistry of 79a was determined by 1H 
NOE experiments. dYields reported are combined isolated yields of 78a and 79a. 
eEnantiomeric excesses were determined by chiral HPLC analysis. fReaction performed 
at 0°C. gReaction performed at 60°C. hReaction was continued for 23 h after the 
completion of adding 59a. 
 
Surprisingly, catalyst loading has a pronounced effect on chemoselectivity 
(78a:79a). For instance, reactions catalyzed by 0.5 mol% (entry 11) and 1.0 mol% 
(entry 6) of Rh2(S-PTIL)4 at room temperature showed low selectivity for the formation 
of the [3+3]-cycloaddition product 78a, and only a slight increase in the 78a:79a ratio 
occurred when the temperature was lowered to 0°C. However, significant increases in 
the ratio were observed with incremental increases in mol % catalyst so that at 2.0 
mol% catalyst the ratio was 15.4±0.4 (entry 13), and a further increase in catalyst 
loading to 2.5 then to 3.0 mol% led to the formation of 78a as the sole reaction product 
[entries 14, 15 and 16 with Rh2(S-PTV)4]. The excellent enantiomeric excesses 
obtained for 78a were not at all affected by catalyst loading, which suggested that the 
formation of 78a and 79a are independent. The [3+2]-cycloaddition product 79a was 
only obtained as a racemate.  
The reaction solvent strongly influenced both chemoselectivity and 
enantioselectivity. As is evident from the results reported in Table 1.2, reactions 
performed in chlorinated hydrocarbons (entries 1-4) gave significantly lower product 
control (78a:79a) and enantioselectivities for [3+3]-cycloaddition; aromatic solvents 





when chlorobenzene was used as solvent (entry 4). Toluene stood out as the optimal 
choice (entry 8). 
Table 1.2 Solvent Screening for the Enantioselective Catalytic Formal [3+3]-



























entrya solvent yield (%)b 78a:79ac ee(%) of 78ad 
1 CH2Cl2 71 2.4:1 72 
2 (CH2Cl)2 59 4.8:1 80 
3 CHCl3 65 1.2:1 88 
4 PhCl 79 1.6:1 90 
5 o-xylene 77 >20:1 91 
6 p-xylene 80 >20:1 80 
7 PhF 74 >20:1 90 
8 toluene 90 >20:1 93 
aReactions were performed on 0.1 mmol of 59a (1.0 equiv), and an excess of 70a (1.8 
equiv) in 1.0 mL solvent was added to the reaction mixture via syringe pump over 1 h, 
and then reaction was continued with stirring for 2 h. bRatios were determined by 1H 
NMR analysis of reaction mixtures. cReported yields are combined isolated yields of 
78a and 79a. dEnantiomeric excesses were determined by chiral HPLC analysis.  
The substrate scope of the enantioselective [3+3]-cycloaddition reaction was 
examined using the optimal conditions obtained with 70a and 59a (Table 1.1 entry 15), 
and these results are presented in Table 1.3. Product yields and enantioselectivities 
appear to be independent of the ester substituent of enol diazoacetate 59a (entries 1 and 
2). The absolute configuration of 78b, and others in this series by analogy, was 
unambiguously determined to be S through X-ray single crystal analysis (Figure 1.5). 
Enol diazoacetate 59c with a methyl group instead of hydrogen attached at the 





diastereocontrol (entry 3). Electronically disparate substituents on the isoquinolinium 
ring are well tolerated (entries 4-7); consistently high reaction yields and high 
enantiomeric excesses were achieved. Furthermore, the more challenging120 
pyridinium dicyanomethylides (entries 8-10) participated in the [3+3]-cycloaddition 
transformation providing high yields and high enantiomeric excesses of quinolizidines 
that were comparable to those from the isoquinolinium systems. Interestingly, only a 
single regioisomer was obtained for 3-picolinium dicyanomethylide 78i, although there 
were two potential reaction sites (entry 9), and the product obtained was the one from 
addition to the less sterically encumbered 6-position rather than to the 2-position. 
































entrya   78:79b yield (%)c ee (%)d 
1 78a 
 
>20:1 90 93 
2 78b 
 



















>20:1 78 82 
4 78d 
 
>20:1 81 96 
5 78e 
 
>20:1 73 94 
6 78f 
 
>20:1 85 96 
7 78g 
 
1.7:1 63 95 
8 78h 
 
>20:1 85 87 
9 78i 
 
>20:1 88 86 
10 78j 
 






























































>20:1 40 52 
aReactions were performed with 0.1 mmol of 70 (1.0 equiv) and an excess of 59 (1.8 
equiv) in 1.0 mL toluene was added to the reaction mixture over 1 h, and then reacted 
for another 2 h. bRatios were determined by 1H NMR analyses of reaction mixtures. 
cYields reported are combined isolated yields of 78 and 79. dEnantiomeric excesses 
were determined by HPLC analyses on a chiral stationary phase. eThe stereochemistry 
of 78c was determined by 1H NOE experiments. fReaction performed at 60 °C. 
 
Figure 1.5 ORTEP View of Benzyl (S)-2-(tert-Butyldimethylsilyl)oxy-4,4-dicyano-
4,11b-dihydro-3H-pyrido-[2,1-a]isoquinoline-1-carboxylate (78b). Ellipsoids are 
Shown at 30% Probability. CCDC 946885 Contains Supplementary Crystallographic 
Data for 78b. 
 
In contrast to the corresponding isoquinolium dicyanomethylides (70a, EWG = 
CN), the dicarbomethoxy isoquinolinium methylide (74b, EWG = COOMe) was much 
less reactive towards dirhodium-catalyzed reaction with enol diazoacetate 59a; 











3 h reaction time. However, at 60°C over the same time period the reaction reached full 
consumption of 74b, and 78k was isolated in moderate yield although with significantly 
lower enantiomeric excess (Table 1.3, entry 11) than from reaction with the 
corresponding dicyanomethylide 70a. Overall, the dearomatizing [3+3]-cycloaddition 
methodology represents a general approach for the catalytic asymmetric 
functionalization of the dicyanomethylides of isoquinoline and pyridine. Although the 
dicarbomethoxy isoquinolinium methylide 74b was much less reactive than 70a, other 
heterocyclic ylides86,121-125 may have enhanced reactivity and selectivity for these 
cycloaddition reactions. 
2.2 Discussions 
To probe the influence from alternate substituents (R4) to the OTBS group on 
the vinyl group of 59, combinations of vinyl diazoacetates 59 and methylide 70a were 
subjected to Rh2(Oct)4 catalysis. Although such determinations have been conducted 
to compare product yields for individual transformations,126 competitive reactions with 
59 have not been reported. Whereas the reaction of 59a (R4 = OTBS) with 70a gave a 
mixture of 78a and 79a (Table 1.1 entry 1); with R4 = Ph the Rh2(Oct)4-catalyzed 
reaction afforded only the [3+2]-cycloaddition product 79b (eq 1.4) and 
vinyldiazoacetate 59d (R4 = H) gave exclusive formation of the [3+3]-cycloaddition 
product 78l. Similar to reaction outcomes with varying catalyst and reaction solvent, 
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The results from these experiments show a gradation in reactivity of the 
intermediate metal carbene towards either intermolecular [3+3]-cycloaddition with 
methylide 70 to form 78 or isomerization to afford donor-acceptor cyclopropene 8015 
that is susceptible to [3+2]-cycloaddition with 70a. Since only racemic product was 
obtained with the diverse array of chiral catalysts that was employed (Table 1.1), the 
diastereoselective [3+2]-cycloaddition of 80 and 70a can be regarded to be a catalyst-
free process. In sharp contrast, the high enantiocontrol in the [3+3]-cycloaddition 
process demonstrates its direct dependence on the dirhodium catalyst. In a separate 
experiment, treating the preformed and catalyst-free cyclopropene 80a with 
isoquinolinium dicyanomethylide 70a produced the [3+2]-cycloaddition product 79a 
















80a was added in one portion  
However, the mechanistic explanation in which the metal carbene formed from 
dirhodium carboxylate and the enol diazoacetate either reacts with methylide 70 to 
produce the product from [3+3]-cycloaddition or dissociates the bound carbene with 





not explain the dramatic increase in the ratio of 78:79 with increasing mol % of catalyst 
loading (Table 1.1, entry 4,6, 11-16). The formation of both 78 and 79 have the same 
catalyst dependence in this scheme; both emanate from the metal carbene intermediate, 
and product formation for both involves reaction with methylide 70. Thus dependence 
of catalyst on product distribution suggests a more complex role for dirhodium in these 



























Scheme 1.32 Formation of Both [3+3]- and [3+2]-Cycloaddition Products are 
Dependent on Metal Carbene Intermediate 81. 
 
The coordination of the dirhodium carboxylate with an isoquinolinium 
methylide was assessed in toluene at room temperature. Unlike most of the methylides 
used in this study, 5-(tert-butyldimethylsilyloxy)isoquinolium dicyanomethylide 70e 
displayed good solubility in most common organic solvents, and this feature enabled 
us to accurately determine the first coordination constant (K1) of 70e and Rh2(S-PTIL)4. 





intense color change of Rh2(S-PTIL)4 from light green to deep red when they were 
mixed. A plot of the spectrum of the Rh2(S-PTIL)4-containing solution as function of 
increasing amounts of methylide 70e with minimal change in volume (Figure 1.6) 
shows a clear isosbestic point at 684 nm. The equilibrium constant for association 
between Rh2(S-PTIL)4 and dicyanomethylides 70e was determined to be 545±14 by the 
methodology that we have previously employed,127 which is a binding affinity 
comparable to that of the same dirhodium compound and acetonitrile (K1 = 155±2). 
Although coordination to rhodium through either the methanide carbon center of 70 or 
through one of its nitrile nitrogens is possible, association through the nitrile nitrogen 
offers the lesser steric resistance.  
 
Rh2(S-PTIL)4









Figure 1.6 UV-Vis Titration Curves and Equilibrium Constant K1 for Complex 
Formation Between 70e and Rh2(S-PTIL)4 in Toluene at Room Temperature. [Rh2(S-
PTIL)4] = 2.0 x 10-3 M; 0.17 equiv of 70e [Relative to Rh2(S-PTIL)4] was Added in 
Each Increment. K1 = 545 ± 14. 
 
Pioneering work by Drago128-130 established that Lewis base coordination with 
Lewis acidic dirhodium carboxylates occurs at the axial positions to form 1:1 and 2:1 
adducts with acetonitrile and with pyridine, and that the second coordination constant 
K2 was at least two to three orders of magnitude lower than K1 (Scheme 1.33). From 
this and a vast array of related investigations of the equilibrium processes of dirhodium 
carboxylates, the influence of one coordinated ligand on the association of a second 
ligand clearly established an inhibition for association;131-135 but attempts to displace 
bound carbenes136-138 or demonstrate the influence of axial ligands on catalytic 
reactivity or selectivity139,140 have not been successful. 
 
 
Scheme 1.33 Lewis Bases Occupy Axial Coordination Sites on Dirhodium Complexes. 
 
In a recent attempt to determine if a bound ligand could influence a catalytic 
reaction, Padwa and coworkers synthesized a stable dirhodium carbene complex 

































unique reactivity or selectivity in cycloaddition or insertion reactions from 
diazocarbonyl compounds for this complex were unsuccessful. Identical catalytic 
reactivities and selectivities were obtained with the parent dirhodium catalyst, and the 
authors concluded that the ligated dirhodium carbene complex underwent dissociation 
of carbene ligand to release the active dirhodium catalyst (Scheme 1.34) that then 
underwent the catalytic metal carbene reactions. In contrast to this SN1-like role for an 
axial carbene ligand, could the dependence of catalyst on product distribution in 
reactions of 70 with 59 be influenced by 70 as an axial ligand?  
 
Scheme 1.34 Stable Carbene on Dirhodium Undergoes Dissociation Prior to Reaction 
of Dirhodium with the Diazocarbonyl Compounds. 
 
Recognizing that the catalyst in the reaction solution is in equilibrium with 
methylide 70, addition of enol diazoacetate 59 could associate with the methylide-
coordinated dirhodium catalyst or the catalyst that is free of 70. The equilibrium 
constant for association between 70e and Rh2(S-PTIL)4 gives evidence of a complex, 
which is highly unlikely to associate the weakly coordinating diazo compound 59. 
Instead, coordination with the catalyst that is free of methylide is most likely, and with 
dinitrogen extrusion this complex forms the metal carbene intermediate (Scheme 1.35). 
However, previous reports of the catalytic formation of donor-acceptor cyclopropenes 










































8081 82  
Scheme 1.35 Reaction Pathway for the Formation of Cyclopropene 80. 
 
Two possible pathways exist for the displacement of the rhodium-bound 
carbene of 81 as cyclopropene 80. One is the SN1-like pathway that was demonstrated 
for the dirhodium carbene complex between an Arduengo carbene and dirhodium 
pivalate (Scheme 1.35). However, in this case increasing the mol% of catalyst could 
not have influenced the ratio of [3+3]- to [3+2]-cycloaddition products, as has been 
explained (Scheme 1.32). However, if methylide 70 serves to induce formation of 
cyclopropene 80 in a through dirhodium SN2ʹ-like displacement reaction, the effect of 
increased dirhodium catalyst concentration will be to increase the concentration of 81 
and thereby increase the rate for formation of [3+3]-cycloaddition product 78 relative 
to that of [3+2]-cycloaddition product 79 whose formation occurs subsequent to the 
formation of 5. There are several lines of evidence that support this interpretation:  (1) 
If the Lewis basic methylide 70 does assist the generation of cyclopropene 80 with 
concomitant release of a Lewis acid-base complex (Scheme 1.32), this effect should 
be more pronounced in reactions catalyzed by more Lewis acidic dirhodium 
compounds (higher Keq, lower concentration of ligand-free catalyst). As predicted, the 





reaction when Rh2(S-TCPTTL)4 (Table 1.1, entry 9) or Rh2(tfa)4 (Table 1.1, entry 10) 
is used. (2) External Lewis base additives decrease the catalyst concentration and 
increase the production of cyclopropene 80, thereby decreasing chemoselectivity for 
[3+3]-cycloaddition obtained from the reaction catalyzed by 3 mol% Rh2(S-PTIL)4 
(Scheme 1.32). As anticipated, more of the [3+2]-cycloaddition product 79 is formed 
in reactions where CH3CN or the more strongly coordinating Lewis base (Et3N or 
pyridine) is present. That these additives do not influence the [3+3]-cycloaddition 
pathway is indicated by the observation that enantiomeric excesses of 78 are not 
influenced by the presence of CH3CN. Use of the stronger σ-donors - Et3N or pyridine 

























>95% (93% ee) 
              none (90% yield) 
                           
<5%  
90% (93% ee) 
              
3 equiv MeCN 
 
(69% yield) 
             
10%  
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5 equiv MeCN 
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16%  
<5% (ee nd) 
                 
1 equiv Et3N (13% yield) 
               
>95%  
<5% (ee nd) 
                 
1 equiv pyridine (<5% yield) 










Although the enantioselective [3+3]-cycloaddition and the diastereoselective 
[3+2]-cycloaddition reactions are linked through the intermediate rhodium carbene 81, 
they are separated by the divergent outcomes from actions of methylide 70 on 81. Lewis 
base additives do not participate in the enantioselective [3+3]-cycloaddition but they 
do induce rearrangement of rhodium carbene to generate cyclopropene 80. Indeed, it is 
possible that the influence of at least some of the chlorinated solvents on reaction 
selectivity may arise from Lewis base displacement of cyclopropene 80 from the 
dirhodium carbene 81.28 However, when the bulky nitriles 78 or 79 were used as 
additives in the catalytic reactions, minimal impact on the product distribution was 











































































0.5 equiv as additive: 78e:79e




1 equiv 1.8 equiv
1 equiv 1.8 equiv
 
Scheme 1.37 Both [3+3]-Cycloaddition and [3+2]-Cycloaddition Product 78 and 79 






Although the uncatalyzed reaction of methylide 70 with donor-acceptor 
cyclopropene 80a, formed by catalytic dinitrogen extrusion from enol diazoacetate 59a, 
underwent [3+2]-cycloaddition exclusively, and this process adequately accounts for 
the formation of 79, the effect of increasing mol% catalyst on the relative yield of 
[3+3]-cycloaddition product 78 (Table 1.1) coupled with the Lewis base promoted 
cyclopropene formation (Schemes 1.33 and 1.34) suggested that the role of the 
cyclopropene intermediate is more complex than what has been portrayed. Could 
cyclopropene 80a form metal carbene 81a in what would be a reversal of the reaction 
that formed 80a? Although there is no precedent for such an interchange, 
cyclopropenes are known to be stoichiometric precursors to metal carbenes in selected 
cases.141-143 Only recently, however, have reports emerged of catalytic reactions of 
cyclopropenes in metal carbene transformations.9-11,144,145 
To test this hypothesis we replaced enoldiazoacetate 59a in eq 1 with 
cyclopropene 80a, generated with rhodium(II) acetate but separated from the catalyst, 
and performed reactions in the presence of variable mol% of Rh2(S-PTIL)4 under 
otherwise identical conditions. As anticipated, high enantiocontrol for the formation of 
the [3+3]-cycloaddition product 78 was achieved; and this transformation and its 
enantioselectivity demonstrated the direct involvement of the chiral catalyst in the 
bond-forming steps. Chemoselectivities (78:79) directly correlated with the mol% of 
Rh2(S-PTIL)4 used, and the enantioselective [3+3]-cycloaddition product 78 was 
obtained with greater than 95% selectivity when the catalyst loading was increased to 





enantioselectivity of 78 and chemoselectivity for 78:79, were identical, independent of 
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Scheme 1.38 Dependence of Product Distribution on Catalyst Loading with 
Cyclopropene 80a as the Metal Carbene Precursor.  
 
   Considering the interconversion between the enol-TBS substituted chiral 
dirhodium carbene 81 and the donor-acceptor cyclopropene 80, the relationship 
between the amount of catalyst and the ratio of products from [3+3]- and [3+2]-
cycloaddition reactions now resembles the experimental observation (Scheme 1.38). If 
the interconversion between (80 + Rh2L4) and 81 is rapid relative to cycloadditions, the 
ratio 78:79 is directly related to the concentration of catalyst (Scheme 1.39). However 
a plot of the ratio 78:79 versus mol% Rh2(S-PTIL)4 suggests a more complex 


























Scheme 1.39 Relationship Between the Cycloaddition Product Ratio (78:79) and the 
Dirhodium Catalyst. 
 
Taking these findings into account, we now have a more complete rationale for 
the events that occur during the highly enantioselective dearomatizing [3+3]-
cycloaddition reaction of enol diazoacetates and isoquinolinium or pyridinium 
methylides (Scheme 1.40). The central outcome is stereoselective cycloaddition that 
results from the vinylogous reaction of enol-TBS substituted chiral dirhodium carbene 
81 with isoquinolinium or pyridinium methylides that is accompanied by ring closure 
to cycloaddition product 78 with displacement of the chiral catalyst. In competition 
with this process the enol-TBS-substituted dirhodium carbene 81 forms donor-acceptor 
cyclopropene 80 that is proposed to occur by a through-rhodium-rhodium bond 
displacement by a Lewis base that includes isoquinolinium or pyridinium methylides. 
The dirhodium catalyst is in equilibrium with reactant isoquinolinium or pyridinium 
methylides that has the effect of lowering the turnover rate for [3+3]-cycloaddition. 
The decreased amount of catalyst allows direct [3+2]-cycloaddition of the donor-
acceptor cyclopropene with isoquinolinium or pyridinium methylides to form 79. As 





for product formation, so also does cyclopropene 80 which undergoes either [3+2]-
cycloaddition with 70 or forms dirhodium carbene 81. The net result is that the catalyst 






































Scheme 1.40 Detailed General Mechanism for the Competing [3+3]- and [3+2]-
Cycloaddition Reactions. 
 
The new processes uncovered in this study – SN2ʹ induced formation of donor-
acceptor cyclopropene 80 and its equilibrium with the axial ligand-free dirhodium 
catalyst - are fundamental to understanding metal carbene reaction chemistry. The 
dirhodium carbene derived from enol diazoacetate 59 is uniquely capable of 
rearrangement to cyclopropene 80 with release of the dirhodium catalyst, and this 
reaction occurs in competition with vinylogous addition. Isoquinolinium and 
pyridinium methylides are relatively strong Lewis bases compared to acetonitrile which 
is a much stronger Lewis base than the reactant diazo compound, and their Lewis 





addition to the enol-TBS substituted dirhodium carbene 81, and displacement of 
cyclopropene 80 from the enol-TBS substituted dirhodium carbene 81. The further 
implications of these processes are under investigation. 
 
III. Conclusion 
  In summary, we have disclosed a highly enantioselective dearomatizing [3+3]-
cycloaddition reaction. A [3+2]-cycloaddition of isoquinolinium or pyridinium 
methylides with the cyclopropene derived from rhodium carbene competes with the 
[3+3]-cycloaddition reaction but can be turned on or off with a higher mol% of catalyst 
or increasing amount of Lewis base.  Investigations of these systems not only revealed 
a highly enantioselective dearomatizing formal [3+3]-cycloaddition transformation of 
isoquinolinium/pyridinium methylides with enol diazacetates catalyzed by chiral 
dirhodium carboxylates in up to 96% ee, but they provided evidence for competitive 
coordination-induced displacement of the dirhodium-bound enol-carbene as a donor-
acceptor cyclopropene that either reforms the enol-carbene of dirhodium or undergos 
[3+2]-cycloaddition to form densely functionalized indolizidines with complete 
regioselectivity and diastereoselectivity.  
IV. Experimental section 
4.1 General Information 
Experiments involving moisture- and/or air-sensitive components were 
performed in flame-dried glassware under a nitrogen atmosphere using freshly distilled 
solvents. Solvents including toluene, p-xylene, o-xylene, chlorobenzene, 





under nitrogen atmosphere and distilled prior to use. Commercial reagents and 
chromatography solvents (hexanes and ethyl acetate) were used without further 
purification. Thin layer chromatography (TLC) was carried out using EM Science silica 
gel 60 F254 plates. Chromatograms were analyzed by UV lamp (254 nm) or by 
development using cerium ammonium molybdate (CAM). Liquid chromatography was 
performed using a forced flow (flash chromatography) of the indicated system on silica 
gel (230-400 mesh). Proton nuclear magnetic resonance spectra (1H NMR) were 
recorded on a Bruker AMX 400 spectrophotometer (in CDCl3 or DMSO-d6 as solvent). 
Chemical shifts for 1H NMR spectra are reported as δ in units of parts per million (ppm) 
downfield from SiMe4 (δ = 0.00) and relative to the signal of chloroform-d (δ = 7.26, 
singlet) or DMSO-d6 (δ = 2.50, pentet). Multiplicities were given as: s (singlet); d 
(doublet); t (triplet); q (quartet); p (pentet); dd (doublet of doublets); ddd (doublet of 
doublet of doublets); dddd (doublet of doublet of doublet of doublets); dt (doublet of 
triplets); m (multiplet), and comp (composite). The number of protons (n) for a given 
resonance is indicated by nH. Coupling constants are reported as a J  value in Hz. 
Carbon nuclear magnetic resonance spectra (13C NMR) are reported in δ units of parts 
per million (ppm) downfield from SiMe4 (δ = 0.0) and relative to the central singlet 
from the signal of chloroform-d (δ = 77.0, triplet) or DMSO-d6 (δ = 39.5, septet). High-
resolution mass spectra (HRMS) were obtained on a JEOL AccuTOF-ESI mass 
spectrometer using CsI as the standard. Enantioselectivity was determined on an 
Agilent 1200 Series HPLC using a Daicel Chiralpak column. Optical rotation was 





589 nm; concentration is denoted as c and was calculated as grams per deciliters 
(g/100mL). 
Isoquinolinium dicyanomethylides 70,80 pyridinium dicyanomethylides 6980 
and isoquinolinium diester methylides 7489 were synthesized according to literature 
procedures. Enol diazoacetate 59a-c146, 147 and vinyldiazoacetates 59d-e240 were 
prepared by known methods. N-phthaloyl-(S,S)-iso-leucine was synthesized by 
literature method.118 Rh2(S-DOSP)4 was purchased from Strem Chemicals, Inc. Rh2(S-
PTA)4, Rh2(S-PTV)4, Rh2(S-PTTL)4, Rh2(S-TCPTTL)4 and Rh2(S-PTIL)4 were 
prepared by established methods.41, 117, 118 
4.2 Experimental Procedures 
Sample Procedure for the Preparation of Isoquinolinium/Pyridinium 
Dicyanomethylides. To a THF solution (2.0 mL) of 4-bromoisoquinoline (416 mg, 2.0 
mmol) cooled to 0°C, tetracyanoethylene oxide (298 mg, 2.1 mmol) dissolved in 2.0 
mL THF was added dropwise over 10 min. The reaction solution was stirred at o °C 
for 12 h during which time a yellow precipitate formed. After warming to room 
temperature, the reaction mixture was diluted with diethyl ether (10 mL), and the 
precipitate was filtered and washed with diethyl ether (5.0 mL). The resulting yellow 
solid was collected then dissolved in CH2Cl2. Celite (3.0 g) was added to the solution 
and then solvent was removed under reduced pressure. The solid residue was loaded 
onto a silica gel column (with CH2Cl2 and ethyl acetate as eluents) to isolate 4-
bromoisoquinolinium dicyanomethylide 70b (234 mg, 0.86 mmol, 43% yield). 
Preparation of Dirhodium(II) Tetrakis[N-Phthaloyl-(S,S)-iso-leucinate] 





single-necked, round-bottomed flask equipped with a magnetic stirring bar, Rh2(OAc)4 
(221 mg, 0.50 mmol), N-phthaloyl-(S,S)-iso-leucine (653 mg, 2.50 mmol) and 
chlorobenzene (25 mL) were added sequentially under a nitrogen pressure. The flask 
was fitted with a 10-mL Soxhlet extraction apparatus into which was placed a thimble 
containing 5 g of an oven-dried mixture of 2 parts sodium carbonate and 1 part of sand. 
The mixture was heated to reflux for 3 h and then cooled to room temperature. Solvent 
was removed under reduced pressure, and the residue was dissolved in ethyl acetate 
(30 mL). The resulting solution was washed with saturated aqueous NaHCO3 (2×20 
mL) and brine (20 mL) and then dried over anhydrous Na2SO4. Filtration and 
subsequent solvent removal under reduced pressure furnished a green solid that was 
purified by column chromatography on silica gel (hexanes/EtOAc). The resulting green 
solid was dissolved in 5 mL ethyl acetate and 50 mL hexanes was then added to the 
solution. Green solids that formed after standing overnight at room temperature were 
collected by filtration, washed with hexanes (2×5 mL) and dried under high vacuum 
(0.1 Torr) at room temperature for 3 h to provide dirhodium(II) tetrakis[N-phthaloyl-
(S,S)-iso-leucinate] bis(ethyl acetate) adduct [Rh2(S-PTIL)4(EtOAc)2] (590 mg, 0.42 
mmol, 83% yield).  
Sample Procedure for the Enantioselective [3+3]-Cycloaddition of 
Isoquinolinium/Pyridinium Methylides (70) and Enol Diazoacetate (59). To a 10-
mL flame-dried Schlenk flask containing a magnetic stirring bar, [Rh2(S-
PTIL)4(EtOAc)2] (4.2 mg, 0.0030 mmol), isoquinolinium dicyanomethylide 70a (20 
mg, 0.10 mmol) and 1.0 mL of toluene were added sequentially under a nitrogen 





was stirred at room temperature for 5 min before methyl 3-(tert-
butyldimethylsilyl)oxy-2-diazobut-3-enoate 59a (46 mg, 0.18 mmol) dissolved in 1.0 
mL of toluene was added via syringe pump over 1 h. Stirring was continued at room 
temperature for 2 h after the completion of adding 59a. Then the reaction solution was 
concentrated under reduced pressure and directly loaded onto a silica gel column (with 
CH2Cl2 as eluent) to isolate methyl (S)-2-(tert-butyldimethylsilyl)oxy-4,4-dicyano-
4,11b-dihydro-3H-pyrido[2,1-a]isoquinoline-1-carboxylate 78a (38 mg, 0.090 mmol, 
90% yield). HPLC analysis of the enantioselective [3+3]-cycloaddition product 78a on 
chiral stationary phase indicated an enantiomeric excess of 93% [Chiralpak OD-H; 
flow: 1 mL/min; hexanes/i-PrOH: 95:5; 254 nm; tR (minor) = 5.5 min; tR (major) = 
6.2 min]. 
Sample Procedure for the Enantioselective [3+3]-Cycloaddition of 
Isoquinolinium/Pyridinium Methylides (70/69) and Enol Diazoacetate (59) in the 
Presence of a Lewis Base. To a 10-mL flame-dried Schlenk flask containing a 
magnetic stirring bar, [Rh2(S-PTIL)4(EtOAc)2] (4.2 mg, 0.0030 mmol), isoquinolinium 
dicyanomethylide 70a (20 mg, 0.10 mmol), 1.0 mL of toluene and CH3CN (12 mg, 
0.30 mmol) were added sequentially under a nitrogen atmosphere. Then the flask was 
capped by a rubber septum and the resulting solution was stirred at room temperature 
for 5 min before methyl 3-(tert-butyldimethylsilyl)oxy-2-diazobut-3-enoate 59a (46 
mg, 0.18 mmol) dissolved in 1.0 mL of toluene was added via syringe pump over 1 h. 
Stirring was continued at room temperature for 2 h after the completion of adding 59a. 
Then the reaction solution was concentrated under reduced pressure. The residue was 





the solution was directly loaded onto a silica gel column (with 1:1 of CH2Cl2:hexanes 
as eluents) to isolate methyl (S)-2-(tert-butyldimethylsilyl)oxy-4,4-dicyano-4,11b-
dihydro-3H-pyrido[2,1-a]isoquinoline-1-carboxylate 78a (26 mg, 0.062 mmol, 62% 
yield). HPLC analysis of 78a on chiral stationary phase showed an enantiomeric excess 
of 93%. 
Procedure for the Generation of Methyl 2-(tert-Butyldimethylsilyl)oxy-
cycloprop-1-enecarboxylate (80a) in Toluene from Enol Diazoacetate (59a) by 
Rh2(OAc)4-catalyzed Dinitrogen Extrusion Reaction. To a flame-dried vial 
equipped with a magnetic stirring bar, Rh2(OAc)4 (0.9 mg, 0.0020 mmol) and 0.75 mL 
toluene were added sequentially under a nitrogen atmosphere and then capped with a 
rubber septum. The solution was stirred at room temperature while methyl 3-(tert-
butyldimethylsilyl)oxy-2-diazobut-3-enoate 59a (46 mg, 0.18 mmol) was added 
dropwise over 1 min. Rapid evolution of nitrogen occurred, and the yellow color of 59a 
disappeared within 5 min. Complete consumption of enol diazoacetate 59a and the 
generation of donor-acceptor cyclopropene 80a were verified by 1H NMR spectroscopy 
by the disappearance of the two vinyl protons [δ (ppm): 5.02 (d, J = 2.1 Hz, 1H), 4.27 
(d, J = 2.1 Hz, 1H)] on enol diazoacetate 59 and the appearance of the methylene 
protons [δ (ppm): 1.88 (s, 2H)] from cyclopropene 80a. The solution was filtered 
through a short pad (~1 cm) of BAKERBOND-CN silica (40 μm Prep LC packing) to 
remove the dirhodium catalyst and the silica pad was washed with 0.25 ml toluene. The 
combined filtrates containing methyl 2-(tert-butyldimethylsilyl)oxy-cycloprop-1-





Sample Procedure for the Diastereoselective [3+2]-Cycloaddition of 
Isoquinolinium/Pyridinium Methylides (69/70) and cyclopropene 80. To the 
prepared toluene solution of methyl 2-(tert-butyldimethylsilyl)oxy-cycloprop-1-
enecarboxylate 80a at room temperature, isoquinolinium dicyanomethylide 70a (20 
mg, 0.10 mmol) was added as a solid under a nitrogen atmosphere. The resulting 
suspension was stirred at room temperature for 3 h during which time the mixture 
gradually became a homogeneous solution. The solution was then concentrated under 
reduced pressure and directly loaded onto a silica gel column (with 1:1 of 
CH2Cl2:hexanes as eluents) to isolate methyl (8aSR,9aSR,9bSR)-8a-(tert-
butyldimethylsilyl)oxy-8,8-dicyano-8a,9,9a,9b-tetrahydro-8H-
cyclopropa[3,4]pyrrolo[2,1-a]isoquinoline-9a-carboxylate 79a (32 mg, 0.076 mmol, 
76% yield). 
Sample Procedure for the Enantioselective [3+3]-Cycloaddition of 
Isoquinolinium/Pyridinium Methylides (69/70) and cyclopropene 80. To a 10-mL 
flame-dried Schlenk flask containing a magnetic stirring bar, [Rh2(S-PTIL)4(EtOAc)2] 
(2.8 mg, 0.0020 mmol), isoquinolinium dicyanomethylide 70a (20 mg, 0.10 mmol) and 
1.0 mL of toluene were added sequentially under a nitrogen atmosphere. Then the flask 
was capped by a rubber septum and the resulting solution was stirred at room 
temperature. The prepared toluene solution of methyl 2-(tert-butyldimethylsilyl)oxy-
cycloprop-1-enecarboxylate 80a was added to the stirring mixture of [Rh2(S-
PTIL)4(EtOAc)2] and isoquinoline dicyanomethylide 70a over 1 h via syringe pump. 
Stirring was continued at room temperature for 2 h after the completion of adding 80a. 





onto a silica gel column (with 1:1 of CH2Cl2:hexanes as eluents) to isolate methyl (S)-
2-(tert-butyldimethylsilyl)oxy-4,4-dicyano-4,11b-dihydro-3H-pyrido[2,1-
a]isoquinoline-1-carboxylate 78a (32mg, 0.075 mmol, 75% yield). HPLC analysis of 
the enantioselective [3+3]-cycloaddition product 78a on chiral stationary phase showed 
an enantiomeric excess of 93%. 
Coordination Constant (K1) Determination for Rh2(S-PTIL)4 and 70e or 
CH3CN by UV-Vis Titration. Rh2(S-PTIL)4(EtOAc)2 was heated at 110 °C under high 
vacuum (0.1 Torr) for 3 h before storage inside an argon-atmosphere glove box, and 
the complete removal of axial EtOAc ligands was verified by 1H NMR analysis through 
the disappearance of the peaks belong to EtOAc. A glass cell (1.0 cm path length) from 
Starna Cells, Inc., with screw top was used. Rh2(S-PTIL)4 (7.5 mg, 0.06 mmol) with no 
axial EtOAc was weighed into the glass cell inside the glovebox, and toluene (3.0 mL) 
was added into the glass cell. The glass was sealed inside the glove box and was then 
taken out into air. A toluene solution of 70e or CH3CN (2.0 ×10-1 M) was prepared in 
a similar way. Absorption measurements were performed on a Carey 50 Bio UV-vis 
spectrometer in air. Prior to addition of the ligand solution, the UV-vis (500-800 nm) 
spectrum of Rh2(S-PTIL)4 was recorded. Then 5.0 μL of the ligand solution was added 
to the cell using a 10.0 μL syringe. The cell was inverted twice to ensure thorough 
mixing before the UV-vis spectrum was recorded at 20 °C. Fifteen additional aliquots 
(5.0 μL each) of the ligand solution were sequentially added to the cell over 20 min, 
and the total change in volume was less than 3%. Upon sequential addition of the ligand 





The UV-vis spectrum was recorded after the addition of each aliquot. Association 













Control Experiment using Cycloadditon Product 78 or 79 as Lewis Base 
Additive: Sample Procedure for the Enantioselective [3+3]-Cycloaddition of 
Isoquinolinium/Pyridinium Methylides (69/70) and Enol Diazoacetate 59 in the 
Presence of [3+3]-Cycloaddition Product 78 or [3+2]-Cycloaddition Product 79. 
In a 10 mL flame-dried Schlenk flask charged with a magnetic stirring bar, Rh2(S-
PTIL)4 (4.2 mg, 0.0030 mmol, 3 mol%), isoquinolinium dicyanomethylide 70a (20 mg, 
0.10 mmol), [3+3]-cycloaddition product 78g (28 mg, 0.050 mmol) and 1.0 ml dry 
toluene were added sequentially under a nitrogen atmosphere. Then the flask was 
capped by a rubber septum and the resulting solution was stirred at room temperature 
for 5 min before enol diazoacetate 59a (46 mg, 0.18 mmol) dissolved in 1.0 ml toluene 


































2h after the completion of adding 59a. Then the solution was concentrated under 
reduced pressure, and the residue was analyzed by 1H NMR to determine the product 
ratio (78:79).  
4.3 Characterization Data 
Dirhodium(II) Tetrakis[N-phthaloyl-(S)-iso-leucinate] Bis(ethyl acetate) 
Adduct [Rh2(S-PTIL)4(EtOAc)2]: 1H NMR (400 MHz, CDCl3) δ: 7.73 (dd, J = 5.5, 
3.0 Hz, 8H), 7.64 (dd, J = 5.5, 3.0 Hz, 8H), 4.70 (d, J = 8.0 Hz, 4H), 4.15 (q, J = 7.1 
Hz, 4H), 2.48 – 2.32 (comp, 4H), 2.05 (s, 6H), 1.49 – 1.32 (comp, 4H), 1.22 (t, J = 7.1 
Hz, 6H), 0.97 (dd, J = 10.4, 5.5 Hz, 12H), 0.94 – 0.85 (comp, 4H), 0.81 (t, J = 7.1 Hz, 
12H). 13C NMR (100 MHz, CDCl3) δ 187.9, 172.7, 167.5, 133.7, 131.9, 123.3, 60.8, 
58.5, 34.8, 25.6, 21.0, 16.7, 14.1, 11.2. [α]23D = -32.0° (c 0.08, CH2Cl2). HRMS (ESI+): 
calcd for C56H58N4O17Rh2 [M+H2O]+ 1264.1907, found 1264.1917. 
 
(4-Bromoisoquinolin-2-ium-2-yl)dicyanomethanide 70b: 43% yield. 1H 
NMR (400 MHz, DMSO-d6) δ: 9.42 (s, 1H), 8.48 (d, J = 1.1 Hz, 1H), 8.42 (d, J = 8.2 
Hz, 1H), 8.13 (dd, J = 8.2, 1.1 Hz, 1H), 8.03 (ddd, J = 8.2, 7.0, 1.1 Hz, 1H), 7.94 (ddd, 
J = 8.2, 7.0, 1.1 Hz, 1H). 13C NMR (100 MHz, DMSO-d6) δ: 134.0, 133.6, 131.6, 130.6, 
128.6, 125.7, 121.8, 118.3, 59.0. HRMS (ESI+): calcd for C12H7BrN3 [M+H]+ 









(5-Bromoisoquinolin-2-ium-2-yl)dicyanomethanide 70c: 49% yield. 1H 
NMR (400 MHz, DMSO-d6) δ: 9.38 (d, J = 1.7 Hz, 1H), 8.50 (dd, J = 7.3, 1.7 Hz, 1H), 
8.38 (d, J = 8.6 Hz, 1H), 8.28 (d, J = 7.3 Hz, 1H), 8.20 (dd, J = 7.3, 0.9 Hz, 1H), 7.74 
(t, J = 8.6 Hz, 1H). 13C NMR (100 MHz, DMSO-d6) δ: 135.6, 133.4, 131.6, 130.2, 
129.9, 129.5, 127.8, 124.5, 120.5, 118.2, 59.1. HRMS (ESI+): calcd for C12H7BrN3 
[M+H]+ 271.9823, found 271.9840. 
 
 (5-Nitroisoquinolin-2-ium-2-yl)dicyanomethanide 70d: 63% yield. 1H 
NMR (400 MHz, DMSO-d6) δ 9.50 (d, J = 1.8 Hz, 1H), 8.73 (d, J = 8.5 Hz, 1H), 8.67 
(d, J = 7.5 Hz, 1H), 8.64 (dd, J = 7.5, 1.8 Hz, 1H), 8.59 (dd, J = 7.5, 1.8 Hz, 1H), 8.00 
(t, J = 8.5 Hz, 1H). 13C NMR (100 MHz, DMSO-d6) δ: 144.2, 134.5, 133.0, 130.5, 
123.0, 129.7, 129.4, 123.3, 121.4, 117.8, 59.5. HRMS (ESI+): calcd for C12H7N4O2 
[M+H]+ 239.0569, found 239.0575. 
 
[5-(tert-Butyldimethylsilyloxy)isoquinolin-2-ium-2-yl]dicyanomethanide 














7.8, 1.3 Hz, 1H), 8.17 (d, J = 7.8 Hz, 1H), 7.64 (t, J = 8.3 Hz, 1H), 7.50 (d, J = 8.3 Hz, 
1H), 7.13 (d, J = 7.8 Hz, 1H), 1.09 (s, 9H), 0.35 (s, 6H). 13C NMR (100 MHz, CDCl3) 
δ 151.9, 132.6, 131.4, 130.6, 126.9, 126.2, 121.4, 119.6, 118.9, 118.5, 26.1, 18.8, 0.4, 
-3.9. HRMS (ESI+): calcd for C18H22N3OSi [M+H]+ 324.1532, found 324.1539. 
 
Methyl (S)-2-(tert-Butyldimethylsilyl)oxy-4,4-dicyano-4,11b-dihydro-3H-
pyrido[2,1-a]isoquinoline-1-carboxylate (78a). 1H NMR (400 MHz, CDCl3) δ: 7.30 
(td, J = 7.5, 1.5 Hz, 1H), 7.24 (td, J = 7.5, 1.5 Hz, 1H), 7.16 (dd, J = 7.5, 1.5 Hz, 1H), 
6.94 (d, J = 7.5 Hz, 1H), 6.69 (d, J = 7.4 Hz, 1H), 6.29 (d, J = 7.4 Hz, 1H), 5.15 (s, 
1H), 3.70 (s, 3H), 3.17 (dd, J = 16.6, 2.4 Hz, 1H), 2.93 (dd, J = 16.6, 1.5 Hz, 1H), 1.02 
(s, 9H), 0.37 (s, 3H), 0.29 (s, 3H). 13C NMR (100 MHz, CDCl3) δ: 165.2, 151.1, 132.6, 
132.0, 130.8, 128.4, 127.9, 124.6, 124.2, 113.3, 112.7, 112.0, 109.1, 56.4, 52.1, 51.3, 
41.6, 26.1, 18.8, -3.3, -3.7. 93% ee, HPLC: OD-H, 95% hexanes, 5% i-PrOH, 1.0 
mL/min, 254 nm, 5.5 min (minor), 6.2 min (major). [α]23D = -164° (c 1.3, CH2Cl2). 
HRMS (ESI+): calcd for C23H28N3O3Si [M+H]+ 422.1900, found 422.1913. 
 
Benzyl (S)-2-(tert-Butyldimethylsilyl)oxy-4,4-dicyano-4,11b-dihydro-3H-
pyrido[2,1-a]isoquinoline-1-carboxylate (78b). 1H NMR (400 MHz, CDCl3) δ 7.28 

















1H), 6.64 (d, J = 7.4 Hz, 1H), 6.24 (d, J = 7.4 Hz, 1H), 5.19 (d, J = 12.3 Hz, 1H), 5.14 
(s, 1H), 5.07 (d, J = 12.3 Hz, 1H), 3.13 (dd, J = 16.6, 2.4 Hz, 1H), 2.90 (dd, J = 16.6, 
1.3 Hz, 1H), 0.98 (s, 9H), 0.31 (s, 3H), 0.24 (s, 3H). 13C NMR (100 MHz, CDCl3) δ: 
164.4, 151.3, 135.7, 132.5, 131.9, 130.5, 128.9, 128.8, 128.6, 128.3, 127.9, 124.6, 
124.5, 113.5, 112.7, 112.0, 109.0, 66.8, 56.4, 51.3, 41.5, 26.1, 18.8, -3.3, -3.7. 93% ee, 
HPLC: OD-H, 95% hexanes, 5% i-PrOH, 1.0 mL/min, 254 nm, 10.0 min (minor), 12.0 
min (major). [α]23D = -133° (c 1.0, CH2Cl2). HRMS (ESI+): calcd for C29H32N3O3Si 
[M+H]+ 498.2213, found 498.2230. 
 
Methyl (3R,11bS)-2-(tert-Butyldimethylsilyl)oxy-4,4-dicyano-3-methyl-
4,11b-dihydro-3H-pyrido[2,1-a]isoquinoline-1-carboxylate (78c). 1H NMR (400 
MHz, CDCl3) δ: 7.29 (td, J = 7.6, 0.6 Hz, 1H), 7.21 (td, J = 7.6, 1.3 Hz, 1H), 7.15 (dd, 
J = 7.3, 1.3 Hz, 1H), 6.95 (d, J = 7.3 Hz, 1H), 6.72 (d, J = 7.4 Hz, 1H), 6.25 (d, J = 7.4 
Hz, 1H), 5.08 (s, 1H), 3.72 (s, 3H), 2.86 (qd, J = 6.8, 0.6 Hz, 1H), 1.47 (d, J = 6.8 Hz, 
3H), 1.06 (s, 9H), 0.33 (s, 3H), 0.31 (s, 3H). 13C NMR (100 MHz, CDCl3) δ: 165.8, 
156.0, 133.1, 132.7, 131.1, 128.2, 127.6, 124.4, 123.4, 112.6, 112.1, 111.9, 107.4, 56.8, 
56.7, 52.2, 45.3, 26.1, 18.7, 15.5, -3.1, -3.6. 82% ee, HPLC: OD-H, 99% hexanes, 1% 
i-PrOH, 1.0 mL/min, 254 nm, 6.0 min (minor), 7.6 min (major). [α]23D = -313° (c 0.3, 














dihydro-3H-pyrido[2,1-a]isoquinoline-1-carboxylate (78d). 1H NMR (400 MHz, 
CDCl3) δ: 7.56 (dd, J = 7.7, 1.2 Hz, 1H), 7.41 (td, J = 7.7, 0.7 Hz, 1H), 7.34 (td, J = 
7.7, 1.2 Hz, 1H), 6.99 (s, 1H), 6.92 (d, J = 7.7 Hz, 1H), 5.25 (s, 1H), 3.72 (s, 3H), 3.11 
(dd, J = 16.7, 2.1 Hz, 1H), 2.97 (dd, J = 16.7, 1.2 Hz, 1H), 1.04 (s, 9H), 0.38 (s, 3H), 
0.32 (s, 3H). 13C NMR (100 MHz, CDCl3) δ: 164.6, 151.6, 132.1, 131.9, 131.1, 129.5, 
128.8, 125.0, 124.2, 112.3, 111.6, 109.0, 108.3, 56.3, 52.1, 50.2, 41.6, 26.2, 18.9, -3.2, 
-3.7. 96% ee, HPLC: OD-H, 97% hexanes, 3% i-PrOH, 1.0 mL/min, 254 nm, 5.2 min 
(minor), 5.6 min (major). [α]23D = -122° (c 0.8, CH2Cl2). HRMS (ESI+): calcd for 
C23H27BrN3O3Si [M+H]+ 500.1005, found 500.1009. 
 
Methyl (S)-8-Bromo-2-(tert-butyldimethylsilyl)oxy-4,4-dicyano-4,11b-
dihydro-3H-pyrido[2,1-a]isoquinoline-1-carboxylate (78e). 1H NMR (400 MHz, 
CDCl3) δ: 7.52 (d, J = 7.9 Hz, 1H), 7.09 (t, J = 7.9 Hz, 1H), 6.88 (dd, J = 7.7, 0.7 Hz, 
1H), 6.82 (d, J = 7.7 Hz, 1H), 6.61 (dd, J = 7.7, 0.7 Hz, 1H), 5.11 (s, 1H), 3.70 (s, 3H), 
3.18 (dd, J = 16.6, 2.4 Hz, 1H), 2.94 (dd, J = 16.6, 1.1 Hz, 1H), 1.03 (s, 9H), 0.37 (s, 



















132.3, 128.6, 123.4, 120.4, 112.4, 111.8, 111.7, 108.5, 56.7, 52.2, 51.2, 41.6, 26.1, 18.8, 
-3.3, -3.7. 94% ee, HPLC: OD-H, 95% hexanes, 5% i-PrOH, 1.0 mL/min, 254 nm, 10.5 
min (minor), 11.6 min (major). [α]23D = -281° (c 0.5, CH2Cl2). HRMS (ESI+): calcd for 
C23H27BrN3O3Si [M+H]+ 500.1005, found 500.1012. 
 
Methyl (S)-2-(tert-Butyldimethylsilyl)oxy-4,4-dicyano-8-nitro-4,11b-
dihydro-3H-pyrido[2,1-a]isoquinoline-1-carboxylate (78f). 1H NMR (400 MHz, 
CDCl3) δ 8.01 (d, J = 7.9 Hz, 1H), 7.35 (t, J = 7.9 Hz, 1H), 7.18 (dd, J = 7.9, 0.6 Hz, 
1H), 7.07 (dd, J = 7.9, 0.6 Hz, 1H), 6.96 (d, J = 7.9 Hz, 1H), 5.14 (s, 1H), 3.71 (s, 3H), 
3.21 (dd, J = 16.6, 2.4 Hz, 1H), 2.96 (dd, J = 16.6, 1.0 Hz, 1H), 1.04 (s, 9H), 0.39 (s, 
3H), 0.32 (s, 3H). 13C NMR (100 MHz, CDCl3) δ: 164.6, 152.6, 144.5, 136.4, 133.0, 
129.2, 127.7, 127.4, 124.9, 112.1, 111.5, 107.8, 107.0, 56.5, 52.3, 51.0, 41.6, 26.0, 18.8, 
-3.2, -3.6. 95% ee, HPLC: IB-3, 90% hexanes, 9% i-PrOH, 1% EtOH, 1.0 mL/min, 254 
nm, 6.7 min (major), 7.0 min (minor). [α]23D = -179° (c 0.4, CH2Cl2). HRMS (ESI+): 
calcd for C23H27N4O5Si [M+H]+ 467.1751, found 467.1771. 
 
Methyl (S)-2,8-Bis(tert-butyldimethylsilyl)oxy-4,4-dicyano-4,11b-dihydro-



















7.07 (t, J = 8.0 Hz, 1H), 6.73 (d, J = 8.0 Hz, 1H), 6.64 (d, J = 8.0 Hz, 1H), 6.52 (d, J = 
7.2 Hz, 1H), 6.51 (d, J = 7.2 Hz, 1H), 5.04 (s, 1H), 3.68 (s, 3H), 3.13 (dd, J = 16.5, 2.5 
Hz, 1H), 2.89 (dd, J = 16.5, 1.2 Hz, 1H), 1.06 (s, 9H), 1.02 (s, 9H), 0.36 (s, 3H), 0.28 
(s, 3H), 0.26 (s, 3H), 0.24 (s, 3H). 13C NMR (100 MHz, CDCl3) δ: 164.9, 150.8, 150.3, 
132.7, 131.1, 128.3, 124.2, 118.7, 117.2, 112.6, 111.8, 109.4, 108.9, 56.5, 51.9, 51.3, 
41.6, 26.3, 26.2, 18.9, 18.8, -3.3, -3.7, -3.7, -3.8. 95% ee, HPLC: IC-3, 99% hexanes, 
1% i-PrOH, 1.0 mL/min, 254 nm, 5.0 min (minor), 6.7 min (major). [α]23D = -330° (c 




quinolizine-1-carboxylate (78h). 1H NMR (400 MHz, CDCl3) δ: 6.57 (d, J = 7.7 Hz, 
1H), 6.08 (dddd, J = 9.1, 5.2, 2.8, 0.7 Hz, 1H), 5.64 (ddd, J = 7.7, 5.2, 1.4 Hz, 1H), 5.43 
(dddd, J = 9.1, 2.8, 1.4, 0.9 Hz, 1H), 4.68 (s, 1H), 3.78 (s, 3H), 3.15 (dd, J = 16.7, 3.1 
Hz, 1H), 2.79 (dd, J = 16.7, 1.8 Hz, 1H), 1.00 (s, 9H), 0.30 (s, 3H), 0.24 (s, 3H). 13C 
NMR (100 MHz, CDCl3) δ: 164.6, 145.0, 132.1, 124.5, 122.0, 112.5, 111.1, 110.2, 
109.8, 52.5, 52.0, 51.9, 41.1, 26.0, 18.7, -3.4, -3.7. 87% ee, HPLC: OD-H, 99% 
hexanes, 1% i-PrOH, 1.0 mL/min, 254 nm, 6.7 min (major), 7.5 min (minor). [α]23D = 














dihydro-3H-quinolizine-1-carboxylate (78i). 1H NMR (400 MHz, CDCl3) δ: 6.30 (s, 
1H), 6.00 (ddd, J = 9.2, 2.5, 0.8 Hz, 1H), 5.48 (dd, J = 9.2, 2.5 Hz, 1H), 4.57 (p, J = 
2.5 Hz, 1H), 3.78 (s, 3H), 3.10 (dd, J = 16.8, 3.0 Hz, 1H), 2.81 (dd, J = 16.8, 1.4 Hz, 
1H), 1.87 (d, J = 1.4 Hz, 3H), 1.00 (s, 9H), 0.29 (s, 3H), 0.24 (s, 3H). 13C NMR (100 
MHz, CDCl3) δ: 164.7, 150.2, 128.2, 127.4, 122.6, 120.4, 113.1, 111.4, 109.9, 52.8, 
51.9, 51.7, 41.2, 26.0, 18.7, 17.9, -3.4, -3.7. 86% ee, HPLC: IB-3, 97% hexanes, 3% 
CH2Cl2, 1.0 mL/min, 254 nm, 10.5 min (major), 17.5 min (minor). [α]23D = -336° (c 




dihydro-3H-quinolizine-1-carboxylate (78j). 1H NMR (400 MHz, CDCl3) δ 6.52 (d, 
J = 7.5 Hz, 1H), 5.50 (dd, J = 7.5, 1.9 Hz, 1H), 5.08 (s, 1H), 4.63 (s, 1H), 3.79 (s, 3H), 
3.11 (dd, J = 16.6, 3.2 Hz, 1H), 2.76 (dd, J = 16.6, 1.9 Hz, 1H), 1.82 (t, J = 1.9 Hz, 
3H), 1.00 (s, 9H), 0.30 (s, 3H), 0.24 (s, 3H). 13C NMR (100 MHz, CDCl3) δ: 164.36, 



















26.08, 20.21, 18.75, -3.35, -3.73. 74% ee, HPLC: IB-3, 97% hexanes, 3% CH2Cl2, 1.0 
mL/min, 254 nm, 9.6 min (major), 11.2 min (minor). [α]23D = -287° (c 0.4, CH2Cl2). 
HRMS (ESI+): calcd for C20H28N3O3Si [M+H]+ 386.1900, found 386.1889. 
 
Trimethyl (S)-2-(tert-Butyldimethylsilyl)oxy-3H-pyrido[2,1a]isoquinoline-
1,4,4(11bH)-tricarboxylate (78k). 1H NMR (400 MHz, CDCl3) δ: 7.15 (td, J = 7.5, 
0.8 Hz, 1H), 7.08 (td, J = 7.5, 1.4 Hz, 1H), 7.01 (dd, J = 7.5, 1.4 Hz, 1H), 6.81 (dd, J = 
7.5, 0.8 Hz, 1H), 6.39 (d, J = 7.5 Hz, 1H), 5.87 (d, J = 7.5 Hz, 1H), 5.00 (s, 1H), 3.86 
(s, 3H), 3.72 (s, 3H), 3.63 (s, 3H), 2.95 (dd, J = 16.1, 2.4 Hz, 1H), 2.86 (dd, J = 16.1, 
1.2 Hz, 1H), 1.02 (s, 9H), 0.34 (s, 3H), 0.27 (s, 3H). 13C NMR (100 MHz, CDCl3) δ: 
168.89, 168.50, 165.78, 155.90, 135.74, 134.18, 131.05, 127.35, 126.14, 123.56, 
123.19, 107.18, 106.53, 70.88, 56.89, 53.62, 53.44, 51.49, 38.98, 26.25, 18.88, -3.23, -
3.71. 52% ee, HPLC: IB-3, 98% hexanes, 2% i-PrOH, 1.0 mL/min, 254 nm, 7.0 min 
(minor), 7.8 min (major). [α]23D = -117° (c 0.1, CH2Cl2). HRMS (ESI+): calcd for 
C25H34NO7Si [M+H]+ 488.2105, found 488.2140. 
 
Methyl 4,4-Dicyano-4,11b-dihydro-3H-pyrido[2,1-a]isoquinoline-1-
carboxylate (78l). 1H NMR (400 MHz, CDCl3) δ: 7.32 (td, J = 7.6, 0.7 Hz, 1H), 7.26 
(td, J = 7.6, 1.5 Hz, 1H), 7.19 (dd, J = 3.5, 1.5 Hz, 1H), 7.17 (dd, J = 4.6, 1.5 Hz, 1H), 















(s, 1H), 3.85 (s, 3H), 3.19 (dd, J = 4.6, 2.5 Hz, 2H). 13C NMR (100 MHz, CDCl3) δ: 
165.6, 132.8, 132.4, 131.6, 131.1, 129.3, 128.6, 128.0, 124.7, 124.4, 114.3, 113.1, 





carboxylate (79a). 1H NMR (400 MHz, CDCl3) δ: 7.28 (tdd, J = 7.5, 1.4, 0.7 Hz, 1H), 
7.22 (td, J = 7.5, 1.4 Hz, 1H), 7.10 (dd, J = 7.5, 1.4 Hz, 1H), 6.91 (d, J = 7.5 Hz, 1H), 
6.47 (d, J = 7.5 Hz, 1H), 5.93 (d, J = 7.5 Hz, 1H), 5.42 (s, 1H), 3.88 (s, 3H), 2.34 (d, J 
= 7.3 Hz, 1H), 1.91 (dd, J = 7.3, 0.5 Hz, 1H), 1.00 (s, 9H), 0.40 (s, 3H), 0.32 (s, 3H). 
13C NMR (100 MHz, CDCl3) δ: 167.2, 132.7, 128.7, 128.3, 128.0, 127.8, 125.2, 124.2, 
112.6, 111.7, 109.4, 73.6, 60.8, 60.2, 53.3, 35.9, 25.8, 18.8, 18.4, -3.2, -3.6. HRMS 
(ESI+): calcd for C23H28N3O3Si [M+H]+ 422.1900, found 422.1939. 
 
Methyl (8aSR,9aRS,9bSR)-8,8-Dicyano-8a-phenyl-8a,9,9a,9b-tetrahydro-
8H-cyclopropa[3,4]pyrrolo[2,1-a]isoquinoline-9a-carboxylate (79b): 1H NMR 
(400 MHz, CDCl3) δ: 7.56 – 7.44 (comp, 5H), 7.31 (tq, J = 7.5, 0.6 Hz, 1H), 7.24 (td, 
J = 7.5, 1.4 Hz, 1H), 7.14 (dd, J = 7.5, 1.4 Hz, 1H), 7.01 (t, J = 5.5 Hz, 1H), 6.52 (d, J 















J = 6.3 Hz, 1H), 2.16 (d, J = 6.3 Hz, 1H), 1.08 (t, J = 7.1 Hz, 3H). 13C NMR (100 MHz, 
CDCl3) δ: 168.1, 132.6, 131.6, 130.6, 130.4, 129.5, 128.75, 128.7, 128.2, 127.8, 125.2, 
124.5, 112.2, 112.2, 109.5, 62.4, 61.8, 61.2, 47.0, 37.9, 17.8, 14.3. HRMS (ESI+): calcd 
for C23H18N3O2 [M+H]+ 368.1399, found 368.1437. 
NMR graphs, HPLC chromatograms and X-ray single crystal analysis data can be 
obtained from the supporting information of the paper published in the Journal of the 
American Chemical Society: Xu, X.; Zavalij, P. Y.; Doyle, M. P. J. Am. Chem. Soc. 
2013, 135, 12439-12447. 
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Chapter 2: Catalytic [3+2]-Cycloaddition of Silyated Ketene 
Imine with Enol Diazoacetate 
 
I. Introduction 
1.1 General Information for Ketene Imines 
Ketene imines are highly reactive species that belong to a subclass of 
cumulenes, which hold at least two cumulative double bonds within the molecules, and 
they are very useful synthetic intermediates.1-3 Due to their reactive nature, only a few 
synthetic methods are known to afford ketene imines and this shortage of 
methodologies for the formation of ketene imines has limited their uses in synthetic 
chemistry and chemical catalysis.4-9 However, during the last two decades, several 
highly reliable and practical synthetic approaches toward the synthesis10-13 or in situ 
generation of ketene imines13,14 have been developed, thereby enabling comprehensive 
studies on their chemical and physical properties as well as the use of ketene imine in 
synthesizing organic compounds in a concise and efficient way.8,9,15,16 
 Ketene imines are structurally similar to allenes and ketenes. The dihedral 
angles between the C=CR1R2 and C=N–R3 planes are close to 90° with C=N–R3 angles 
proximating 120° (Figure 2.1).17,18 Although ketene imines are active intermediates 
and most often generated in situ, heteroatoms including silicon, phosphorous, and 
sulfur at the N-terminus, and conjugated functional groups, for instance, vinyl, aryl, 





even storable ketene imines.15,16 Ketene imines can undergo nucleophilic additions, 





normal ketene imine  
Figure 2.1 Structures for Ketene Imines. 
1.2 Representative Examples for the Preparation of Ketene Imine and Their Chemical 
Properties 
The Wittig reaction is a high efficient means for the conversion of carbonyl 
groups into C=C or C=N bonds, and it has been used in the synthesis of ketene imines 
from ketenes.10,11 For instance, the condensation between the ketenes 3 and aza-Wittig 
reagents 4 generates highly reactive ketene imines 5 that react further with aryl azides 
2 to afford amidines 6 (Scheme 2.1).10  
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Catalytic generation of ketene imines can be achieved between sulfonyl azides 
and terminal alkynes under Cu(I) catalysis (Scheme 2.2).13 Cu(I)-catalyzed 
azide/alkyne cycloaddition reaction reliably produces the 1-sulfonyl 1,2,3-triazole 9, 
which is in equilibrium with the α-diazo imine 10. Catalytic dinitrogen extrusion and 
the following hetero-Wolff rearrangement yield N-sulfonyl ketene imines 11. Further 
trapping of the catalytically generated ketene imine species 11 by amines or alcohols 
provides functionalized amidines 12 and imidates 13 in good reaction yields.  


























Scheme 2.2 Ketene Imine Generation via Hetero-Wolff Rearrangement of 1-Sulfonyl 
1,2,3-Triazole. 
1.3 General Information and the Synthesis of Silylated Ketene Imines 
Ambident anions can be produced by deprotonating nitriles.19-21 They react with 
electrophiles at either the C- or N-terminus (Scheme 2.3).22,23 The selective alkylation 
of nitrile carboanions at the C-terminus with alkyl halides has been used extensively 





nitriles, and the subsequent selective N-silylation of the resulting substituted ketene 
iminoanion with electrophilic silylating reagents (TBSCl and others), produces 
silylated ketene imines (SKIs) (Scheme 2.4).24,25 This strategy has been the most used 
method to access to disubstituted SKIs from simple nitriles (Scheme 2.5).  
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SiCl = TMSCl; C-Silyation:N-Silylation>98:2
SiCl = TBSCl; C-Silyation:N-Silylation<98:2
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89% yield  
Scheme 2.5 Preparation of TBS-substituted SKIs. 
 
SKIs are nucleophiles that closely resemble silyl enol ethers,26-28 which are 
synthesized by the selective O-silylation of enolates. Silyl enol ethers can be viewed as 
enolate analogues;29-31 SKIs can be similarly treated as the equivalents of α-
cyanocarboanions.19-21,32 Moreover, the preparations of SKIs and silyl enol ethers are 
uniform as well, with both invoking deprotonation and subsequent silylation.  
SKIs and silyl enol ethers are structurally different in spite of many shared 
features. One immediate unique characteristic of SKIs, unlike intrinsically achiral silyl 
enol ethers, is the axial chirality imparted by the pair of orthogonal substituent planes 














Configuration isomers of silyl enol ether  






1.4 Reactions Involving Nucleophilic SKIs 
Nucleophilic addition of SKIs to aldehydes is reported by Frainnet and co-
workers.37 In the absence of a catalyst, mixing N-(trimethylsilyl)diphenylketene imine 
14 and benzaldehyde in their pure forms results in the generation of β-silyloxy nitrile 
16 in quantitative yield (Scheme 2.7). As expected, electron-poor aromatic aldehydes 
also engaged in the addition reaction; however, the use of benzaldehyde having strong 
electron-donating substituents is not reported. Nevertheless, α,β-unsaturated aldehydes 
could also undergo the reaction with diphenyl ketene imine 14, and selectivity in 1,2- 
to 1,4-addition appeared to be substrate-dependent.37 While a 1:2 ratio of 1,2- to 1,4-
addition products (18 and 19, respectively) was observed for cinnamaldehyde, the use 
of crotonaldehyde only afforded the 1,4-addition product 19 (Scheme 2.7b). The less 
electrophilic ketones could also be used as the electrophilic counterparts only when an 
activator was present.37 For instance, the reaction of diphenyl ketene imine 14 with 
various ketones proceeded under catalysis of an equal molar amount of HgI2 with 
significant enolization of ketones (Scheme 2.7c). Although, the reaction with ketones 
generated two vicinal quaternary carbons, the lack of efficiency and the enolization of 
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Scheme 2.7 Nucleophilic Addition of SKIs to Aldehydes and Ketones. 
 
The acylation reaction of SKIs with acid chlorides has also been studied 
(Scheme 2.8).38 Unlike the reaction with ketones, the highly electrophilic acid 
chlorides condense with SKIs smoothly at room temperature in the absence of a 
catalyst. The steric factors associated with the substituents attached to the terminal 
carbon influence the reaction outcome. For example, diphenyl ketene imines 14 reacts 
with acid chlorides to afford the β-nitrile ketones 22, and the very bulky di-tert-butyl 





























23 24  
Scheme 2.8 Reactions of SKIs with Acid Chlorides. 
Matsuda and co-workers have reported an interesting method for the 
preparation of vinyl nitriles by employing the SKI/aldehyde addition and the Lewis 
acid-catalyzed Peterson-type elimination (Scheme 2.9).39 α-Silyl substituted SKI 34 
reacts with an alkyl or aromatic aldehyde under catalysis by a mixture of TiCl4 and 
Ti(Oi-Pr)4 to provide the β-silyl alcohols 35 after aqueous workup. The β-silyl alcohols 
35, upon loss of TMSOH, rearranges to the vinyl nitriles 36 in good yields and 

















25 26 27  
Scheme 2.9 Syntheses of Vinyl Nitriles from SKIs. 
 
The conversion of a nitrile to a ketone can be achieved via a SKI intermediate 
(Scheme 2.10).43 The SKIs 29 derived from the parent nitriles 28 react with iodine in 
the absence of a catalyst and result in the generation of β-iodonitriles 30, which can 



























Scheme 2.10 Conversion of Nitriles to Ketones through SKI Intermediates. 
 
Vinyl nitrile 32, when treated with 2.2 equivalents of a strong base (LDA) and 
sterically encumbered TIPSCl at a low temperature affords exclusively the N-TIPS 
vinyl SKI 33, which reacts as a diene at high temperature with electron-deficient 
















 = TBS: 46% 33, 23% 34
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35 36 37  
Scheme 2.11 Cycloaddition Reaction of Vinyl SKIs with Propargylic Esters. 
 
Although SKIs have been demonstrated to be highly potent nucleophiles in 
several studies, the first catalytic asymmetric reaction involving SKIs has surfaced 
recently. Fu and Mermerian have studied the acylation reaction of SKIs with acid 
anhydrides under catalysis of chiral pyridines (Scheme 2.12).45-47 The Lewis basic 
pyridine catalyst 40 could only deliver good yields and moderate to good 





substituted nucleophiles display no reactivity under the optimal conditions. Although 
electrophilic reagents such as cyanoformates and chloroformates exhibit good 























up to 93% yield, 83% ee38 39
 
Scheme 2.12 A Planar Chiral Pyridine Complex Catalyzes Asymmetric Addition of 
SKIs to Acid Anhydrides. 
 
Very recently Feng and coworkers have reported an asymmetric Mannich-type 
reaction between in situ generated imines and TBS-substituted SKIs under chiral Lewis 
acid catalysis in excellent reaction yields, diastereoselectivity and enantioselectivity 
(Scheme 2.13).32 The base additive - i-PrNH2 - is critical to achieving high enantio- 
and diastereocontrol. Its role in the reaction is believed to be deprotonation of the 
phenolic imine to give the corresponding imino phenolic oxide, which supposedly 
coordinates more tightly to the chiral Lewis acid catalyst than the phenolic imine. 
Although the enantioenriched products can be transformed into a variety of chiral 
molecules, deprotection of the N-protecting group requires a multistep derivatization 




































up to 96% yield, 96%ee, 98:2 dr
41 42 43
Scheme 2.13 Chiral Sc(OTf)3/N-Oxide Ligand Complex Promoted Aymmetric  
Mannich Addition of SKIs.  
 
1.5 Reaction of Enol Diazoacetate with Silyl Enol Ether by Dirhodium Catalysis 
Silyl enol ethers have previously been identified as alkene components in 
reactions with catalytically generated rhodium carbene intermediates.48-59 However, the 
diversities of this type of reaction are far beyond original anticipation. Davies and 
coworkers recognize that the nucleophilic silyl enol ether can be a highly effective 
counterpart in the allylic C-H insertion/Cope rearrangement reaction of methyl-
substituted enol diazoacetate 44 (Scheme 2.14).48-51 Interestingly, the corresponding 
cyclopropanation reaction60 does not occur, which probably reflects the congested 
nature of the tri-substituted silyl enol ether. Under the catalysis by Rh2(S-PTAD)4 
exceptional  levels of enantioselectivity and diastereoselectivity have been achieved 




















Scheme 2.14 Catalytic Enantioselective Allylic C-H insertion/Cope Rearrangement 
of Methyl-Substituted Enol Diazoacetate with Silyl Enol Ether. 
 
Further studies of reactions with enol diazoacetate 46 surprisingly afford a 
completely different product that clearly comes from the selective vinylogous addition 
rather than carbene addition.61 Under catalysis by Rh2(esp)2, the reaction of enol 
diazoacetate 46 with 1-(trimethylsiloxy)cyclohexene 45 produces alkynecarboxylate 
47, whose structure is unambiguously confirmed by X-ray analysis, in 53% yield and 












Scheme 2.15 Alkynecaroxylate Formation through the Vinylogous Addition of Silyl 






The reaction outcome evidently originates from the initial vinylogous addition 
of 1-(trimethylsiloxy)-cyclohexene to the rhodium enol carbene intermediate; however, 
subsequent stereoselective migration of OTBS group from the rhodium bound 
zwitteronic intermediate intermediate is exceptionally uncommon. The substrate scope 
study suggests that reaction yields are only moderate for most of the substrates tested, 
although consistently high diastereoselectivity could be achieved. The reaction for 
several substrates, for instance, siloxyindene 48 and siloxycyclobutene 49, have shown 
clear competition from the carbene addition/Cope rearrangement and introducing the 
tert-butyl ester instead of a methyl ester dramatically enhances the selectivity toward 
alkynecarboxylate (Scheme 2.16a). Intriguingly, tetrasubstituted vinyl ethers such as 
52 and 53 are also applicable to the reaction and the corresponding alkynoates 











R = Me; 33% yield
R = t-Bu; 84% yield
R = Me; 51% yield





































Methyl Enol Diazoacetate. (b) Tetrasubstituted Silyl Enol Ethers are Viable Substrates 
for Alkynecarboxylate Formation. 
 
A tentative mechanism proposed by Davies is shown in Scheme 2.17. The 
reaction outcome is in accordance with the rationale that the unsubstituted vinylogous 
position of the rhodium bound vinyl carbene 56 is crucial for the initial addition by the 
silyl enol ether 45.  The use of sterically demanding nucleophiles, essentially tri- and 
tetrasubstituted silyl enol ethers, enhances the vinylogous reactivity. Nucleophilic 
addition of the silyl enol ether 45 to rhodium bound 1,3-dipole equivalent 57 provides 
the zwitterionic intermediate 58. Subsequent direct 1,4-siloxy group transfer with the 
concomitant release of dirhodium catalyst constitutes one possible reaction pathway. 
Alternatively, stepwise intramolecular addition of OTBS group to the oxocarbenium 
ion 58 via intermediate 59 followed by β-elimination yielded the same product (47). 
Rhodium-stabilized β-siloxyvinylcarbene has a strong tendency to adopt the s-cis 
conformation with the sterically encumbered siloxy group pointing away from the 
“wall” of the catalyst. This same conformation adopted by the rhodium bound enol 
carbene could facilitate β-elimination or migration of the OTBS group to afford the 
alkynoate product. In an attempt to develop the chiral variant for this transformation, 
only moderate levels of asymmetric induction by a chiral dirhodium carboxylate 
catalyst could be achieved (Scheme 2.18). Although with increasing ring size of the 
cyclic silyl enol ether higher enantioselectivity could be achieved, the highest ee 








































69% yield, 70% ee, >20:1 dr
4645 47
Scheme 2.18 Catalytic Asymmetric Synthesis of Alkynecarboxylate under The 
Catalysis by Rh2(S-PTAD)4. 
 
In order to develop a highly enantioselective variant of this unusual 
transformation, the use of enantioenriched (S)-1-trimethylsilyloxy-3-
phenylcyclopentene 71 (98% ee) as the silyl enol ether component results in the 
complete transfer of chirality to the alkynoate product with excellent 





















Scheme 2.19 Chirality Transfer from Optical Active Silyl Enol Ether to 
Alkynecarboxylate by Catalysis of Rh2(esp)2.  
 
The use of stereodefined acyclic (Z)-silyl enol ethers 62 in the same reaction 
stated above delivers disiloxyketal alkynecarboxylate with the opposite 
diastereoselectivity in comparison to the cyclic system (Scheme 2.20).62 Strikingly, a 
small amount of highly substituted cyclopentene 64 is also isolated. More importantly, 
unlike the modest enantioselectivity obtained with cyclic silyl enol ethers, acyclic silyl 
enol ethers appear to offer better enantiocontrol, and up to 97% ee has been achieved 
when performing the reaction in 2,2-dimethylbutane with Rh2(S-PTAD)4 used as the 
chiral catalyst. Notably, the high chemoselectivity toward the akynecarboxylate was 




















85% yield, 95% ee 8% yield, 97% ee
Scheme 2.20 Catalytic Enantioselective Synthesis of Alkynecarboxylate by Using 
Acyclic (Z)-Silyl Enol Ether. 
 
The observation that performing the reaction at elevated temperatures is 
effective for promoting the formal [3+2]-cycloaddition reaction coupled with use of 
more sterically hindered silyl enol ethers leads to the disclosure of the optimal 





(Scheme 2.21). Although the authors attempt to rationalize the differential reaction 
outcome from the perspective of steric factors, no convincing evidence is provided to 




















0 % yield 86% yield, 91% ee
Scheme 2.21 Catalytic Enantioselective Formal [3+2]-Cycloaddition Between Acyclic 
(Z)-Silyl Enol Ether and Enol Diazoacetate. 
1.6 Research Proposal 
Cyclopentenones are ubiquitous structural frameworks of natural products and 
important pharmaceuticals.63-65 Both simple and highly functionalized cyclopentenones 
serve as building blocks for the construction of complex molecular architectures.66 The 
Nazarov cyclization67-72 and the Pauson-Khand reaction72-75 constitute powerful 
approaches for the synthesis of cyclopentenones. However, the need to use a 
stoichiometric amount of activator,67-75 the availability of starting materials67-70 and the 
often-harsh reaction conditions67-70 have limited the practicality of these methods. 
Recently, transition metal catalyzed annulation approaches to functionalized 
cyclopentenones have been reported,76-80 but the reported methods also have structural 
limitations; and none of them introduces an amino functional group into the product. 
Silylated ketene imines (SKIs),19,20 generated by the deprotonation and subsequent N-
silylation of α-branched nitriles,22,24,25,43 are nucleophiles that can react with 
electrophilic counterparts to form a quaternary carbon center under Lewis acid32 or 
base23,45-47,81-85 catalysis (Scheme 2.22a); and, possibly due to the unique placement of 





is in sharp contrast to their ketene and ketene imine analogues.21 However, the potential 
of SKIs to serve as dipole acceptors in such transformations has not been explored. 
The chemistry of nucelophilic SKIs in combination with catalytically generated 
electrophilic metallated 1,3-dipole equivalents has not, to my knowledge, been 
previously documented.21,88 A highly efficient protocol for the assembly of 
enoldiazoacetates and SKIs under dirhodium catalysis to produce substituted 3-amino-
2-cyclopentenones could be viable in light of this author’s previous success in applying 

































Scheme 2.22 (a) SKIs as Nucleophiles. (b) Formal [3+2]-Cycloaddition of SKIs 
and Enol Diazoacetate. 
 
II. Results and Discussions 
2.1 Results 
The investigation was initiated by controlled addition of a solution of enol 
diazoacetate 46a to the mixture of dirhodium catalyst and SKI 38a in 
dichloromethane at room temperature. Results are reported in Table 2.1. By 





the consumption of SKI 38a and the formation of a new product 68a (eq 2.1), 
whose structure was assigned by spectroscopic analysis to have originated from 
[3+2]-annulation, was observed. However, the isolated yield of 68a was very 
low (<10%), and hydrolysis of SKI 38a to the parent nitrile dominated. Adding 
activated 4Å MS to the reaction system dramatically increased the reaction yield 
by suppressing the proton desilylation of SKI 38a, and the TBS-protected 3-
amino-2-cyclopentenone 68a was produced in excellent yield (Table 2.1, entry 
2). Treatment of 68a with a catalytic amount of aqueous HCl in THF cleaved the 
Si-N bond and provided the desilylated 3-amino-2-cyclopentenone product 69a 
in quantitative yield. While the less soluble Rh2(OAc)4 gave a slightly lower 
product yield than did Rh2(Oct)4 (entry 3), Rh2(OPiv)4 with its sterically 
encumbered ligands was much less effective (entry 4). The more Lewis acidic 
catalyst Rh2(TFA)4 (entry 5), which was probably deactivated by the Lewis basic 
SKI 38a,12 only generated a trace amount of 68a. The less Lewis acidic 
Rh2(Cap)4 did not catalyze the cycloaddition reaction, even at 80 °C in 1,2-
dichloroethane (entry 6). Use of other transition metal catalysts, including 
Cu(OTf)2 (entry 7) and AgSbF6 (entry 8), only resulted in complex product 
mixtures under otherwise identical conditions without forming 68a. The Lewis 
acid Sc(OTf)3 showed no catalytic reactivity (entry 9). 






























Entrya  Catalyst Mol% Additiveb Yield of 83c 
1 Rh2(Oct)4 2 mol% none <10% 
2 Rh2(Oct)4 2 mol% 4Å MS 91% 
3 Rh2(OAc)4 2 mol% 4Å MS 87% 




Rh2(TFA)4 2 mol% 4Å MS <10% 
6d Rh2(Cap)4 2 mol% 4Å MS <5% 
7 Cu(OTf)2 5 mol% 4Å MS <5% 
8 AgSbF6 5 mol% 4Å MS <5% 
9 Sc(OTf)3 5 mol% 4Å MS No reaction 
aReactions were performed on 0.4 mmol of SKI 38a (1.0 equivalent). 
Enoldiazoacetate 46a (1.1 equivalent) in dichloromethane was added via syringe 
pump over 30 min. b4Å MS was activated prior to use. cIsolated product yield 
after chromatography. dReaction performed at 80 °C in 1,2-dichloroethane. 
 
Having identified the optimal reaction condition, a diverse array of substrates 
was surveyed to test the generality of this formal [3+2]-cycloaddition strategy, and 
results from this investigation are reported in Table 2.2. Changing the ester substitutent 
of the enoldiazoacetate from methyl (entry 1) to benzyl (entry 2) shows minimal impact 
on the reaction outcome, and the resulting benzyl ester product was obtained in 
comparable reaction yield. Single crystal X-ray analysis of 69b confirmed the structural 
assignment (Figure 2.2). Different aryl and alkyl substituents of the SKIs were well 





marginal influence on the reaction yield. However, replacement of the methyl group 
with an isopropyl group (entry 4) significantly lowered the reaction yield. An SKI with 
an allyl group attached to the terminal carbon was also compatible with the reaction 
conditions, and no cyclopropanation product was observed (entry 5). Substituents with 
distinctive electronic properties on the phenyl ring were accommodated as well (entries 
6-9). A SKI bearing a naphthyl, instead of a phenyl, group also underwent reaction 
(entry 10). Finally, SKIs derived from diphenylacetonitrile (entry 11) and 
cyclohexanecarbonitrile (entry 12) participated in the reaction and afforded the 
corresponding products in good yields. Overall, the [3+2]-annulation methodology 
represents a general approach for introducing a quaternary carbon onto the 3-amino-2-
cyclopentenone skeleton. 







































































































aReactions were performed on 0.4 mmol of SKI 38 (1.0 equivalent). 
Enoldiazoacetate 46 (1.1 equivalent) in dichloromethane was added via syringe 
pump over 30 min. bIsolated reaction yield. cReaction performed on 1.0 gram 























Figure 2.2 X-ray Crystal Structure of 69b and CCDC 965494 Contains The 
Supplementary Crystallographic data. Thermal Ellipsoids Set at 30% Probability.  
2.2 Discussion 
The unusual outcome of the dirhodium(II)-catalyzed reaction is consistent with 
the mechanism that is outlined in Scheme 2.23. Dirhodium-catalyzed dinitrogen 
extrusion from 46 forms the electrophilic rhodium carbene intermediate 70 that 
preferentially undergoes vinylogous electrophilic addition to form nitrilium ion 
intermediate 71. Intramolecular nitrilium ion addition to the nucleophilic vinylrhodium 
carbon center with release of the catalyst forms cyclopentane-imine 72. The 
cyclopentane-imine 72 appears to be highly unstable and undergoes facile hydrolysis 
and subsequent 1,3-proton transfer reaction to yield the TBS-protected 3-amino-2-
cyclopentenone 68. In a control experiment, the triisopropylsilyl (TIPS)-substituted 
enoldiazoacetate engaged in the [3+2]-cycloaddition reaction and provided the 





hydrolysis of 72 occurring exclusively from oxygen rather than from nitrogen. Upon 
treating the product 68 with a catalytic amount of HCl, the 3-amino-2-cyclopentenone 






















































Scheme 2.23 The Proposed Mechanism for the [3+2]-Annulation Reaction. 
 
This [3+2]-cyclization complements a recent report by Davies and 
coworkers for reactions of enoldiazoacetates with silylated enol ethers that 
involve vinylogous oxonium ion addition to the intermediate metal carbene, but 
in their case ring closure requires a bulky substituent on the vinyl ether to prevent 
OTBS transfer that forms propargylic products. 
III. Conclusion 
A catalytic [3+2]-cycloaddition reaction of SKIs and enoldiazoacetates with 





under mild conditions with remarkable functional group tolerance with structurally 
diverse 3-amino-2-cyclopentenones bearing a quaternary carbon at the 4-position 
produced in high reaction yields.  
IV. Experimental Section 
4.1 General Information 
Experiments involving moisture and/or air sensitive components were 
performed in flame-dried glassware under a nitrogen atmosphere using freshly distilled 
solvents. Dichloromethane and 1,2-dichloroethane were dried over activated molecular 
sieves 4Å under argon and distilled prior to use. Commercial reagents and 
chromatography solvents (hexanes and ethyl acetate) were used without further 
purification. Thin layer chromatography (TLC) was carried out using EM Science silica 
gel 60 F254 plates. Chromatograms were analyzed by UV lamp (254 nm) or by 
development using cerium ammonium molybdate (CAM). Liquid chromatography was 
performed using a forced flow (flash chromatography) of the indicated system on silica 
gel (230-400 mesh). Proton nuclear magnetic resonance spectra (1H NMR) were 
recorded on a Bruker AMX 400 spectrophotometer (in CDCl3 or DMSO-d6 as solvent). 
Chemical shifts for 1H NMR spectra are reported as δ in units of parts per million (ppm) 
downfield from SiMe4 (δ = 0.00) and relative to the signal of chloroform-d (δ = 7.26, 
singlet) or DMSO-d6 (δ = 2.50, pentet). Multiplicities were given as: s (singlet); d 
(doublet); t (triplet); q (quartet); p (pentet); dd (doublet of doublets); ddd (doublet of 
doublet of doublets); dddd (doublet of doublet of doublet of doublets); dt (doublet of 





resonance is indicated by nH. Coupling constants are reported as a J  value in Hz. 
Carbon nuclear magnetic resonance spectra (13C NMR) are reported in δ units of parts 
per million (ppm) downfield from SiMe4 (δ = 0.00) and relative to the central singlet 
for the signal of chloroform-d (δ = 77.00, triplet) or DMSO-d6 (δ = 39.50, septet). High-
resolution mass spectra (HRMS) were obtained on a JEOL AccuTOF-ESI mass 
spectrometer using CsI as the standard.  
Molecular sieves 4Å (powder, ~325 mesh), Sc(OTf)3, AgSbF6, Cu(OTf)2 were 
purchased from Sigma-Aldrich. Rh2(OAc)4 and Rh2(Oct)4 were obtained from Pressure 
Chemical and Johnson Matthey, respectively.  Rh2(Cap)4 was prepared according to 
established protocol.29 Silylated ketene imines 38 were synthesized according to 
literature procedures.81, 83, 84 Enol diazoacetate 4613 was prepared by the known method.  
4.2 Experimental Procedure 
Sample procedure for the [3+2]-annulation of silylated ketene imine 38 and 
enol diazoacetate 46: A 10-mL Schlenk tube charged with 4Å molecular sieves (200 
mg) and a magnetic stirring bar was heated by an oil bath at 200 °C under high vacuum 
(0.05 Torr) for 30 min. Then the Schlenk tube was cooled to room temperature with 
high vacuum (0.05 Torr) persisting. Rh2(Oct)4 (6.3 mg, 0.0080 mmol) was added to the 
Schlenk tube under a positive nitrogen atmosphere and the Schlenk tube was then 
sealed by a rubber septum. Dichloromethane (2.0 mL) and silylated ketene imine 38a 
(102 mg, 0.40 mmol) were added sequentially by syringe at room temperature. The 
resulting green solution was stirred at room temperature while enol diazoacetate 46a 
(113 mg, 0.44 mmol) dissolved in 2.0 ml dichloromethane was added to the Schlenk 





Then the reaction mixture was filtrated through a short pad of celite. The celite pad was 
washed with ~1 ml EtOAc three times, and the combined filtrate was concentrated 
under reduced pressure.  The residue was purified by column chromatography to afford 
the TBS-protected product 68a together with a small amount of 69a. The two fractions 
were combined and dissolved in 1.0 ml THF. Two droplets (~ 0.05 ml) of 1.0 M 
aqueous HCl were added to the resulting THF solution, which was further stirred for 5 
min at room temperature. The THF solution was concentrated under reduced pressure 
and the solid residue was washed with ~3 ml of hexanes to afford the 3-
aminocyclopentenone 69a (89 mg, 91% yield). 
4.3 Characterization Data  
 
Methyl 2-(tert-Butyldimethylsilyl)amino-3-methyl-5-oxo-3-phenyl-
cyclopent-1-enecarboxyl-ate (68a). 1H NMR (400 MHz, CDCl3) δ 9.64 (s, 1H), 7.38 
– 7.30 (comp, 2H), 7.30 – 7.19 (comp, 3H), 3.90 (s, 3H), 2.57 (s, 2H), 1.77 (s, 3H), 
0.93 (s, 9H), 0.09 (s, 3H), -0.55 (s, 3H). 13C NMR (100 MHz, CDCl3) δ 196.8, 193.4, 
167.7, 144.1, 128.9, 127.2, 126.0, 105.5, 55.8, 51.3, 47.1, 25.6, 24.6, 17.5, -2.6, -4.8. 











(69a). 1H NMR (400 MHz, CDCl3) δ 8.44 (br s, 1H), 7.40 – 7.33 (comp, 2H), 7.33 – 
7.25 (comp, 3H), 5.59 (br s, 1H), 3.87 (s, 3H), 2.71 (d, J = 18.0 Hz, 1H), 2.58 (d, J = 
18.0 Hz, 1H), 1.75 (s, 3H). 13C NMR (100 MHz, CDCl3) δ 196.7, 187.9, 166.5, 142.7, 
129.1, 127.6, 126.0, 102.1, 53.2, 51.4, 45.6, 25.0. HRMS (ESI+): calcd for C14H16NO3 
[M+H]+ 246.1125, found 246.1133. 
 
Benzyl 2-Amino-3-methyl-5-oxo-3-phenylcyclopent-1-enecarboxylate 
(69b). 1H NMR (400 MHz, CDCl3) δ 8.35 (br s, 1H), 7.53 (dd, J = 7.9, 0.9 Hz, 2H), 
7.42 – 7.27 (comp, 8H), 5.59 (br s, 1H), 5.38 (s, 2H), 2.72 (d, J = 18.0 Hz, 1H), 2.59 
(d, J = 18.0 Hz, 1H), 1.75 (s, 3H). 13C NMR (100 MHz, CDCl3 δ 196.5, 187.7, 165.6, 
142.8, 136.4, 129.0, 128.5, 127.8, 127.7, 127.6, 126.1, 102.1, 65.5, 53.3, 45.6, 25.0. 


















Methyl 2-Amino-3-ethyl-5-oxo-3-phenylcyclopent-1-enecarboxylate (69c). 
1H NMR (400 MHz, CDCl3) δ 8.49 (br s, 1H), 7.38 – 7.31 (comp, 2H), 7.31 – 7.22 
(comp, 3H), 5.92 (br s, 1H), 3.85 (s, 3H), 2.60 (d, J = 18.2 Hz, 1H), 2.53 (d, J = 18.2 
Hz, 1H), 2.24 (dq, J = 14.6, 7.3 Hz, 1H), 2.08 (dq, J = 14.6, 7.3 Hz, 1H), 0.94 (t, J = 
7.3 Hz, 3H). 13C NMR (100 MHz, CDCl3) δ 197.6, 186.5, 166.7, 143.6, 129.5, 127.9, 
126.6, 104.1, 51.7, 50.1, 49.9, 29.1, 8.8. HRMS (ESI+): calcd for C15H18NO3 [M+H]+ 
260.1281, found 260.1288. 
 
Methyl 2-Amino-3-isopropyl-5-oxo-3-phenylcyclopent-1-enecarboxylate 
(69d). 1H NMR (400 MHz, CDCl3) δ 8.48 (br s, 1H), 7.44 – 7.35 (comp, 4H), 7.34 – 
7.29 (m, 1H), 5.61 (br s, 1H), 3.87 (s, 3H), 2.79 (dq, J = 13.3, 6.6 Hz, 1H), 2.74 (d, J = 
18.5 Hz, 1H), 2.68 (d, J = 18.5 Hz, 1H), 1.06 (d, J = 6.6 Hz, 3H), 1.00 (d, J = 6.6 Hz, 
3H). 13C NMR (100 MHz, CDCl3) δ 198.0, 186.8, 166.9, 142.2, 129.7, 127.9, 126.9, 
103.0, 53.5, 51.8, 45.3, 30.8, 18.7, 17.8. HRMS (ESI+): calcd for C16H20NO3 [M+H]+ 
274.1438, found 274.1450. 
 
Methyl 3-Allyl-2-amino-5-oxo-3-phenylcyclopent-1-enecarboxylate (69e). 















(comp, 3H), 5.79 – 5.56 (comp, 2H), 5.27 (dd, J = 16.9, 1.4 Hz, 1H), 5.21 (dd, J = 10.1, 
1.4 Hz, 1H), 3.89 (s, 3H), 2.99 – 2.81 (m, 2H), 2.75 (d, J = 18.1 Hz, 1H), 2.61 (d, J = 
18.1 Hz, 1H). 13C NMR (100 MHz, CDCl3) δ 197.0, 186.0, 166.8, 142.8, 132.0, 129.6, 
128.1, 126.6, 121.2, 104.1, 51.8, 50.4, 49.3, 41.2. HRMS (ESI+): calcd for C16H18NO3 
[M+H]+ 272.1281, found 272.1293.  
 
Methyl 2-Amino-3-(4-methoxyphenyl)-3-methyl-5-oxocyclopent-1-ene-
carboxylate (69f). 1H NMR (400 MHz, CDCl3) δ 8.41 (br s, 1H), 7.20 (d, J = 8.0 Hz, 
2H), 6.88 (d, J = 8.0 Hz, 2H), 5.53 (br s, 1H), 3.88 (s, 3H), 3.80 (s, 3H), 2.70 (d, J = 
18.0 Hz, 1H), 2.57 (d, J = 18.0 Hz, 1H), 1.72 (s, 3H). 13C NMR (100 MHz, CDCl3) δ 
197.3, 188.6, 166.9, 159.4, 135.0, 127.7, 114.8, 102.4, 55.8, 53.7, 51.8, 45.5, 25.8. 
HRMS (ESI+): calcd for C15H18NO4 [M+H]+ 276.1230, found 276.1243. 
 
Methyl 2-Amino-3-(4-chlorophenyl)-3-methyl-5-oxocyclopent-1-ene-
carboxylate (69g). 1H NMR (400 MHz, CDCl3) δ 8.46 (br s, 1H), 7.34 (dt, J = 8.8, 2.7 















Hz, 1H), 2.57 (d, J = 18.0 Hz, 1H), 1.74 (s, 3H). 13C NMR (100 MHz, CDCl3) δ 196.7, 
187.7, 166.8, 141.8, 134.1, 129.7, 127.9, 102.6, 53.5, 51.9, 45.7, 25.3. HRMS (ESI+): 
calcd for C14H15ClNO3 [M+H]+ 280.0735, found 280.0737. 
 
Methyl 2-Amino-3-(3-chlorophenyl)-3-methyl-5-oxocyclopent-1-ene-
carboxylate (69h). 1H NMR (400 MHz, DMSO-d6) δ 8.51 (br s, 1H), 8.47 (br s, 1H), 
7.40 (dd, J = 14.7, 7.9 Hz, 1H), 7.37 – 7.33 (m, 1H), 7.31 (t, J = 1.8 Hz, 1H), 7.20 (dt, 
J = 7.9, 1.8 Hz, 1H), 3.68 (s, 3H), 2.46 (d, J = 17.7 Hz, 1H), 2.33 (d, J = 17.7 Hz, 1H), 
1.70 (s, 3H). 13C NMR (100 MHz, DMSO-d6) δ 194.4, 185.9, 165.1, 147.3, 133.1, 
130.5, 126.8, 125.8, 124.7, 99.8, 52.9, 50.2, 45.1, 23.6. HRMS (ESI+): calcd for 
C14H15ClNO3 [M+H]+ 280.0735, found 280.0739. 
 
Methyl 3-[2-Amino-3-(methoxycarbonyl)-1-methyl-4-oxocyclopent-2-en-
1-yl]benzoate (69i). 1H NMR (400 MHz, CDCl3) δ 8.47 (br s, 1H), 8.03 – 7.92 (comp, 
2H), 7.51 – 7.44 (comp, 2H), 5.50 (br s, 1H), 3.93 (s, 3H), 3.89 (s, 3H), 2.71 (d, J = 
18.1 Hz, 1H), 2.62 (d, J = 18.1 Hz, 1H), 1.80 (s, 3H). 13C NMR (100 MHz, CDCl3) δ 



















carboxylate (69j). 1H NMR (400 MHz, CDCl3) δ 8.40 (br d, J = 2.9 Hz, 1H), 7.82 – 
7.68 (comp, 4H), 7.50 – 7.39 (comp, 2H), 7.16 (dd, J = 8.7, 2.0 Hz, 1H), 6.34 (br d, J 
= 2.9 Hz, 1H), 3.81 (s, 3H), 2.57 (d, J = 18.1 Hz, 1H), 2.37 (d, J = 18.1 Hz, 1H), 1.74 
(s, 3H). 13C NMR (100 MHz, CDCl3) δ 197.4, 188.4, 166.7, 140.5, 133.4, 132.7, 129.5, 
128.3, 127.9, 127.1, 126.9, 125.1, 124.4, 102.2, 53.2, 51.7, 46.1, 25.1. HRMS (ESI+): 
calcd for C18H18NO3 [M+H]+ 296.1281, found 296.1266. 
 
Methyl 2-Amino-5-oxo-3,3-diphenylcyclopent-1-enecarboxylate (69k). 1H 
NMR (400 MHz, CDCl3) δ 8.71 (br d, J = 2.5 Hz, 1H), 7.39 – 7.26 (comp, 6H), 7.26 – 
7.21 (comp, 4H), 5.99 (br d, J = 2.5 Hz, 1H), 3.83 (s, 3H), 3.12 (s, 2H). 13C NMR (100 
MHz, CDCl3) δ 195.8, 184.4, 166.3, 142.8, 128.8, 127.7, 127.5, 102.6, 55.8, 54.0, 51.3. 














Methyl 1-Amino-3-oxospiro[4.5]dec-1-ene-2-carboxylate (69l). 1H NMR 
(400 MHz, CDCl3) δ 8.63 (br s, 1H), 6.28 (br s, 1H), 3.83 (s, 3H), 2.36 (s, 2H), 1.83 – 
1.71 (comp, 3H), 1.66 – 1.51 (comp, 4H), 1.49 – 1.32 (comp, 2H), 1.30 – 1.14 (m, 1H). 
13C NMR (100 MHz, CDCl3) δ 197.3, 189.5, 167.2, 101.1, 51.6, 46.5, 43.5, 35.6, 25.5, 
23.1. HRMS (ESI+): calcd for C12H18NO3 [M+H]+ 224.1281, found 224.1288. 
NMR graphs, HPLC chromatograms and X-ray single crystal analysis data can be 
obtained from the supporting information of the paper published in the Chemical 
Communications: Xu, X.; Leszczynski, J. S.; Mason, S. M.; Zavalij, P. Y.; Doyle, M. 
P. Chem. Commun., 2014, 50, 2462-2464. 
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1.1. General Information for α-Diazo Carbonyl compounds in Nucleophilic Addition 
Reactions. 
α-Diazo carbonyl compounds can react with both electrophiles and 
nucleophiles (Scheme 3.1).1 While it is obvious that nucleophilic addition reaction of 
α-diazo carbonyl compounds occurs at the α-carbon position,2 the terminal nitrogen, 

















Electrophilic Nitrogen  
Scheme 3.1 The Resonance Structures for an α-Diazo Carbonyl Compound. 
 
The relatively high acidity for the α-proton of α-diazo carbonyl compounds 
(pKa ~ 13 for ethyl diazoacetate)1,5 enables generation of the corresponding carbanion 
which bears a diazo group under basic conditions.5 This carbanion is highly reactive 
towards nucleophilic addition to imines, aldehydes and ketones without a catalyst.6 





thereby enables the synthesis of complex α-diazo carbonyl compounds from readily 
































Scheme 3.2 Construction of Complex α-Diazocarbonyl Compounds from α-Diazo 
Ketones or Esters. 
 
More intriguingly, Ti- or Si-enol diazoacetates can be generated from α-diazo-
β-ketoesters with great ease (Scheme 3.3).7-10 Although the Ti-enol diazoacetates are 
generated in situ and used directly, the TBS-substituted enol diazoacetates, as stated in 
the previous chapters, are stable; and they do not undergo the intramolecular [1,5]-
cyclization (Scheme 1.16) which is commonly observed for vinyl diazoacetates.11 Both 
Ti- and Si-enol diazoacetates are nucleophilic and they serve as versatile precursors for 























1 2 3  
Scheme 3.3 Generation of Si- and Ti-enol Diazoacetate from α-Diazo-β-ketoesters. 
 
1.2 Ti(IV)-enol Diazoacetates in Nucleophilic Additions. 
As reported by Calter and co-workers, while Ti-enol diazoacetate 4 and 
aldehydes react smoothly in the absence of a catalyst,8 the same reaction for ketones is 
very sluggish.9,10 The use of Lewis acid promoter-Ti(Oi-Pr)4 effectively enhances the 
reaction rate, and the tertiary alcohol product 6 is obtained in good reaction yields. 
Dehydration of the reaction product 6 at room temperature produces the γ,δ-unsaturated 
β-keto-α-diazoester 7, which undergoes intramolecular allylic C-H insertion reaction 


























Scheme 3.4 Ti(Oi-Pr)4-catalyzed Addition of Ti-enol Diazoacetate to Ketones and 
Subsequent Intramolecular Allylic C-H Insertion. 
 
Wang and coworkers have investigated a similar transformation with a γ-
subtituted Ti-enol diazoacetate 9.12 As expected, the addition reaction with ketones 





β-ketoester 11 with a catalytic amount of Rh2(OAc)4 in refluxing toluene generates 
exclusively the intramolecular O-H insertion product 13. Alternatively, photon-
irradiation of the addition product 11 induces the Wolff rearrangement and affords a 
ketene intermediate which is intramolecularly trapped by OH group to produce the 



































9 10 11 13
12  
Scheme 3.5 Addition of Ti-enol Diazoacetate to Ketones and Subsequent 
Intramolecular OH-insertion or Lactone Formation. 
 
Addition of enol diazoacetate to α,β-unsaturated carbonyl substrates invariably 
encounters competition between 1,4- and 1,2-addition. As demonstrated by Wang and 
coworker,13 the use of Ti-enol diazoacetate 4 with judicious selection of the promoter 
results in the complete selectivity reversal from 1,4- to 1,2-addition. While in the 
absence of any Lewis acid promoter, a 67:33 ratio for 1,2-/1,4-addition (15:16) was 
observed, the use of one equivalent of Ti(Oi-Pr)4 enhances the selectivity to 99:1. 
Remarkably, a complete reversal of selectivity preference to 1:99 for 1,2-/1,4-addition 
(15:16) is achieved when switching to 1 equivalent TiCl4 as the promoter (Scheme 
3.6). Although the authors propose that the selectivity preference in the TiCl4-promoted 





between TiCl4 and Ti-enol diazoacetate, such an explanation obviously overlooks the 
















1,2-addition product 1,4-addition product
CH2Cl2, -78°C
Lewis acid: TiCl4, 15:16
 = 1:99
Lewis acid: Ti(Oi-Pr)4, 15:16 =
 
99:1







Scheme 3.6 Selectivity Reversal in Ti-promoted Addition of Ti-enol diazoacetate to 
α,β-Unsaturated Ketones. 
 
1.3 Si-enol Diazoacetate in Nucleophilic Additions. 
The use of Si-enol diazoacetate in nucleophilic addition reactions dates back to 
1981.7 Since this initial report, several isolated studies have also emerged.15 It is from 
the recent efforts of Doyle and coworkers that systematic surveys of the behaviors of 
these highly valuable nucleophiles have become available.4,11,16-23 As stated previously, 
unlike Ti-enol diazoacetates, Si-enol diazoacetates are easy to handle and less 
susceptible to hydrolysis. Notably, for those reactions that invlove Si-enol 
diazoacetates, intramolecular migration of silyl group often occurs and this feature, 
when coupled with the use of appropriate catalyst in the subsequent dinitrogen 
extrsusion reaction, can yield totally unexpected reaction outcomes.23  
The Mukaiyama-Adol addition of Si-enol diazoacetate 17 to both aromatic and 
aliphatic aldehydes has been reported by Doyle in 2005 (Scheme 3.7).11 In contrast to 





substrate, the use of Si-enol diazoacetate 17 offers several advantages. First of all, as 
low as 2 mol% Sc(OTf)3 is sufficient to reach full conversion of the starting materials. 
Secondly, the reaction conditions are mild and operationally simple, while in Ti(Oi-
Pr)4- or BF3-catalyzed reactions performing the reaction at -78°C is necessary to 
suppress byproduct generation. Finally, the resulting product, upon treatment with a 
catalytic amount of Rh2(OAc)4, undergoes intramolecular oxonium ylide formation and 



































Scheme 3.7 Sc(OTf)3-catalyzed Mukaiyama Aldol Addition of Si-enol Diazoacetate to 






















Scheme 3.8 Rh2(OAc)4-Catalyzed Intramolecular Oxonium Ylide Formation/1,2-
Stevens Rearrangement. 
 
In an effort to render the catalytic Mukaiyama-Aldol addition reaction 





Ag/BINAP catalytic system can offer superior enantiocontrol.17 With the use of the 
more reactive TMS-enol diazoacetate in combination with fluoride activation, 
consistently good reaction yields could be obtained with aryl- and cinnmyl aldehyde at 
















Scheme 3.9 Catalytic Asymmetric Mukaiyama Aldol Reactions for TMS-enol 
Diazoacetate. 
 
The Mukaiyama-Michael reaction is the condensation between silyl enol ethers 
and α,β-unsaturated carbonyl compounds and it represents a suitable extension of the 
Mukaiyama-Aldol reaction.18 Studies of the Mukaiyama Michael addition between 
cyclohexenone and TBS-enol diazoacetate 17 under Lewis acid catalysis suggest that 
Sc(OTf)3, the optimal catalyst for Mukaiyama-aldol reactions of TBS-enol 
diazoacetate, only provides moderate yields for the desired addition products after 
acidic workup. The sluggish reaction rate and proton desilylation of TBS-enol 
diazoacetate 17 to methyl diazoacetoacetate account for the moderate reaction yield. A 
survey of several mild Lewis acids identifies the inexpensive zinc(II) triflate as the 
preferred catalyst, which gives an improved yield to 79%. The use of excess TBS-enol 
diazoacetate 17 (1.5 equiv) further enhances the reaction yield to 96%. Notably, the 
catalyst loading of Zn(OTf)2 can be reduced to as low as 0.1 mol% while maintaining 
the excellent reaction yield (94%). The optimal reaction conditions are extended to a 














































Scheme 3.10 Mukaiyama-Michael Addition of TBS-enol Diazoacetate to Cyclic and 
Acyclic enones. 
 
Initial attempts to develop the asymmetric variant of the Mukaiyama-Michael 
addition reaction by the use of TBS-enol diazoacetate 17 and N-oxazolidinone-
derivatized α,β-unsaturated carbonyl compounds were not successful with catalysis by 
several Cu(II)-based chiral Lewis acids.21 This lack of reactivity is attributed to the 
strong basicity of N-oxazolidinone group, but use of less basic α,β-unsaturated 2-
acylimidazole 31 showed enhanced reactivity. After careful screening of a series of 
chiral bisoxazoline ligands, (S,S)-t-Bu-Box was identified to be the most effective one 
for enantiocontrol. Under the assistance of 1 equiv hexafluoroisopropyl alcohol, benzyl 
3-(tert-butyldimethylsilyl)oxy-2-diazobut-3-enoate 30 gave exceptional 
enantioselectivity together with a good reaction yield (Scheme 3.11). This 
methodology has been demonstrated to be general applicable to a number of α,β-
unsaturated 2-acylimidazoles with consistently high enantiocontrol. The synthesis of 





the resulting Mukaiyama-Michael addition product 32 without loss of 



















62-88% yield, 80-96% ee
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Scheme 3.12 Synthesis of Enantioenriched 3-Phenyl Pentanedioic Acid Diesters.  
The outstanding synthetic power of the Mukaiyama-Michael addition using 
enol diazoacetates has enabled the construction of highly functionalized β-keto-α-diazo 
carbonyl compounds in a straightforward and efficient manner, and two recent 
intriguing examples of this kind have allowed for exceptionally rapid buildup of 
molecular complexity within only a few steps.4,16  The Lewis acid catalyzed addition 
of TBS-enol diazoacetate 17 to trans-4-methoxy-3-buten-2-one 36 affords the β-keto-





resorcinol product 43 is generated in high isolated yield. A plausible mechanistic 
proposal states that the conjugated enolate anion 38 generated by deprotonation of the 
most acidic proton by NaOH from β-keto-α-diazoester 37 is the key intermediate in 
this transformation. The conjugated enolate anion 38 isomerizes into the conjugated 
triene 40, which is appropriately placed for pericyclization. The resulting diazonium 
ion intermediate 41 undergoes the dinitrogen extrusion with concomitant 1,2-methyl 
migration and eventually tautomerizes to the resorcinol product 43 in a good yield. 
Interestingly, when changing the methyl ester of the highly functionalized β-keto-α-
diazoester to the corresponding isopropyl, tert-butyl, and benzyl ester, a 1,2-diazepine 
46 is formed as a minor product. The formation of this product clearly comes from 
nucleophilic addition to the terminal nitrogen of the diazo group and subsequent 
rearrangement (Scheme 3.13c).                        
In another example, the Lewis acid catalyzed Mukaiyama Michael addition of 
TBS-enol diazoacetate 17 to pyranones 47 furnishes highly functionalized diazoester 
48 with complete diastereoselectivity.16 Treating the diazoester with a catalytic amount 
of dirhodium catalyst forms an oxonium ylide intermediate, which undergoes a 1,2-
Stevens rearrangement to produce highly functionalized oxabicyclo[4.2.1]nonane 50 
and 51 (Scheme 3.14).  
In these two examples access to highly functionalized diazoacetates would be 
very difficult without using the Lewis acid catalyzed Mukaiyama-Michael addition 
reaction. This approach to prepare highly functionalized diazoesters has great potential 


















































































Scheme 3.13 (a) Mukaiyama-Michael Addition of TBS-enol Diazoacetate to trans-4-
methoxy-3-buten-2-one. (b) NaOH-Catalyzed Denitrogenative Cyclization of Highly 
Functionalized β-Keto-α-diazoesters to Produce Resorcinol. (c) NaOH-Catalyzed 













































Scheme 3.14 Diastereoselective Mukaiyama Michael Addition of TBS-enol 
Diazoacetate to Pyranones, Dirhodium-catalyzed Oxonium Ylide Formation and 1,2-
Stevens Rearrangement. 
 
The use of diaryl nitrone 52 as Mukaiyama-Mannich acceptor has also been 
studied. The reaction is effectively catalyzed by 5 mol% CuPF6 at 0°C and catalytic 
dinitrogen extrusion of the resulting product 53 with Rh2(OAc)4 furnishes a substituted 
pyrrole 54 that could be formally viewed as coming from the N-O bond insertion of a 
rhodium carbene (Scheme 3.15).23 The same reaction applied to the desilylated product 
55 results mainly in the formation of the intramolecular OH-insertion product 57 with 




























Scheme 3.15 Mukaiyama-Mannich Addition of TBS-enol Diazoacetate with Diaryl 





























66% yield, dr = 2:133% yield, dr = 9:1
53
55
56 57  
Scheme 3.16 Competitive OH-Insertion versus Formal N-O-Insertion. 
 
1.4 Research Proposal. 
1,2-Migration to an electrophilic carbon center is a common transformation in 
organic chemistry that has been widely investigated for its intriguing mechanistic 





encompass these 1,2-migrations are the semipinacol rearrangement and its multiple 
varients,33-35 solvolysis reactions27 that include Wagner-Meerwein rearrangements,36-40 
ring-enlargement reactions41-45 and, more recently, gold-catalyzed migrations.46-53 
With free rotation around the C–C bond to the electrophilic carbon, migration of A, B, 
or C is dependent upon migratory aptitude as well as on the spacial positioning of the 
migrating group relative to the electrophilic center (Scheme 3.17).24,25,36,38 In general, 
although highly selective migrations are most desirable, competition between two 
migrating groups is commonly observed.26,26,33,35,42,43,48-50,52 In these reactions the 
product that is formed is dependent on the structure of the reactant,36,38,40and external 
control of which group migrates has long been problematic.35,42,43,48-50,52 Catalytically 
generated metal carbenes from α-diazo carbonyl compounds are highly electrophilic, 
and 1,2-migration occurs if a saturated carbon is directly bonded to the carbene 
center.54,55 However, examples of catalyst-controlled migrations are rarely 
encountered,56,57 and effective catalyst-controlled selectivity in these transformations 
remains unsolved.58 
Reported results from Doyle and coworkers have presented diverse catalyst-
dependent outcomes from reactions of enol diazoacetates with α,β-unsatured 
aldehydes10 and with nitrones.11 Could a catalytically generated metal carbene 
intermediate with an adjacent saturated carbon atom be induced by different catalysts 
to undergo selective 1,2-migration by each of its substituents? In order to answer this 
question, facile access to α-diazocompounds bearing β-quaternary carbons was the first 
objective. Inspired by the success of using enol diazoacetates in Lewis acid catalyzed 





accomplished by [3+2]-cycloaddition of dipolar species and an enol diazoacetate 
(Scheme 3.17). Azomethine imines 58 are promising candidates since they are stable, 
easily accessible dipolar compounds and precursors for the synthesis of dinitrogen-
fused heterocyclic rings,59-69 which display broad biological activities.70-72 If the [3+2]-
cycloaddition reactions of azomethine imines 58 with enol diazoacetate 17 indeed 
occur under Lewis acid catalysis, the resulting diazoester will have the β-quaternary 
carbon directly bound to carbon, nitrogen, and oxygen substituents that are poised to 
rearrange to an adjacent electrophilic carbon. With the use of different metal catalysts, 
direct migration by carbon, nitrogen, and oxygen substituents could be achieved with 
a high degree of selectivity to generate a diverse array of highly functionalized fused-


















































Scheme 3.17 Stereoelectronic Factors Influencing 1,2-Migration and the Strategy for 
the Synthesis of α-Diazoacetates Bearing β-Quaternary Carbons. 
 
II. Results and Discussions 
I initiated our study with the Lewis acid catalyzed reaction between azomethine 





diastereoselective [3+2]-cycloaddition occurred with the pendant phenyl and TBSO 
groups cis as confirmed by X-ray analysis (Figure 3.1). Further investigations with 5-
phenyl-azomethine imines 58 (R2 = Ph) revealed that In(OTf)3 afforded a higher level 
of diastereoselectivity than Sc(OTf)3 (Table 3.1). As shown in Table 3.2, azomethine 
imines containing electron-withdrawing (entries 3, 9, 11 and 12) and electron-donating 
substituents (entries 2, 4, 5 and 10) on the phenyl rings afford the desired products in 
high isolated yields. Furthermore, substituents at the para- (entries 2-3, 5, 9-11), meta- 
(entry 12) and ortho- (entry 4) positions on the phenyl rings are well tolerated. 
Azomethine imines derived from cinnamaldehyde (entry 7) and from 
cyclohexylcarboxaldehyde (entries 6 and 13) show similar reactivity profiles as those 
derived from aromatic aldehydes, and all substrates shown in Table 3.2 afford the 



























Figure 3.1 X-Ray Single Crystal Structure for 59a. 
 





















Entrya Lewis acid Time Yieldb dr (cis:trans)c 
1 Mg(OTf)2 12h no reaction -- 
2 Zn(OTf)2 3h 78% >20:1 
3 In(OTf)3 12h 81% >20:1 
4 Sc(OTf)3 12h 73% ~1:1 





6 Yb(OTf)3 12h Trace -- 
7 Cu(SbF6)2 3h 76% >20:1 
aReaction performed with 0.25 mmol of azomethine imine 58 (1.0 eq) and enol 
diazoacetate 17 (1.8 eq) with 5 mol% Lewis acid in CH2Cl2 at room temperature. 
bYields reported are isolated yields. cdr is determined by 1H NMR analysis of the 
reaction mixture. 
 
Table 3.2 Lewis Acid Catalyzed Diastereoselecive [3+2]-Cycloaddition of 


























entrya R1 R2 59d yield, %e 
1b Ph H 59a 90 
2b 4-MeC6H4 H 59b 74 
3b 4-ClC6H4 H 59c 78 
4b 2-MeOC6H4 H 59d 65 
5b 4-MeOC6H4 H 59e 69 
6b Cyclohexyl H 59f 80 
7b (E)-Ph-CH=CH- H 59g 67 
8c Ph Ph 59h 81 
9c 4-NO2C6H4 Ph 59i 66 
10c 4-MeOC6H4 Ph 59j 71 
11c 4-BrC6H4 Ph 59k 78 





13c Cyclohexyl Ph 59m 56 
aReaction performed with 0.25 mmol of azomethine imine 58 (1.0 equiv) and enol 
diazoacetate 17 (1.8 equiv) in CH2Cl2 for 12h at room temperature. b5 mol% Sc(OTf)3 
used as catalyst. c5 mol% In(OTf)3 used as catalyst. dSingle diastereomer obtained. 
eIsolated yields.  
 
Having prepared highly functionalized α-diazoacetates 59 bearing quaternary 
carbons at the β-positions, I next investigated their transition-metal catalyzed 
dinitrogen extrusion and subsequent rearrangement of the catalytically generated metal 
carbene intermediates, and these results are reported in Table 3.3. In the reaction of 
59a with Rh2(OAc)4 three products were obtained in 90% combined yield, and these 
were determined by X-ray difraction and/or spectroscopically to be those from 1,2-
C→C migration (60a, 58%), stereoselective 1,2-O→C migration (61a, 25%) and 1,2-
N→C migration (62a, 17%). Using the more Lewis acidic Rh2(tfa)4 (entry 2) and 
Rh2(pfb)4 (entry 3) under the same conditions showed that the 1,2-N→C migration 
pathway was inhibited in favor of 1,2-C→C and -O→C migrations with approximately 
3:1 selectivity. In contrast, performing this reaction with the less Lewis acidic 
Rh2(cap)4 in ClCH2CH2Cl at 80°C revealed that both the 1,2-N→C and 1,2-O→C 
migration pathways were suppressed, and 1,2-C→C migration was dominant (entry 4). 
In a control experiment, where the same reaction was conducted with Rh2(OAc)4 (entry 
5) under otherwise identical conditions as that with Rh2(cap)4, comparable selectivity 
to the reaction performed in CH2Cl2 at 40°C (entry 1) was shown but with much lower 
selectivity than with Rh2(cap)4 (entry 4). The use of Rh2(piv)4 and Rh2(esp)2 that 
contain sterically bulky ligands gave high selectivities for both 1,2-N→C and 1,2-





distinctive and virtually exclusive selectivity for 1,2-N→C migration (entries 8-11) 
compared with dirhodium complexes. Thus, catalysts derived from different metals (Rh 
and Cu) direct competitive 1,2-C→C and 1,2-N→C migration pathways with high 
selectivities, and the 1,2-C→C migration product 60a and the 1,2-N→C migration 
product 62a can be obtained with high yields under catalysis of Rh2(cap)4 and CuPF6 
respectively. 1,2-C→C and 1,2-O→C migrations appear to be linked, but highly 
selective catalyst-directed 1,2-O→C migration could not be achieved with 59a. 
 





























60a 61a 62a  
entrya catalyst temp solvent time, h 60a:61ad:62ae 
yield, 
%f 
1b Rh2(OAc)4 40°C CH2Cl2 3 58:25:17 90 
2b Rh2(tfa)4 40°C CH2Cl2 3 78:22:– 94 
3b Rh2(pfb)4 40°C CH2Cl2 3 71:29:– 91 
4b Rh2(cap)4 80°C (CH2Cl)2 3 78:9:13 93 
5b Rh2(OAc)4 80°C (CH2Cl)2 3 61:25:14 85 





7b Rh2(esp)2 40°C CH2Cl2 3 20:39:41 87 
8c Cu(OTf)2 rt CH2Cl2 12 –:–:100 70 
9c Cu(hfacac)2 rt CH2Cl2 12 9: –:91 88 
10c AgBF4 rt CH2Cl2 12 –:–:100 40 
11c CuPF6 rt CH2Cl2 12 –:–:100 86 
aReaction performed with 0.1 mmol of 59a. b1 mol% Rh2Ln catalyst was used. c5 mol% 
catalyst was used. d61a was obtained as the (E)-configuration exclusively. eRatios 
determined by 1H NMR analysis of reaction mixtures. fYields reported are combined 
yields of 60a, 61a and 62a. 
 
The influence of R1 on the selective 1,2-C→C migration catalyzed by Rh2(cap)4 
and the 1,2-N→C migration catalyzed by CuPF6 was investigated, and these results are 
summarized in Table 3.4. Reactions performed with CuPF6 as catalyst uniformly 
afford the 1,2-N→C migration product, and Rh2(cap)4 promotes the 1,2-C→C 
migration process with high selectivities but without significant dependence on R1. 
 































  Rh2(cap)4b CuPF6e 





59a Ph 60a 85:15 85 62a 86 
59b 4-MeC6H4 60b 89:11 81 62b 85 
59c 4-ClC6H4 60c 88:12 83 62c 80 
59d 2-MeOC6H4 60d 81:19 79 62d 86 
59e 4-MeOC6H4 60e 88:12 86 62e 78 
59f Cyclohexyl 60f 87:13 88 62f 77 
59g (E)-Ph-CH=CH- 60g 86:14 85 62g 84 
aReaction performed with 0.1 mmol of 59. bReaction performed with 1.0 mol% of 
Rh2(cap)4 in ClCH2CH2Cl at 80°C for 3h. cRatios determined by 1H NMR analysis of 
crude reaction mixtures. dYields reported are combined (60+61) yields. eReaction 
performed with 5 mol% of CuPF6 in CH2Cl2 for 12h at room temperature. fYields 
reported are isolated yields of 60. 
 
In an effort to selectively achieve 1,2-C→C migration, 1,2-O→C migration, 
and 1,2-N→C migration with different catalysts, diazoacetate 59h, which has an 
additional phenyl group on the pyrazolidinone ring, was subjected to the same series of 
catalytic reactions (Table 3.5). With 1 mol% of Rh2(OAc)4, the formation of the 1,2-
C→C migration product 60h and the stereoselective 1,2-O→C migration product 61h 
occurred without evidence for formation of the 1,2-N→C migration product 62h (eq 
4). Once again, Rh2(cap)4 selected the 1,2-C→C migration pathway (entry 6), and 
CuPF6 effected exclusive 1,2-N→C migration (entry 9). Consistent with entries 6 and 
7 in Table 3.3, but more dramatic, increasing the steric size of the ligand by using 





of the 1,2-O→C migration product 61h, and this outcome is mirrored with the use of 
Rh2(esp)4 (entry 5) but in higher overall yield. Hence, by simply changing the ligand 
attachments to the dirhodium centers, the competing 1,2-C→C and 1,2-O→C 
migrations become dominant through the catalysis by Rh2(esp)2 [or Rh2(piv)4] and 
Rh2(cap)4, respectively; and the 1,2-O→C migration product 62h, which was not 
detected in dirhodium complexe catalyzed reactions, was the sole migration outcome 
with catalysis by CuPF6. In addition, as shown in Table 3.6, these reactions have the 
same selectivities irrespective of the electronic nature of the substituents on the phenyl 
ring of R1 even when cyclohexyl is used in place of aryl.  
 





































1,2-N→C migration1,2-C→C migration 1,2-O→C migration  
entrya catalyst solvent time, h 60h:61hd:62he yield, %f 
1b Rh2(OAc)4 CH2Cl2 3 60:40:– 91 
2b Rh2(Oct)4 CH2Cl2 3 43:57:– 88 
3b Rh2(OBz)4 CH2Cl2 3 25:75:– 82 
4b Rh2(piv)4 CH2Cl2 3 12:88:– 74 
5b Rh2(esp)2 CH2Cl2 3 15:85:– 88 





7b Rh2(tfa)4 CH2Cl2 3 69:31:– 81 
8b Rh2(pfb)4 CH2Cl2 3 64:36:– 79 
9c CuPF6 CH2Cl2 12 –:–:100 72 
aReactions performed with 0.1 mmol of 59h. bReaction performed with 1.0 mol% of 
Rh2Ln as catalyst. cReaction performed with 5.0 mol% CuPF6. d61h was obtained in the 
(E)-configuration exclusively. eRatio determined by 1H NMR analysis of crude reaction 
mixture. fYields reported are combined yields of 60h, 61h and 62h. 
 


























  Rh2(cap)4b Rh2(esp)2c 
59a R1 60 60/61d Yield, %e 61f 60/61d 
Yield, 
%e 
59h Ph 60h 91:9 91% 61h 15:85 88% 
59i 4-NO2C6H4 60i 97:3 90% 61i 16:84 86% 
59j 4-MeOC6H4 60j 96:4 92% 61j 17:83 85% 





59l 3-BrC6H4 60l 88:12 91% 61l 14:86 82% 
59m Cyclohexyl 60m 75:25 86% 61m 15:85 92% 
aReaction performed with 0.1 mmol of 59 with 1.0 mol% Rh2Ln as catalyst. bReaction 
performed in ClCH2CH2Cl at 80°C for 1h. c Reaction performed in CH2Cl2 at room 
temperature for 3h. dRatios determined by 1H NMR analysis of crude reaction mixture. 
eYields reported are combined yields of 60 and 61. f61 was obtained in the (E)-
configuration exclusively.  
 
Competition between formation of 60 (1,2-C→C migration) and 61 (1,2-O→C 
migration) is linked in dirhodium catalyzed reactions, and the causes for selectivity 
may be attributed to the steric [e.g., results with Rh2(piv)4 and Rh2(esp)2] and electronic 
[results with Rh2(cap)4] factors. However, the unexpected 1,2-N→C migration from 
59, which is formally an amide nitrogen migration, stands out as exceptionally 
favourable when copper, rather than dirhodium, catalysts are employed. This hightened 
selectivity for 62 may be due to coordination of the copper carbene intrermediate with 
the carbonyl oxygen of the pyrazolidinone ring (63 in Scheme 3.18) – a complexation 
that is not expected with the coordinatively saturated dirhodium complexes.16 
Consequently, the overall 1,2-N→C migration is facilitated by transition metal 


































In summary, I have discovered catalyst-controlled highly selective 1,2-C→C, -
O→C and -N→C migrations of β-methylene-β-silyloxy-β-amido-α-diazoacetates. The 
key to achieving this unique display of differential selectivities relies on steric and 
stereoelectronic control by their catalytically generated metal carbenes. These 
rearrangement reactions produce a variety of highly functionalized dinitrogen-fused 
heterocyclic compounds.  
 
IV. Experimental Section 
4.1 General Information 
Experiments involving moisture and/or air sensitive components were 
performed in oven-dried glassware under a nitrogen atmosphere using freshly distilled 
solvents. CH2Cl2 and ClCH2CH2Cl were dried over activated molecular sieves and 
distilled prior to use. Commercial reagents and solvents (hexanes and ethyl acetate) 
were used without further purification. Thin layer chromatography (TLC) was carried 
out using EM Science silica gel 60 F254 plates. The chromatogram was analyzed by 
UV lamp (254 nm), or by development using cerium ammonium molybdate (CAM). 
Liquid chromatography was performed using a forced flow (flash chromatography) of 
the indicated system on silica gel (230-400 mesh). Proton nuclear magnetic resonance 
spectra (1H NMR) were recorded on a Bruker AMX 400 spectrophotometer (in CDCl3 
as solvent). Chemical shifts for 1H NMR spectra are reported as δ in units of parts per 
million (ppm) downfield from SiMe4 (δ = 0.00) and relative to the signal of chloroform-





(quartet); dd (doublet of doublets); ddd (doublet of doublet of doublets); dddd (doublet 
of doublet of doublet of doublets); dt (doublet of triplets); m (multiplet). The number 
of protons (n) for a given resonance is indicated by nH. Coupling constants are reported 
as a J value in Hz. Carbon nuclear magnetic resonance spectra (13C NMR) are reported 
as δ in units of parts per million (ppm) downfield from SiMe4 (δ = 0.00) and relative to 
the signal of chloroform-d (δ = 77.00, triplet). High-resolution mass spectra (HRMS) 
were obtained on a JEOL AccuTOF-ESI mass spectrometer using CsI as the standard. 
Sc(OTf)3, In(OTf)3, Cu(OTf)2, Cu(hfacac)2, CuPF6(CH3CN)4, AgBF4, Rh2(esp)4 were 
purchased from Aldrich. Rh2(OAc)4 was purchased from Pressure chemicals. 
Azomethine imines 58a-m59-69 and enol diazoacetate 174, 5 were prepared according to 
known procedures.  
4.2 Experimental Procedure 
General Procedure for Diastereoselective [3+2]-Cycloaddition of 
Azomethine Imines (58a-58g) and Enol Diazoacetate 2. In a 10 ml flame-dried 
Schlenk flask charged with a magnetic stirring bar, Sc(OTf)3 (6.2 mg, 0.0125 mmol), 
azomethine imine 58a (43.5 mg, 0.25 mmol) and 1.0 mL dry CH2Cl2 were added 
sequentially under a nitrogen atmosphere. Then the flask was capped by a rubber 
septum and the resulting solution was stirred at room temperature for 5 min before enol 
diazoacetate 17 (116.0 mg, 0.45 mmol) was added. Stirring was continued at room 
temperature for 12h. Then the reaction mixture was concentrated under reduced 
pressure and directly loaded onto a silica gel column (with 1:5 of ethyl acetate/hexanes 





General Procedure for the Diastereoselective [3+2]-Cycloaddition of 
Azomethine Imines (58h-58m) and Enol Diazoacetate 17: In a 10 ml flame-dried 
Schlenk flask charged with a magnetic stirring bar, In(OTf)3 (7.0 mg, 0.0125 mmol), 
azomethine imine 58h (62.5 mg, 0.25 mmol) and 1.0 mL dry CH2Cl2 were added 
sequentially under a nitrogen atmosphere. The flask was capped by a rubber septum 
and the resulting solution was stirred at room temperature for 5 min before enol 
diazoacetate 17 (116.0 mg, 0.45 mmol) was added. Stirring was continued at room 
temperature for 12h. Then the reaction mixture was concentrated under reduced 
pressure and directly loaded onto a silica gel column (with 1:7 of ethyl acetate/hexanes 
as eluents) to isolate product 59h as a yellow solid in 103.0 mg (81% yield). 
General Procedure for Rh2(cap)4 Catalyzed 1,2-C→C Migration: Rh2(cap)4 
(0.7 mg, 0.001mmol) was added to a 5 ml flame-dried two-neck round-bottom flask 
under a nitrogen atmosphere. Then the flask was fitted with a condenser and a rubber 
septum, and 1.0 mL of dry CH2Cl2 was added through the septum. The resulting 
solution was heated to 80°C under a nitrogen atmosphere and a solution of diazoacetate 
59a (43.0 mg, 0.1 mmol) in 1.0 mL of dry CH2Cl2 was then added through the septum 
over 1h by syringe pump. After completion of addition, the reaction mixture was stirred 
for another 3h under reflux. Then the solution was cooled to room temperature, and 
solvent was removed under reduced pressure. The desired 1,2-C→C migration product 
60a was obtained by flash column chromatography (with 1:10 of ethyl acetate/hexanes 
as eluent) as a white solid (29.3 mg, 72% yield).  
General Procedure for Rh2(esp)2 Catalyzed Selective 1,2-O→C 





with a magnetic stirring bar under a nitrogen atmosphere. The vial was then capped 
with a rubber septum, and 1.0 mL of dry CH2Cl2 was added to the vial. The resulting 
solution was stirred while a solution of diazoacetate 59a (50.7 mg, 0.1 mmol) in 1.0 
mL of dry dichloromethane was added over 1h by syringe pump. After completion of 
addition, the reaction mixture was stirred for another 3h at room temperature. The 
reaction product 61a was obtained by flash column chromatography (with 1:5 of ethyl 
acetate/hexanes as eluents) in 38.0 mg (75% yield) as a white solid.  
General Procedure for CuPF6 Catalyzed Selective 1,2-N→C Migrations: 
CuPF6 (1.0 mg, 0.005 mmol) was added to a flame-dried vial under a nitrogen 
atmosphere. Then the vial was capped by a rubber septum and 1.0 mL of dry CH2Cl2 
was added. The resulting solution was stirred while a solution of diazoacetate 59a (43.0 
mg, 0.1 mmol) in 1.0 mL of dry dichloromethane was added by syringe pump over 1h 
at room temperature. After completion of addition, the reaction mixture was stirred for 
another 12h at room temperature. The desired 1,2-N→C migration product 62a was 
obtained by flash column chromatography (1:3 of ethyl acetate/hexanes as eluent) in 
35.0 mg (86% yield) as a white solid.  















(400 MHz, CDCl3) δ: 7.51 – 7.43 (m, 2H), 7.43 – 7.29 (m, 3H), 4.44 (dd, J = 11.2, 6.8 
Hz, 1H), 3.78 (s, 3H), 3.46 (ddd, J = 9.8, 8.3, 4.8 Hz, 1H), 3.23 (dd, J = 13.5, 6.8 Hz, 
1H), 2.91 (ddd, J = 11.2, 9.8, 8.9 Hz, 1H), 2.83 – 2.68 (m, 2H), 2.62 (dd, J = 13.5, 11.2 
Hz, 1H), 0.90 (s, 9H), 0.39 (s, 3H), 0.23 (s, 3H). 13C NMR (100 MHz, CDCl3) δ: 166.6, 
165.3, 138.1, 128.7, 127.9, 127.2, 83.2, 70.7, 55.9, 51.4, 49.3, 34.8, 25.6, 17.9, -3.3, -









hexahydro-pyrazolo[1,2-a]pyrazol-1-yl]-2-diazoacetate (59b): 74% yield, 1H NMR 
(400 MHz, CDCl3) δ: 7.36 (d, J = 8.0 Hz, 2H), 7.20 (d, J = 8.0 Hz, 2H), 4.40 (dd, J = 
11.2, 6.8 Hz, 1H), 3.78 (s, 3H), 3.45 (ddd, J = 9.7, 8.3, 4.9 Hz, 1H), 3.21 (dd, J = 13.5, 
6.8 Hz, 1H), 2.90 (dt, J = 11.2, 9.7 Hz, 1H), 2.79-2.67 (m, 2H), 2.61 (dd, J = 13.5, 11.2 
Hz, 1H), 2.37 (s, 3H), 0.90 (s, 9H), 0.39 (s, 3H), 0.23 (s, 3H). 13C NMR (100 MHz, 
CDCl3) δ: 166.5, 165.2, 137.7, 135.0, 129.4, 127.2, 83.2, 70.5, 55.9, 51.4, 49.3, 34.9, 














oxo-hexahydropyrazolo[1,2-a]pyrazol-1-yl]-2-diazoacetate (59c): 78% yield, 1H 
NMR (400 MHz, CDCl3) δ: 7.41 (d, J = 8.7 Hz, 2H), 7.36 (d, J = 8.7 Hz, 2H), 4.43 (dd, 
J = 11.0, 6.8 Hz, 1H), 3.78 (s, 3H), 3.46 (ddd, J = 10.0, 8.3, 4.8 Hz, 1H), 3.21 (dd, J = 
13.5, 6.8 Hz, 1H), 2.89 (dt, J = 11.0, 10.0 Hz, 1H), 2.83-2.68 (m, 2H), 2.56 (dd, J = 
13.5, 11.0 Hz, 1H), 0.90 (s, 9H), 0.37 (s, 3H), 0.22 (s, 3H). 13C NMR (100 MHz, CDCl3) 
δ: 166.6, 165.4, 136.7, 133.7, 129.0, 128.6, 83.3, 70.0, 56.0, 51.5, 49.3, 34.8, 25.6, 18.0, 











7-oxohexahydropyrazolo[1,2-a]pyrazol-1-yl]-2-diazoacetate (59d): 65% yield, 1H 
NMR (400 MHz, CDCl3) δ: 7.64 (dd, J = 7.6, 1.4 Hz, 1H), 7.27 (td, J = 8.2, 1.4 Hz, 





7.0 Hz, 1H), 3.83 (s, 3H), 3.79 (s, 3H), 3.53 (ddd, J = 10.0, 7.0, 5.6 Hz, 1H), 3.39 (dd, 
J = 13.6, 7.0 Hz, 1H), 2.88 (dt, J = 11.0, 10.0 Hz, 1H), 2.78-2.64 (m, 2H), 2.44 (dd, J 
= 13.5, 11.0 Hz, 1H), 0.85 (s, 9H), 0.30 (s, 3H), 0.21 (s, 3H). 13C NMR (100 MHz, 
CDCl3) δ: 166.6, 165.6, 157.8, 128.7, 127.4, 126.8, 121.1, 110.7, 83.4, 64.9, 55.8, 54.2, 
51.9, 50.5, 35.7, 26.0, 18.4, -2.9, -3.7. HRMS (ESI+): calcd for C22H33N4O5Si [M+H]+ 









7-oxohexahydropyrazolo[1,2-a]pyrazol-1-yl]-2-diazoacetate (59e): 69% yield, 1H 
NMR (400 MHz, CDCl3) δ: 7.38 (d, J = 8.8 Hz, 2H), 6.91 (d, J = 8.8 Hz, 2H), 4.37 (dd, 
J = 11.2, 6.7 Hz, 1H), 3.82 (s, 3H), 3.78 (s, 3H), 3.43 (ddd, J = 9.7, 8.8, 4.7 Hz, 1H), 
3.18 (dd, J = 13.5, 6.7 Hz, 1H), 2.89 (ddd, J = 11.2, 9.7, 8.8 Hz, 1H), 2.81-2.66 (m, 
2H), 2.60 (dd, J = 13.5, 11.2 Hz, 1H), 0.90 (s, 9H), 0.39 (s, 3H), 0.22 (s, 3H). 13C NMR 
(100 MHz, CDCl3) δ: 167.0, 165.8, 159.8, 130.3, 128.9, 114.5, 83.6, 70.7, 56.4, 55.7, 
51.9, 49.6, 35.3, 26.0, 18.4, -2.8, -3.7. HRMS (ESI+): calcd for C22H33N4O5Si [M+H]+ 













hexahydropyrazolo[1,2-a]pyrazol-1-yl]-2-diazoacetate (59f): 80% yield, 1H NMR 
(400 MHz, CDCl3) δ: 3.74 (s, 3H), 3.60 (td, J = 8.8, 1.8 Hz, 1H), 3.07 (dt, J = 10.6, 7.1 
Hz, 1H), 3.03-2.83 (m, 2H), 2.74 (ddd, J = 16.0, 13.1, 8.8 Hz, 1H), 2.60 (ddd, J = 16.0, 
8.8, 1.8 Hz, 1H), 2.39 (dd, J = 13.1, 10.6 Hz, 1H), 1.94-1.64 (m, 5H), 1.54-1.39 (m, 
1H), 1.36-1.08 (m, 3H), 1.10-0.94 (m, 2H), 0.89 (s, 9H), 0.30 (s, 3H), 0.16 (s, 3H). 13C 
NMR (100 MHz, CDCl3) δ: 165.1, 164.7, 82.1, 72.4, 53.7, 51.4, 50.6, 41.0, 36.0, 30.8, 
29.1, 26.4, 26.1, 26.1, 25.6, 18.0, -3.4, -4.2. HRMS (ESI+): calcd for C21H37N4O4Si 









hexahydropyrazolo[1,2-a]pyrazol-1-yl]-2-diazoacetate (59g): 67% yield, 1H NMR 
(400 MHz, CDCl3) δ: 7.48-7.24 (m, 5H), 6.68 (d, J = 15.9 Hz, 1H), 6.07 (dd, J = 15.9, 
8.4 Hz, 1H), 3.99 (dt, J = 10.8, 7.7 Hz, 1H), 3.78 (s, 3H), 3.53 (ddd, J = 9.8, 8.4, 4.6 





2.61 (m, 2H), 2.56 (dd, J = 13.6, 10.8 Hz, 1H), 0.91 (s, 9H), 0.37 (s, 3H), 0.20 (s, 3H). 
13C NMR (100 MHz, CDCl3) δ: 166.8, 165.8, 136.7, 134.2, 129.1, 128.4, 127.0, 126.9, 
83.4, 70.3, 53.5, 51.9, 49.8, 35.4, 26.2, 26.1, 25.9, 18.4, -2.9, -3.7. HRMS (ESI+): calcd 










diphenyl-hexahydropyrazolo[1,2-a]pyrazol-1-yl]-2-diazoacetate (59h): 81% yield, 
1H NMR (CDCl3, 400 MHz) δ: 7.25-7.23 (m, 2H), 7.20-7.17 (m, 2H), 7.14-7.07 (m, 
6H), 4.66 (dd, J = 11.6, 7.2 Hz, 1H), 4.28 (dd, J = 11.6, 8.8 Hz, 1H), 3.84 (s, 3H), 3.27 
(dd, J = 14.0, 7.2 Hz, 1H), 3.09 (dd, J = 16.8, 8.8 Hz, 1H), 2.92 (dd, J = 16.8, 11.6, Hz, 
1H), 2.74 (dd, J = 14.0, 11.6 Hz, 1H), 0.94 (s, 9H), 0.49 (s, 3H), 0.35 (s, 3H); 13C NMR 
(CDCl3, 100 MHz) δ: 165.4, 164.8, 139.1, 137.5, 128.1, 128.1, 127.7, 127.6, 127.6, 
127.4, 82.8, 71.9, 68.7, 65.2, 56.3, 51.6, 44.4, 25.7, 18.1, -3.0, -4.0; HRMS (ESI+): 














-7-oxo-5-phenylhexahydropyrazolo[1,2-a]pyrazol-1-yl]-2-diazoacetate (59i): 66% 
yield, 1H NMR (CDCl3, 400 MHz) δ: 7.93 (d, J = 8.8 Hz, 2H), 7.37 (d, J = 8.8 Hz, 2H), 
7.20-7.13 (m, 5H), 4.80 (dd, J = 11.6, 7.2 Hz, 1H), 4.27 (dd, J = 12.4, 8.4 Hz, 1H), 3.83 
(s, 3H), 3.31 (dd, J = 11.6, 7.2 Hz, 1H), 3.02-2.95 (m, 2H), 2.64 (dd, J = 12.4, 11.2 Hz, 
1H), 0.92 (s, 9H), 0.46 (s, 3H), 0.33 (s, 3H); 13C NMR (CDCl3, 100 MHz) δ: 165.5, 
164.4, 147.2, 145.5, 138.1, 128.4, 128.3, 128.2, 127.5, 123.3, 82.7, 70.8, 69.8, 65.1, 
56.3, 51.6, 44.4, 25.6, 18.0, -3.0, -4.0; HRMS (ESI+): calcd for C27H34N5O6Si [M+H]+ 











(59j): 71% yield, 1H NMR (CDCl3, 400 MHz) δ: 7.17-7.11 (m, 7H), 6.64 (d, J = 8.8 
Hz, 2H), 4.60 (dd, J = 11.6, 6.8 Hz, 1H), 4.26 (dd, J = 10.0, 8.4, Hz, 1H), 3.82 (s, 3H), 
3.70 (s, 3H), 3.22 (dd, J = 10.0, 6.8 Hz, 1H), 3.08 (dd, J = 16.4, 8.4 Hz, 1H), 2.89 (dd, 
J = 16.4, 11.6 Hz, 1H), 2.70 (dd, J = 13.6, 11.2 Hz, 1H), 0.93 (s, 9H), 0.47 (s, 3H), 0.32 





127.5, 127.3, 113.5, 82.8, 71.4, 68.3, 65.2, 56.2, 55.2, 51.5, 44.3, 25.7, 18.0, -3.0, -4.0; 











78% yield, 1H NMR (CDCl3, 400 MHz) δ: 7.21-7.15 (m, 7H), 7.09 (d, J = 8.8 Hz, 2H), 
4.63 (dd, J = 11.6, 7.6 Hz, 1H), 4.24 (dd, J = 12.4, 8.4 Hz, 1H), 3.82 (s, 3H), 3.25 (dd, 
J = 16.4, 7.6 Hz, 1H), 3.07 (dd, J = 16.4, 8.4 Hz, 1H), 2.93 (dd, J = 16.4, 11.6, Hz, 1H), 
2.63 (dd, J = 16.4, 12.4, Hz, 1H), 0.92 (s, 9H), 0.45 (s, 3H), 0.32 (s, 3H); 13C NMR 
(CDCl3, 100 MHz) δ: 165.9, 165.1, 139.2, 137.2, 134.9, 131.6, 129.6, 128.7, 128.3, 
127.8, 121.8, 116.3, 83.2, 71.5, 69.3, 65.5, 56.7, 52.0, 44.7, 26.0, 18.4, -2.6, -3.6; 
















72% yield, 1H NMR (CDCl3, 400 MHz) δ: 7.38 (s, 1H), 7.23-7.11 (m, 7H), 6.96 (t, J = 
8.0 Hz, 1H), 4.63 (dd, J = 11.6, 7.2 Hz, 1H), 4.25 (dd, J = 11.6, 8.4, Hz, 1H), 3.83 (s, 
3H), 3.27 (dd, J = 11.6, 7.2, Hz, 1H), 3.03 (dd, J = 16.4, 8.4 Hz, 1H), 2.93 (dd, J = 16.4, 
8.4 Hz, 1H), 2.67 (dd, J = 16.4, 11.6 Hz, 1H), 0.93 (s, 9H), 0.47 (s, 3H), 0.34 (s, 3H); 
13C NMR (CDCl3, 100 MHz) δ: 165.4, 164.5, 140.1, 138.5, 130.8, 130.6, 129.6, 128.2, 
128.0, 127.5, 126.0, 122.1, 82.7, 71.0, 69.3, 56.2, 51.6, 44.4, 25.6, 18.0, -3.0, -4.0; 










oxo-5-phenylhexahydropyrazolo[1,2-a]pyrazol-1-yl]-2-diazoacetate (59m): 56% 
yield, 1H NMR (CDCl3, 400 MHz) δ: 7.48-7.46 (m, 2H), 7.39-7.29 (m, 3H), 4.19 (dd, 
J = 12.4, 8.0 Hz, 1H), 3.75 (s, 3H), 3.46-3.40 (m, 1H), 2.96 (dd, J = 12.4, 8.0 Hz, 1H), 
2.80-2.73 (m, 2H), 2.51 (dd, J = 13.2, 7.2 Hz, 1H), 1.66-1.50 (m, 5H), 1.04-0.75 (m, 
15H), 0.40 (s, 3H), 0.27 (s, 3H); 13C NMR (CDCl3, 100 MHz) δ: 165.2, 163.8, 140.2, 
128.5, 128.0, 127.4, 82.4, 72.4, 70.3, 65.1, 51.4, 47.3, 45.9, 37.7, 30.6, 26.5, 26.5, 26.4, 













1H-pyrazolo[1,2-a]pyridazine-6-carboxylate (60b): 72% yield; 1H NMR (400 MHz, 
CDCl3) δ: 7.48-7.31 (m, 5H), 3.72 (s, 3H), 3.65 (dd, J = 9.9, 4.6 Hz, 1H), 3.22 (ddd, J 
= 11.2, 8.7, 6.7 Hz, 1H), 2.87-2.77 (m, 2H), 2.70 (dd, J = 16.9, 9.9 Hz, 1H), 2.63-2.33 
(m, 2H), 1.07 (s, 9H), 0.25 (s, 3H), 0.23 (s, 3H). 13C NMR (100 MHz, CDCl3) δ: 171.0, 
167.7, 149.0, 139.8, 129.4, 128.9, 128.3, 94.3, 66.6, 51.4, 47.3, 35.6, 31.5, 26.1, 18.7, 








1H-pyrazolo[1,2-a]pyridazine-6-carboxylate (60b): 72% yield, 1H NMR (400 MHz, 
CDCl3) δ: 7.24 (d, J = 8.3 Hz, 2H), 7.20 (d, J = 8.3 Hz, 2H), 3.72 (s, 3H), 3.62 (dd, J = 
9.8, 4.6 Hz, 1H), 3.21 (ddd, J = 11.2, 8.7, 6.6 Hz, 1H), 2.90-2.74 (m, 2H), 2.69 (dd, J 
= 16.9, 9.8 Hz, 1H), 2.60-2.41 (m, 2H), 2.38 (s, 3H), 1.07 (s, 9H), 0.25 (s, 3H), 0.23 (s, 





94.3, 66.3, 51.4, 47.2, 35.5, 31.6, 26.1, 21.6, 18.7, -3.79, -3.82. HRMS (ESI+): calcd 








tetrahydro-1H-pyrazolo[1,2-a]pyridazine-6-carboxylate (60c): 73% yield, 1H 
NMR (400 MHz, CDCl3) δ: 7.38 (d, J = 8.0 Hz, 2H), 7.30 (d, J = 8.0 Hz, 2H), 3.72 (s, 
3H), 3.64 (dd, J = 10.0, 4.5 Hz, 1H), 3.22 (ddd, J = 11.1, 8.7, 6.6 Hz, 1H), 2.80 (m, 
2H), 2.64 (dd, J = 16.8, 10.0 Hz, 1H), 2.60-2.40 (m, 2H), 1.07 (s, 9H), 0.25 (s, 3H), 
0.23 (s, 3H). 13C NMR (100 MHz, CDCl3) δ: 170.7, 167.6, 149.0, 138.3, 134.7, 129.6, 
129.6, 94.0, 65.9, 51.5, 47.3, 35.6, 31.5, 26.1, 18.7, -3.79, -3.81. HRMS (ESI+): calcd 









tetrahydro-1H-pyrazolo[1,2-a]pyridazine-6-carboxylate (60d): 64% yield, 1H 





J = 7.6, 0.9 Hz, 1H), 6.93 (dd, J = 8.3, 0.9 Hz, 1H), 4.34 (dd, J = 9.9, 4.6 Hz, 1H), 3.86 
(s, 3H), 3.72 (s, 3H), 3.28 (ddd, J = 11.4, 8.6, 7.8 Hz, 1H), 2.90 (ddd, J = 11.4, 8.6, 6.8 
Hz, 1H), 2.76 (dd, J = 16.8, 4.6 Hz, 1H), 2.69-2.54 (m, 2H), 2.52-2.33 (m, 1H), 1.07 
(s, 9H), 0.26 (s, 3H), 0.25 (s, 3H). 13C NMR (100 MHz, CDCl3) δ: 172.1, 167.8, 157.6, 
148.9, 129.4, 128.6, 127.8, 121.7, 111.0, 94.8, 57.1, 56.0, 51.4, 46.6, 34.0, 31.6, 26.1, 









tetrahydro-1H-pyrazolo[1,2-a]pyridazine-6-carboxylate (60e): 76% yield, 1H 
NMR (400 MHz, CDCl3) δ: 7.27 (d, J = 8.7 Hz, 2H), 6.93 (d, J = 8.7 Hz, 2H), 3.84 (s, 
3H), 3.72 (s, 3H), 3.61 (dd, J = 9.8, 4.6 Hz, 1H), 3.19 (ddd, J = 11.1, 8.7, 6.6 Hz, 1H), 
2.90-2.74 (m, 2H), 2.68 (dd, J = 16.9, 9.8 Hz, 1H), 2.59-2.36 (m, 2H), 1.07 (s, 9H), 
0.25 (s, 3H), 0.23 (s, 3H). 13C NMR (100 MHz, CDCl3) δ: 171.0, 167.8, 160.1, 148.9, 
131.6, 129.4, 114.7, 94.3, 65.9, 55.7, 51.4, 47.1, 35.5, 31.6, 26.1, 18.7, -3.79, -3.82. 












tetrahydro-1H-pyrazolo[1,2-a]pyridazine-6-carboxylate (60f): 77% yield, 1H NMR 
(400 MHz, CDCl3) δ: 3.72 (s, 3H), 3.48 (ddd, J = 10.0, 8.3, 4.4 Hz, 1H), 2.91 (td, J = 
10.0, 8.3 Hz, 1H), 2.73-2.48 (m, 3H), 2.48-2.38 (m, 2H), 1.80 (m, 5H), 1.56 (m, 1H), 
1.40-1.12 (m, 5H), 1.04 (s, 9H), 0.19 (s, 3H), 0.15 (s, 3H). 13C NMR (100 MHz, CDCl3) 
δ: 169.0, 168.4, 148.9, 92.9, 65.6, 51.4, 47.4, 39.1, 32.6, 30.5, 27.3, 27.1, 26.7, 26.6, 
26.2, 25.3, 18.6, -3.78, -3.81. HRMS (ESI+): calcd for C21H37N2O4Si [M+H]+ 









tetrahydro-1H-pyrazolo[1,2-a]pyridazine-6-carboxylate (60g): 73% yield, 1H 
NMR (400 MHz, CDCl3) δ: 7.46-7.30 (m, 5H), 6.70 (d, J = 15.9 Hz, 1H), 6.09 (dd, J 
= 15.9, 8.8 Hz, 1H), 3.74 (s, 3H), 3.52-3.33 (m, 2H), 3.27 (dt, J = 11.3, 8.8 Hz, 1H), 
2.72 (dd, J = 16.8, 4.7 Hz, 1H), 2.68 – 2.51 (m, 3H), 1.06 (s, 9H), 0.24 (s, 3H), 0.22 (s, 





126.5, 92.9, 64.1, 51.0, 46.5, 32.6, 31.1, 25.7, 18.3, -4.29, -4.33. HRMS (ESI+): calcd 
for C23H33N2O4Si [M+H]+ 429.2210, found 429.2230.  
 
Methyl (1RS,8SR)-5-(tert-Butyldimethylsilyl)oxy-3-oxo-1,8-diphenyl-
2,3,7,8-tetrahydro-1H-pyrazolo[1,2-a]pyridazine-6-carboxylate (60h): 83% yield, 
1H NMR (CDCl3, 400 MHz) δ: 7.34-7.23 (m, 10H), 4.32 (dd, J = 7.6, 3.2 Hz, 1H), 3.93 
(t, J = 7.6 Hz, 1H), 3.72 (s, 3H), 3.22 (dd, J = 18.0, 9.6 Hz, 1H), 2.81 (d, J = 7.6 Hz, 
1H), 2.71 (dd, J = 18.0, 3.2 Hz, 1H), , 1.01 (s, 9H), 0.21 (s, 3H), 0.07 (s, 3H); 13C NMR 
(CDCl3, 100 MHz) δ: 171.9, 167.0, 148.0, 141.1, 139.7, 128.9, 128.4, 128.4, 127.8, 
127.4, 126.4, 95.1, 66.2, 57.7, 51.1, 37.5, 35.7, 25.6, 18.3, -4.3, -4.4; HRMS (ESI+): 






















Hz, 2H), 7.28-7.20 (m, 5H), 4.19 (dd, J = 9.2, 4.4 Hz, 1H), 4.05 (dd, J = 9.2, 4.4 Hz, 
1H), 3.73 (s, 3H), 3.20 (dd, J = 17.6, 8.8, Hz, 1H), 2.83-2.68 (m, 3H), 1.02 (s, 9H), 0.22 
(s, 3H), 0.11 (s, 3H); 13C NMR (CDCl3, 100 MHz) δ: 170.4, 166.8, 148.1, 147.80, 
146.8, 140.4, 128.8, 128.6, 127.8, 126.3, 123.9, 94.3, 66.0, 59.6, 51.2, 38.4, 35.4, 25.6, 





(60j): 88% yield, 1H NMR (CDCl3, 400 MHz) δ: 7.31-7.21 (m, 7H), 6.83 (d, J = 8.4 
Hz, 2H), 4.31 (dd, J = 9.2, 3.2, Hz, 1H), 3.86 (dd, J = 8.4, 6.8 Hz, 1H), 3.79 (s, 3H), 
3.72 (s, 3H), 3.20 (dd, J = 13.6, 9.2 Hz, 1H), 2.78 (d, J = 8.4 Hz, 2H), 2.71 (dd, J = 
17.6, 3.2 Hz, 1H), 1.00 (s, 9H), 0.20 (s, 3H), 0.06 (s, 3H); 13C NMR (CDCl3, 100 MHz) 
δ: 171.8, 167.1, 159.6, 148.0, 141.2, 131.5, 129.0, 128.3, 127.3, 126.40, 114.3, 95.1, 
65.6, 57.6, 55.3, 51.1, 37.6, 35.7, 25.6, 18.3, -4.3, -4.4; HRMS (ESI+): calcd for 















(60k): 87% yield, 1H NMR (CDCl3, 400 MHz) δ: 7.40 (d, J = 8.8 Hz, 2H), 7.30-7.22 
(m, 5H), 7.19 (d, J = 8.8 Hz, 2H), 4.25 (dd, J = 8.0, 4.0 Hz, 1H), 3.89 (dd, J = 9.2, 4.0 
Hz, 1H), 3.72 (s, 3H), 3.20 (dd, J = 17.6, 8.0 Hz, 1H), 2.79-2.65 (m, 3H), 1.00 (s, 9H), 
0.20 (s, 3H), 0.08 (s, 3H); 13C NMR (CDCl3, 100 MHz) δ: 171.3, 166.9, 148.0, 140.8, 
138.6, 132.0, 129.5, 128.4, 127.5, 126.3, 122.3, 94.7, 65.7, 58.4, 51.1, 37.9, 35.6, 25.6, 
























8.0 Hz, 1H), 7.31-7.23 (m, 6H), 7.16 (t, J = 8.0 Hz, 1H), 4.26 (dd, J = 9.2, 4.0 Hz, 1H), 
3.88 (dd, J = 9.2, 6.0 Hz, 1H), 3.72 (s, 3H), 3.19 (dd, J = 18.0, 9.2 Hz, 1H), 2.78-2.68 
(m, 3H), 1.01 (s, 9H), 0.20 (s, 3H), 0.09 (s, 3H); 13C NMR (CDCl3, 100 MHz) δ: 171, 
166.9, 148.0, 141.8, 140.7, 131.6, 131.1, 130.4, 128.5, 127.6, 126.4, 126.4, 126.4, 
126.4, 122.8, 94.7, 66.0, 58.8, 51.1, 38.0, 35.5, 25.6, 18.3, -4.3, -4.4; HRMS (ESI+): 
calcd for C27H34BrN2O4Si [M+H]+ 557.1471, found 557.1473. 
 
Methyl (1RS,8SR)-5-(tert-Butyldimethylsilyl)oxy-8-cyclohexyl-3-oxo-1-
phenyl- 2,3,7,8-tetrahydro-1H-pyrazolo[1,2-a]pyridazine-6-carboxylate (60m): 
65% yield, 1H NMR (CDCl3, 400 MHz) δ: 7.48 (d, J = 7.2 Hz, 2H), 7.40 (t, J = 7.2 Hz, 
2H), 7.33-7.28 (m, 1H), 4.56 (t, J = 8.4 Hz, 1H), 3.74 (s, 3H), 3.07 (dd, J = 18.0, 11.6 
Hz, 1H), 2.87-2.84 (m, 1H), 2.73-2.59 (m, 2H), 2.34 (dd, J = 16.4, 3.6 Hz, 1H), 1.76-
0.85 (m, 20H), 0.17 (s, 3H), 0.04 (s, 3H); 13C NMR (CDCl3, 100 MHz) δ: 169.8, 167.5, 
147.5, 140.6, 128.6, 127.8, 127.0, 94.9, 65.5, 59.2, 51.1, 39.6, 39.5, 30.1, 26.8, 26.4, 
25.9, 25.7, 25.7, 25.6, 18.2, -4.4, -4.5; HRMS (ESI+): calcd for C27H41N2O4Si [M+H]+ 

















pyrazolo-[1,2-a]pyrazol-1(5H)-ylidene]acetate (61a): 23% yield (Reaction catalyzed 
by 1 mol% Rh2(OAc)4 at 40°C for 3h), 1H NMR (400 MHz, CDCl3) δ: 7.51-7.33 (m, 
5H), 3.82 (s, 3H), 3.72 (dd, J = 10.4, 7.0 Hz, 1H), 3.59 (dt, J = 12.0, 9.7 Hz, 1H), 3.37 
(dd, J = 17.0, 7.0 Hz, 1H), 3.06 (ddd, J = 12.0, 9.7, 7.0 Hz, 1H), 2.87 (dd, J = 17.0, 
10.4 Hz, 1H), 2.82-2.63 (m, 2H), 0.94 (s, 9H), 0.23 (s, 3H), 0.17 (s, 3H). 13C NMR 
(100 MHz, CDCl3) δ: 171.6, 165.7, 137.9, 130.6, 129.3, 128.9, 128.2, 126.8, 69.3, 52.4, 
45.5, 41.3, 31.4, 26.2,18.8, -3.8, -4.0. HRMS (ESI+): calcd for C21H31N2O4Si [M+H]+ 










diphenyltetra-hydropyrazolo[1,2-a]pyrazol-1(5H)-ylidene]acetate (61h): 75% 
yield, 1H NMR (CDCl3, 400 MHz) δ: 7.36-7.21 (m, 10H), 4.30 (dd, J = 9.2, 7.2 Hz, 
1H), 3.88 (dd, J = 10.0, 7.2 Hz, 1H), 3.90 (m, 1H), 3.82 (s, 3H), 3.46 (dd, J = 17.6, 7.2 
Hz, 1H), 3.27 (dd, J = 17.6, 13.6 Hz, 1H), 2.92-2.83 (m, 2H), 0.94 (s, 9H), 0.25 (s, 3H), 





128.5, 128.3, 127.7, 127.5, 126.5, 125.7, 69.9, 62.3, 52.0, 40.9, 40.4, 25.8, 18.4, -4.2, -










72% yield, 1H NMR (CDCl3, 400 MHz) δ: 8.11 (d, J = 8.8 Hz, 2H), 7.53 (d, J = 8.8 
Hz, 2H), 7.32-7.23 (m, 5H), 4.27 (t, J = 8.8 Hz, 1H), 4.09 (dd, J = 10.0, 8.0 Hz, 1H), 
3.84 (s, 3H), 3.54 (dd, J = 17.2, 8.0 Hz, 1H), 3.23 (dd, J = 17.2, 9.2 Hz, 1H), 2.97 (dd, 
J = 17.2, 8.0 Hz, 1H), 2.86 (dd, J = 17.2, 10.0 Hz, 1H), 0.92 (s, 9H), 0.25 (s, 3H), 0.15 
(s, 3H); 13C NMR (CDCl3, 100 MHz) δ: 167.7, 165.1, 147.7, 145.5, 140.2, 130.1, 128.7, 
128.4, 128.0, 126.6, 124.0, 123.8, 68.9, 64.8, 52.0, 41.4, 40.9, 25.7, 18.4, -4.12, -4.4; 














(61j): 71% yield, 1H NMR (CDCl3, 400 MHz) δ: 7.31-7.22 (m, 7H), 6.82 (d, J = 8.4 
Hz, 2H), 4.28 (dd, J = 9.6, 6.4 Hz, 1H), 3.83-3.81 (m, 1H), 3.79 (s, 3H), 3.78 (s, 3H), 
3.36 (dd, J = 16.8, 7.6 Hz, 1H), 3.27 (dd, J = 16.8, 7.6 Hz, 1H), 2.89-2.82 (m, 2H), 0.94 
(s, 9H), 0.25 (s, 3H), 0.16 (s, 3H); 13C NMR (CDCl3, 100 MHz) δ: 169.5, 165.3, 159.6, 
141.7, 130.0, 129.2, 128.8, 128.5, 127.4, 126.4, 125.9, 114.1, 69.4, 61.8, 55.3, 51.9, 
40.9, 40.2, 25.8, 18.4, -4.2, -4.4; HRMS (ESI+): calcd for C28H37N2O5Si [M+H]+ 










(61k): 77% yield, 1H NMR (CDCl3, 400 MHz) δ: 7.40 (d, J = 8.8 Hz, 2H), 7.29-7.20 
(m, 7H), 4.25 (dd, J = 10.0, 3.6 Hz, 1H), 3.86-3.84 (m, 1H), 3.81 (s, 3H), 3.39 (dd, J = 
8.0, 3.6 Hz, 1H), 3.24 (dd, J = 16.0, 8.0 Hz, 1H), 2.90-2.77 (m, 2H), 0.93 (s, 9H), 0.24 
(s, 3H), 0.15 (s, 3H); 13C NMR (CDCl3, 100 MHz) δ: 168.9, 165.2, 141.1, 136.7, 131.8, 

















(61l): 71% yield, 1H NMR (CDCl3, 400 MHz) δ: 7.48 (t, J = 1.6 Hz, 1H), 7.37-7.24 
(m, 7H), 7.14 (t, J = 8.0 Hz, 1H), 4.25 (dd, J = 13.2, 10.8 Hz, 1H), 3.86 (dd, J = 10.8, 
3.6 Hz, 1H), 3.82 (s, 3H), 3.46 (dd, J = 16.8, 8.0 Hz, 1H), 3.23 (dd, J = 16.8, 9.2 Hz, 
1H), 2.94-2.80 (m, 3H), 0.94 (s, 9H), 0.24 (s, 3H), 0.16 (s, 3H); 13C NMR (CDCl3, 100 
MHz) δ: 168.8, 165.5, 141.13, 140.4, 131.7, 131.2, 130.6, 130.5, 129.0, 128.2, 127.0, 
126.5, 125.1, 123.0, 69.6, 63.9, 52.4, 41.3, 41.3, 26.2, 18.8, -3.8, -4.0; HRMS (ESI+): 














yield, 1H NMR (CDCl3, 400 MHz) δ: 7.49 (d, J = 7.2 Hz, 2H), 7.40 (t, J = 7.2 Hz, 2H), 
7.32-7.28 (m, 1H), 4.21 (dd, J = 10.0, 8.8 Hz, 1H), 3.79 (s, 3H), 3.05 (dd, J = 16.4, 8.0 
Hz, 1H), 2.96-2.70 (m, 4H), 1.68-0.84 (m, 20H), 0.23 (s, 3H), 0.19 (s, 3H); 13C NMR 
(CDCl3, 100 MHz) δ: 165.9, 165.3, 140.7, 129.4, 128.7, 128.0, 127.0, 125.0, 70.4, 67.5, 
51.8, 43.1, 39.0, 32.4, 30.3, 26.8, 26.4, 26.3, 25.8, 18.4, -4.1, -4.4; HRMS (ESI+): calcd 








1H-pyrazolo[1,2-a]pyridazine-5-carboxylate (62a): 86% yield, 1H NMR (400 MHz, 
CDCl3) δ: 7.47-7.31 (m, 5H), 3.98-3.73 (m, 4H), 3.39 (dt, J = 11.6, 8.9 Hz, 1H), 2.93 
(s, 1H), 2.71-2.29 (m, 4H), 0.94 (s, 9H), 0.21 (s, 3H), 0.20 (s, 3H). 13C NMR (100 MHz, 
CDCl3) δ: 168.7, 161.9, 147.6, 139.2, 129.2, 128.7, 127.6, 113.3, 66.1, 51.9, 46.5, 39.9, 













1H-pyrazolo[1,2-a]pyridazine-5-carboxylate (62b): 85% yield, 1H NMR (400 MHz, 
CDCl3) δ: 7.24 (s, 4H), 3.85 (m, 4H), 3.38 (dt, J = 11.6, 8.6 Hz, 1H), 2.98-2.88 (m, 
1H), 2.70-2.41 (m, 4H), 2.40 (s, 3H), 0.95 (s, 9H), 0.22 (s, 3H), 0.20 (s, 3H). 13C NMR 
(100 MHz, CDCl3) δ: 169.6, 162.6, 148.8, 139.0, 136.4, 130.3, 128.1, 113.5, 66.1, 52.4, 
46.8, 40.6, 30.0, 25.9, 21.6, 18.5, -3.4, -3.5. HRMS (ESI+): calcd for C22H33N2O4Si 








tetrahydro-1H-pyrazolo[1,2-a]pyridazine-5-carboxylate (62c): 80% yield, 1H 
NMR (400 MHz, CDCl3) δ: 7.41 (d, J = 8.5 Hz, 2H), 7.30 (d, J = 8.5 Hz, 2H), 3.99-
3.82 (m, 4H), 3.41 (dt, J = 11.5, 9.0 Hz 1H), 2.95-2.85 (m, 1H), 2.73-2.35 (m, 4H), 
0.95 (s, 9H), 0.22 (s, 3H), 0.20 (s, 3H). 13C NMR (100 MHz, CDCl3) δ: 169.0, 162.3, 
147.6, 138.1, 135.0, 130.0, 129.4, 113.8, 65.9, 52.4, 47.0, 40.4, 30.0, 25.9, 18.5, -3.4, -













tetrahydro-1H-pyrazolo[1,2-a]pyridazine-5-carboxylate (62d): 86% yield, 1H 
NMR (400 MHz, CDCl3) δ: 7.39 (dd, J = 7.5, 1.5 Hz, 1H), 7.33 (ddd, J = 8.3, 7.5, 1.5 
Hz, 1H), 7.05 (td, J = 7.5, 0.8 Hz, 1H), 6.94 (dd, J = 8.3, 0.8 Hz, 1H), 4.59-4.50 (m, 
1H), 3.86 (s, 3H), 3.84 (s, 3H), 3.45 (dt, J = 11.7, 8.8 Hz, 1H), 3.10-2.87 (m, 1H), 2.78-
2.30 (m, 4H), 0.95 (s, 9H), 0.22 (s, 3H), 0.20 (s, 3H). 13C NMR (100 MHz, CDCl3) δ: 
170.2, 162.4, 157.4, 149.5, 129.7, 128.3, 127.5, 121.9, 113.5, 111.1, 55.9, 52.3, 46.6, 
39.0, 30.2, 25.9, 25.8, 25.6, 18.6, -3.4, -3.5. HRMS (ESI+): calcd for C22H33N2O5Si 








tetrahydro-1H-pyrazolo[1,2-a]pyridazine-5-carboxylate (62e): 78% yield, 1H 
NMR (400 MHz, CDCl3) δ: 7.27 (d, J = 8.7 Hz, 2H), 6.95 (d, J = 8.7 Hz, 2H), 3.97-





0.95 (s, 9H), 0.22 (s, 3H), 0.20 (s, 3H). 13C NMR (100 MHz, CDCl3) δ: 169.4, 162.5, 
160.2, 148.4, 131.5, 129.3, 114.9, 113.7, 65.9, 55.7, 52.4, 46.7, 40.4, 30.0, 25.9, 18.6, 








tetrahydro-1H-pyrazolo[1,2-a]pyridazine-5-carboxylate (62f): 77% yield, 1H NMR 
(400 MHz, CDCl3) δ: 3.79 (s, 3H), 3.60 (ddd, J = 10.5, 8.7, 6.6 Hz, 1H), 3.06 (dt, J = 
10.5, 8.7 Hz, 1H), 2.81-2.73 (m, 1H), 2.64-2.57 (m, 2H), 2.39 (dd, J = 17.4, 9.8 Hz, 
1H), 2.13 (dd, J = 17.4, 4.8 Hz, 1H), 1.90-1.67 (m, 5H), 1.54 (d, J = 12.2 Hz, 1H), 1.36-
0.98 (m, 6H), 0.94 (s, 9H), 0.22 (s, 3H), 0.19 (s, 3H). 13C NMR (100 MHz, CDCl3) δ: 
166.9, 162.5, 146.5, 113.4, 65.6, 52.3, 47.4, 39.2, 31.5, 30.9, 30.7, 30.1, 27.5, 27.5, 
27.0, 26.9, 26.5, 26.0, 25.9, 25.0, 18.5, -3.3, -3.6. HRMS (ESI+): calcd for 














NMR (400 MHz, CDCl3) δ: 7.45-7.28 (m, 5H), 6.67 (d, J = 15.9 Hz, 1H), 6.03 (dd, J 
= 15.9, 8.9 Hz, 1H), 3.81 (s, 3H), 3.64-3.46 (m, 2H), 3.46-3.26 (m, 1H), 2.84-2.26 (m, 
4H), 0.94 (s, 9H), 0.22 (s, 3H), 0.20 (s, 3H). 13C NMR (100 MHz, CDCl3) δ: 169.3, 
162.3, 147.6, 136.0, 135.3, 129.2, 128.9, 127.0, 113.6, 64.9, 52.4, 46.6, 38.0, 30.1, 25.9, 










2,3,7,8-tetrahydro-1H-pyrazolo[1,2-a]pyridazine-5-carboxylate (62h): 72% yield; 
1H NMR (CDCl3, 400 MHz) δ: 7.32-7.17 (m, 10H), 4.20 (dd, J = 12.0, 4.0 Hz, 1H), 
4.11 (dd, J = 8.0, 4.0 Hz, 1H), 3.83 (s, 3H), 3.20 (dd, J = 16.0, 8.0 Hz, 1H), 2.68-2.58 
(m, 3H), 0.95 (s, 9H), 0.24 (s, 3H), 0.21 (s, 3H); 13C NMR (CDCl3, 100 MHz) δ: 168.6, 
161.7, 150.4, 142.4, 139.1, 129.0, 128.7, 128.5, 127.8, 127.3, 126.4, 112.8, 67.5, 59.6, 
51.9, 40.9, 37.5, 25.5, 18.2, -3.73, -3.76; HRMS (ESI+): C27H35N2O4Si [M+H]+ 
479.2366, found 479.2309. 
NMR graphs and HPLC chromatograms can be obtained from the supporting 
information of the paper published in the Journal of the American Chemical Society: 
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